1.1 	A bill for an act
1.2 	relating to cannabis; modifying cannabis business, hemp business, and cannabis 
1.3 	event organizer license and endorsement provisions; establishing a cannabis 
1.4 	macrobusiness license; modifying labeling requirements for cannabinoid products 
1.5 	and lower-potency hemp edibles; modifying studies and an annual market analysis 
1.6 	conducted by the Office of Cannabis Management; providing that data reported 
1.7 	to the Office of Cannabis Management through statewide monitoring system is 
1.8 	not public data; modifying provisions related to public data on cannabis business 
1.9 	license applicants and license holders; modifying provisions relating to local unit 
1.10 	of government's regulation of cannabis businesses; defining ratio hemp-infused 
1.11 	cannabis product; requiring reports;amending Minnesota Statutes 2024, sections 
1.12 	342.01, subdivisions 14, 20, 52, 54, by adding a subdivision; 342.02, subdivision 
1.13 	2; 342.07, subdivision 3; 342.09, subdivision 3; 342.15, subdivisions 2, 5; 342.175; 
1.14 	342.19, subdivision 6; 342.20, subdivisions 1, 2, 3; 342.22, subdivisions 1, 4, 5; 
1.15 	342.23, subdivision 5; 342.25, subdivisions 1, 2, 3, 4, 5, 6, 7; 342.26, subdivisions 
1.16 	1, 2, 3, 4, 5; 342.27, subdivisions 1, 2, 12, by adding a subdivision; 342.28, 
1.17 	subdivisions 6, 7, 9, 11, by adding subdivisions; 342.29, subdivisions 5, 6, 8, 8a, 
1.18 	10, by adding subdivisions; 342.30, subdivision 3, by adding a subdivision; 342.31, 
1.19 	subdivisions 3, 5; 342.32, subdivision 3, by adding a subdivision; 342.35, 
1.20 	subdivision 1; 342.37, subdivision 1; 342.39, as amended; 342.40, subdivision 1; 
1.21 	342.41, subdivision 1; 342.44, subdivision 2; 342.45, subdivision 3; 342.51, by 
1.22 	adding subdivisions; 342.515, as amended; 342.61, subdivision 5; 342.63, 
1.23 	subdivision 4, by adding a subdivision; 342.66, subdivision 3; 342.80; Minnesota 
1.24 	Statutes 2025 Supplement, sections 342.01, subdivision 48; 342.04; 342.10; 342.11; 
1.25 	342.12; 342.13; 342.14, subdivisions 3, 6; 342.16; 342.18, subdivision 2; 342.22, 
1.26 	subdivision 3; 342.28, subdivision 8; 342.29, subdivision 7; 342.30, subdivision 
1.27 	1; 342.32, subdivision 1; 342.40, subdivision 7; 342.43, subdivision 2; 342.44, 
1.28 	subdivision 1; 342.46, subdivision 8; 342.51, subdivision 2; 342.61, subdivision 
1.29 	4; 342.62, subdivision 2; 342.63, subdivisions 2, 3, 5, 6; proposing coding for new 
1.30 	law in Minnesota Statutes, chapter 342; repealing Minnesota Statutes 2024, sections 
1.31 	151.72, subdivisions 1, 2, 4, 5, 5b, 5c, 6, 7; 342.51, subdivision 1; Minnesota 
1.32 	Statutes 2025 Supplement, section 151.72, subdivisions 3, 5a.
2.1 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

2.2 	ARTICLE 1
2.3 	OFFICE OF CANNABIS MANAGEMENT POLICY AND TECHNICAL 
2.4 	PROVISIONS

2.5 	Section 1. Minnesota Statutes 2024, section 342.02, subdivision 2, is amended to read:
2.6 		Subd. 2.Powers and duties. (a) The office has the following powers and duties:
2.7 	(1) to develop, maintain, and enforce an organized system of regulation for the cannabis 
2.8 	industry and hemp consumer industry;
2.9 	(2) to establish programming, services, and notification to protect, maintain, and improve 
2.10 	the health of citizens;
2.11 	(3) to prevent unauthorized access to cannabis flower, cannabis products, lower-potency 
2.12 	hemp edibles, and hemp-derived consumer products by individuals under 21 years of age;
2.13 	(4) to establish and regularly update standards for product manufacturing, testing, 
2.14 	packaging, and labeling, including requirements for an expiration, sell-by, or best-used-by 
2.15 	date;
2.16 	(5) to promote economic growth with an emphasis on growth in areas that experienced 
2.17 	a disproportionate, negative impact from cannabis prohibition;
2.18 	(6) to issue and renew licenses;
2.19 	(7) to require fingerprints from individuals determined to be subject to fingerprinting, 
2.20 	including the submission of fingerprints to the Federal Bureau of Investigation where 
2.21 	required by law and to obtain criminal conviction data for individuals seeking a license 
2.22 	from the office on the individual's behalf or as a cooperative member or director, manager, 
2.23 	or general partner of a business entity;
2.24 	(8) to receive reports required by this chapter and inspect the premises, records, books, 
2.25 	and other documents of license holders to ensure compliance with all applicable laws and 
2.26 	rules;
2.27 	(9) to authorize the use of unmarked motor vehicles to conduct seizures or investigations 
2.28 	pursuant to the office's authority;
2.29 	(10) to impose and collect civil and administrative penalties as provided in this chapter;
3.1 	(11) to publish such information as may be deemed necessary for the welfare of cannabis 
3.2 	businesses, cannabis workers, hemp businesses, and hemp workers and the health and safety 
3.3 	of citizens;
3.4 	(12) to make loans and grants in aid to the extent that appropriations are made available 
3.5 	for that purpose;
3.6 	(13) to authorize research and studies on cannabis flower, cannabis products, artificially 
3.7 	derived cannabinoids, lower-potency hemp edibles, hemp-derived consumer products, the 
3.8 	cannabis industry, and the hemp consumer industry;
3.9 	(14) to provide reports as required by law;
3.10 	(15) to develop a warning label regarding the effects of the use of cannabis flower and 
3.11 	cannabis products by persons 25 years of age or younger;
3.12 	(16) to determine, based on a review of medical and scientific literature, whether it is 
3.13 	appropriate to require additional health and safety warnings containing information that is 
3.14 	both supported by credible science and helpful to consumers in considering potential health 
3.15 	risks from the use of cannabis flower, cannabis products, lower-potency hemp edibles, and 
3.16 	hemp-derived consumer products, including but not limited to warnings regarding any risks 
3.17 	associated with use by pregnant or breastfeeding individuals, or by individuals planning to 
3.18 	become pregnant, and the effects that use has on brain development for individuals under 
3.19 	the age of 25;
3.20 	(17) to establish limits on the potency of cannabis flower and cannabis products that can 
3.21 	be sold to customers by licensed cannabis retailers, licensed cannabis microbusinesses, and 
3.22 	licensed cannabis mezzobusinesses with an endorsement to sell cannabis flower and cannabis 
3.23 	products to customers;
3.24 	(18) to establish rules authorizing an increase in plant canopy limits and outdoor 
3.25 	cultivation limits to meet market demand and limiting cannabis manufacturing consistent 
3.26 	with the goals identified in subdivision 1;
3.27 	(19) to order a person or business that cultivates cannabis flower or manufactures or 
3.28 	produces cannabis products, medical cannabinoid products, artificially derived cannabinoids, 
3.29 	lower-potency hemp edibles, hemp-derived consumer products, or hemp-derived topical 
3.30 	products to recall any cannabis flower, product, or ingredient containing cannabinoids that 
3.31 	is used in a product if the office determines that the flower, product, or ingredient represents 
3.32 	a risk of causing a serious adverse incident; and
3.33 	(20) to exercise other powers and authority and perform other duties required by law.
4.1 	(b) In addition to the powers and duties in paragraph (a), the office has the following 
4.2 	powers and duties until January 1, 2027:
4.3 	(1) to establish limits on the potency of adult-use cannabis flower and adult-use cannabis 
4.4 	products that can be sold to customers by licensed cannabis retailers, licensed cannabis 
4.5 	microbusinesses, and licensed cannabis mezzobusinesses with an endorsement to sell 
4.6 	adult-use cannabis flower and adult-use cannabis products to customers; and
4.7 	(2) to permit, upon application to the office in the form prescribed by the director of the 
4.8 	office, a licensee license holder under this chapter to perform any activity if such permission 
4.9 	is substantially necessary for the licensee license holder to perform any other activity 
4.10 	permitted by the applicant's license and is not otherwise prohibited by law.

4.11 	EFFECTIVE DATE. This section is effective the day following final enactment.

4.12 	Sec. 2. Minnesota Statutes 2025 Supplement, section 342.04, is amended to read:
4.13 	342.04 STUDIES; REPORTS.
4.14 		Subdivision 1.Studies required. (a) The office shall conduct a study to determine the 
4.15 	expected size and growth of the regulated cannabis industry and hemp consumer industry, 
4.16 	including an estimate of the demand for cannabis flower and cannabis products, the number 
4.17 	and geographic distribution of cannabis businesses needed to meet that demand, and the 
4.18 	anticipated business from residents of other states.
4.19 	(b) The office shall conduct a study to determine the size of the illicit cannabis market, 
4.20 	the sources of illicit cannabis flower and illicit cannabis products in the state, the locations 
4.21 	of citations issued and arrests made for cannabis offenses, and the subareas, such as census 
4.22 	tracts or neighborhoods, that experience a disproportionately large amount of cannabis 
4.23 	enforcement.
4.24 	(c) The office shall conduct a study on impaired driving to determine:
4.25 	(1) the number of accidents involving one or more drivers who admitted to using cannabis 
4.26 	flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products, 
4.27 	or who tested positive for cannabis or tetrahydrocannabinol;
4.28 	(2) the number of arrests of individuals for impaired driving in which the individual 
4.29 	tested positive for cannabis or tetrahydrocannabinol; and
4.30 	(3) the number of convictions for driving under the influence of cannabis flower, cannabis 
4.31 	products, lower-potency hemp edibles, hemp-derived consumer products, or 
4.32 	tetrahydrocannabinol.
5.1 	(d) The office shall provide preliminary reports on the studies conducted pursuant to 
5.2 	paragraphs (a) to (c) to the legislature by January 15, 2024, and shall provide final reports 
5.3 	to the legislature by January 15, 2025. The reports may be consolidated into a single report 
5.4 	by the office.
5.5 	(e) The office shall collect existing data from the Department of Human Services, 
5.6 	Department of Health, Direct Care and Treatment, Minnesota state courts, and hospitals 
5.7 	licensed under chapter 144 on the utilization of mental health and substance use disorder 
5.8 	services, emergency room visits, and commitments to identify any increase in the services 
5.9 	provided or any increase in the number of visits or commitments. The office shall also obtain 
5.10 	summary data from existing first episode psychosis programs on the number of persons 
5.11 	served by the programs and number of persons on the waiting list. All information collected 
5.12 	by the office under this paragraph shall be included in the report required under paragraph 
5.13 	(f).
5.14 		Subd. 2.Annual market analysis. (f) (a) The office shall conduct an annual market 
5.15 	analysis on the status of the regulated cannabis industry and submit a report of the findings. 
5.16 	An annual market analysis under this subdivision must include:
5.17 	(1) the number of licenses issued by the office;
5.18 	(2) recommendations on the number of licenses that the office should make available;
5.19 	(3) information about the stability of the regulated market, including an assessment of 
5.20 	the available supply and whether the supply is sufficient for consumer demand in the state;
5.21 	(4) the impact of unregulated sales of cannabis flower and cannabis products on the 
5.22 	regulated market; and
5.23 	(5) the status of the medical cannabis patient registry program.
5.24 	(b) The office may solicit the input of consumers, market stakeholders, and potential 
5.25 	new applicants for the annual market analysis under paragraph (a). The office shall submit 
5.26 	the report by January 15, 2025, and each January 15 thereafter and the report may be 
5.27 	combined with the annual report submitted by the office. The process of completing the 
5.28 	market analysis must include holding public meetings to solicit the input of consumers, 
5.29 	market stakeholders, and potential new applicants and must include an assessment as to 
5.30 	whether the office has issued the necessary number of licenses in order to: annual market 
5.31 	analysis under paragraph (a) as part of the annual report required in subdivision 3.
5.32 	(1) ensure the sufficient supply of cannabis flower and cannabis products to meet demand;
5.33 	(2) provide market stability;
6.1 	(3) ensure a competitive market; and
6.2 	(4) limit the sale of unregulated cannabis flower and cannabis products.
6.3 		Subd. 3.Annual report required. (g) (a) The office shall submit an annual report to 
6.4 	the legislature by January 15, 2024, and each January 15 thereafter year. The annual report 
6.5 	shall must include but not be limited to the following:
6.6 	(1) the status of the regulated cannabis industry;
6.7 	(2) the status of the illicit cannabis market and;
6.8 	(3) the status of the hemp consumer industrycommercial and consumer industries;
6.9 	(3) the number of accidents, arrests, and convictions involving drivers who admitted to 
6.10 	using cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
6.11 	consumer products or who tested positive for cannabis or tetrahydrocannabinol;
6.12 	(4) the change in potency, if any, of cannabis flower and cannabis products available 
6.13 	through the regulated market;
6.14 	(5) progress on providing opportunities to individuals and communities that experienced 
6.15 	a disproportionate, negative impact from cannabis prohibition, including but not limited to 
6.16 	providing relief from criminal convictions and increasing economic opportunities;
6.17 	(6) the status of racial and geographic diversity in the cannabis industry; and
6.18 	(7) proposed legislative changes, including but not limited to recommendations to 
6.19 	streamline licensing systems and related administrative processes;.
6.20 	(8) information on the adverse effects of second-hand smoke from any cannabis flower, 
6.21 	cannabis products, and hemp-derived consumer products that are consumed by the 
6.22 	combustion or vaporization of the product and the inhalation of smoke, aerosol, or vapor 
6.23 	from the product; and
6.24 	(9) recommendations for the levels of funding for:
6.25 	(i) a coordinated education program to address and raise public awareness about the top 
6.26 	three adverse health effects, as determined by the commissioner of health, associated with 
6.27 	the use of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
6.28 	consumer products by individuals under 21 years of age;
6.29 	(ii) a coordinated education program to educate pregnant individuals, breastfeeding 
6.30 	individuals, and individuals who may become pregnant on the adverse health effects of 
7.1 	cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
7.2 	products;
7.3 	(iii) training, technical assistance, and educational materials for home visiting programs, 
7.4 	Tribal home visiting programs, and child welfare workers regarding safe and unsafe use of 
7.5 	cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
7.6 	products in homes with infants and young children;
7.7 	(iv) model programs to educate middle school and high school students on the health 
7.8 	effects on children and adolescents of the use of cannabis flower, cannabis products, 
7.9 	lower-potency hemp edibles, hemp-derived consumer products, and other intoxicating or 
7.10 	controlled substances;
7.11 	(v) grants issued through the CanTrain, CanNavigate, CanStartup, and CanGrow 
7.12 	programs;
7.13 	(vi) grants to organizations for community development in social equity communities 
7.14 	through the CanRenew program;
7.15 	(vii) training of peace officers and law enforcement agencies on changes to laws involving 
7.16 	cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
7.17 	products and the law's impact on searches and seizures;
7.18 	(viii) training of peace officers to increase the number of drug recognition experts;
7.19 	(ix) training of peace officers on the cultural uses of sage and distinguishing use of sage 
7.20 	from the use of cannabis flower, including whether the Board of Peace Officer Standards 
7.21 	and Training should approve or develop training materials;
7.22 	(x) the retirement and replacement of drug detection canines; and
7.23 	(xi) the Department of Human Services and county social service agencies to address 
7.24 	any increase in demand for services.
7.25 	(g) In developing the recommended funding levels under paragraph (f), clause (9), items 
7.26 	(vii) to (xi), the office shall consult with local law enforcement agencies, the Minnesota 
7.27 	Chiefs of Police Association, the Minnesota Sheriff's Association, the League of Minnesota 
7.28 	Cities, the Association of Minnesota Counties, and county social services agencies.
7.29 	(b) The annual report under this subdivision must include:
7.30 	(1) an assessment of available data and updated information regarding the impact of 
7.31 	cannabis use on impaired driving;
8.1 	(2) an assessment of available data and updated information regarding the impact of the 
8.2 	adverse effects of secondhand smoke from cannabis flower and cannabis products;
8.3 	(3) updated information from the Department of Human Services, Department of Health, 
8.4 	Direct Care and Treatment, Minnesota state courts, and hospitals licensed under chapter 
8.5 	144 regarding the utilization of mental health and substance use disorder services, emergency 
8.6 	room visits, and civil commitments; and
8.7 	(4) updated information about existing summary data on first episode psychosis programs.
8.8 		Subd. 4.Collaboration with other agencies and organizations. The office must 
8.9 	collaborate with state agencies and leading organizations with expertise on cannabis-related 
8.10 	programs to support education, prevention, public safety initiatives, and industry and market 
8.11 	evaluations, including:
8.12 	(1) the Department of Employment and Economic Development;
8.13 	(2) the Department of Health;
8.14 	(3) the Department of Public Safety;
8.15 	(4) the Department of Education;
8.16 	(5) the Department of Human Services;
8.17 	(6) the Department of Children, Youth, and Families;
8.18 	(7) Direct Care and Treatment;
8.19 	(8) the Department of Agriculture;
8.20 	(9) local government organizations;
8.21 	(10) law enforcement agencies; and
8.22 	(11) county social service agencies.

8.23 	Sec. 3. Minnesota Statutes 2025 Supplement, section 342.13, is amended to read:
8.24 	342.13 LOCAL CONTROL.
8.25 	(a) A local unit of government may not prohibit the possession, transportation, or use 
8.26 	of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
8.27 	consumer products authorized under this chapter.
8.28 	(b) Except as provided in section 342.22, a local unit of government may not prohibit 
8.29 	the establishment or operation of a cannabis business or hemp business licensed under this 
8.30 	chapter.
9.1 	(c) By ordinance, a local unit of government may adopt reasonable restrictions on the 
9.2 	time, place, and manner of the operation of a cannabis business provided that such restrictions 
9.3 	do not prohibit the establishment or operation of cannabis businesses. A local unit of 
9.4 	government may prohibit the operation of a cannabis business within 1,000 feet of a school, 
9.5 	or 500 feet of a day care, residential treatment facility, or an attraction within a public park 
9.6 	that is regularly used by minors, including a playground or athletic field.
9.7 	(d) The office shall work with local units of government to:
9.8 	(1) develop model ordinances for reasonable restrictions on the time, place, and manner 
9.9 	of the operation of a cannabis business;
9.10 	(2) develop standardized forms and procedures for the issuance of a retail registration 
9.11 	pursuant to section 342.22; and
9.12 	(3) develop model policies and procedures for the performance of compliance checks 
9.13 	required under section 342.22.
9.14 	(e) If a local unit of government is conducting studies or has authorized a study to be 
9.15 	conducted or has held or has scheduled a hearing for the purpose of considering adoption 
9.16 	or amendment of reasonable restrictions on the time, place, and manner of the operation of 
9.17 	a cannabis business, the governing body of the local unit of government may adopt an 
9.18 	interim ordinance applicable to all or part of its jurisdiction for the purpose of protecting 
9.19 	the planning process and the health, safety, and welfare of its citizens. Before adopting the 
9.20 	interim ordinance, the governing body must hold a public hearing. The interim ordinance 
9.21 	may regulate, restrict, or prohibit the operation of a cannabis business within the jurisdiction 
9.22 	or a portion thereof until January 1, 2025.
9.23 	(f) (e) Within 30 days of receiving a copy of an application from the office, a local unit 
9.24 	of government shall certify on a form provided by the office whether a proposed cannabis 
9.25 	business complies with local zoning ordinances and, if applicable, whether the proposed 
9.26 	business complies with the State Fire Code and the State Building Code. The office may
9.27 	must not issue a license to an applicant if the local unit of government informs the office 
9.28 	that the proposed cannabis business does not meet comply with local zoning and ordinances,
9.29 	land use laws, the State Fire Code, or the State Building Code and submits evidence of the 
9.30 	proposed cannabis business's lack of compliance. If the local unit of government does not 
9.31 	provide the certification under this paragraph to the office within 30 days of receiving a 
9.32 	copy of an application from the office, the office may waive the requirement for local 
9.33 	government certification and may issue a license to the applicant. Regardless of whether 
10.1 	the office has waived local government certification, the proposed cannabis business's 
10.2 	location must meet the requirements of this chapter.
10.3 	(g) (f) The office by rule shall establish an expedited complaint process to receive, 
10.4 	review, and respond to complaints made by a local unit of government about a cannabis 
10.5 	business. At a minimum, the expedited complaint process shall require the office to provide 
10.6 	an initial response to the complaint within seven days and perform any necessary inspections 
10.7 	within 30 days. Nothing in this paragraph prohibits a local unit of government from enforcing 
10.8 	a local ordinance. If a local unit of government notifies the office that a cannabis business 
10.9 	other than a cannabis retailer, cannabis microbusiness, cannabis mezzobusiness or 
10.10 	lower-potency hemp edible retailer with a retail operations endorsement, or medical cannabis 
10.11 	combination business operating a retail location poses an immediate threat to the health or 
10.12 	safety of the public, the office must respond within one business day and may take any 
10.13 	action described in section 342.19 or 342.21.
10.14 	(h) (g) A local government unit that issues a cannabis retailer registration under section 
10.15 	342.22 may, by ordinance, limit the number of licensed cannabis retailers, cannabis 
10.16 	mezzobusinesses with a retail operations endorsement, and cannabis microbusinesses with 
10.17 	a retail operations endorsement to no fewer than one registration for every 12,500 residents.
10.18 	After each increment of 12,500 residents, the number of required registrations must be 
10.19 	rounded up to the next whole number of registrations.
10.20 	(i) If a county has one active registration for every 12,500 residents, a city or town within 
10.21 	the county is not obligated to register a cannabis business.
10.22 	(h) A county that has consent from a city or town to issue retail registrations for the 
10.23 	jurisdiction according to section 342.22, subdivision 1, may develop a process, in consultation 
10.24 	with the consenting city or town, for issuing retail registrations throughout the county that 
10.25 	meets the required minimum in paragraph (g) and limits the number of registrations allowed 
10.26 	in each city or town that has delegated authority to the county.
10.27 	(j) (i) Nothing in this section shall prohibit a local government unit from allowing licensed 
10.28 	cannabis retailers in excess of the minimums set in paragraph (h) (g).
10.29 	(k) (j) Notwithstanding the foregoing provisions, the state shall not issue a license to 
10.30 	any cannabis business to operate in Indian country, as defined in United States Code, title 
10.31 	18, section 1151, of a Minnesota Tribal government without the consent of the Tribal 
10.32 	government.

11.1 	Sec. 4. Minnesota Statutes 2025 Supplement, section 342.14, subdivision 3, is amended 
11.2 	to read:
11.3 		Subd. 3.Review. (a) After an applicant submits an application that contains all required 
11.4 	information and pays the applicable application fee, the office must review the application.
11.5 	(b) The office may deny an application if:
11.6 	(1) the application is incomplete;
11.7 	(2) the application contains a materially false statement about the applicant or omits 
11.8 	information required under subdivision 1;
11.9 	(3) the applicant does not meet the qualifications under section 342.16;
11.10 	(4) the applicant is prohibited from holding the license under section 342.18, subdivision 
11.11 	2;
11.12 	(5) the application does not meet the minimum requirements under section 342.18, 
11.13 	subdivision 3;
11.14 	(6) the applicant fails to pay the applicable application fee;
11.15 	(7) the application was not submitted by the application deadline;
11.16 	(8) the applicant submitted more than one application for a license type; or
11.17 	(9) the office determines that the applicant would be prohibited from holding a license 
11.18 	for any other reason.
11.19 	(c) If the office denies an application, the office must notify the applicant of the denial 
11.20 	and the basis for the denial.
11.21 	(d) The office may request additional information from any applicant if the office 
11.22 	determines that the information is necessary to review or process the application. If the 
11.23 	applicant does not provide the additional requested information within 14 calendar days of 
11.24 	the office's request for information, the office may deny the application.
11.25 	(e) An applicant whose application is not denied under this subdivision is a qualified 
11.26 	applicant.
11.27 	(f) An applicant's status as a qualified applicant under this section expires after six 
11.28 	months. For an applicant who achieved qualified applicant status before June 1, 2026, 
11.29 	qualified applicant status expires on January 1, 2027. The office must deny an application 
11.30 	submitted by an applicant whose qualified applicant status has expired. An applicant whose 
11.31 	qualified applicant status expired may apply anew according to this section.
12.1 	(g) If the office determines that an applicant is not eligible for a license under this section, 
12.2 	the office may revoke the applicant's qualified applicant status.

12.3 	EFFECTIVE DATE. This section is effective the day following final enactment.

12.4 	Sec. 5. Minnesota Statutes 2025 Supplement, section 342.14, subdivision 6, is amended 
12.5 	to read:
12.6 		Subd. 6.Completed application; final authorization; issuance of license. (a) Within 
12.7 	18 months of receiving notice of preliminary license approval, an applicant must provide:
12.8 	(1) the address and legal property description of the location where the business will 
12.9 	operate;
12.10 	(2) the name of the local unit of government where the business will be located; and
12.11 	(3) if applicable, an updated description of the location where the business will operate, 
12.12 	an updated security plan, and any other additional information required by the office.
12.13 	(b) Upon receipt of the information required under paragraph (a) from an applicant that 
12.14 	has received preliminary license approval, the office must:
12.15 	(1) forward a copy of the application to the local unit of government in which the business 
12.16 	operates or intends to operate with a form for certification as to whether a proposed cannabis 
12.17 	business complies with local zoning ordinances and, if applicable, whether the proposed 
12.18 	business complies with the state fire code and building code;
12.19 	(2) schedule a site inspection; and
12.20 	(3) require the applicant to pay the applicable license fee.
12.21 	(c) The office may deny final authorization if:
12.22 	(1) an applicant fails to submit any required information;
12.23 	(2) the applicant submits a materially false statement about the applicant or fails to 
12.24 	provide any required information;
12.25 	(3) the office confirms that the cannabis business for which the office granted a 
12.26 	preliminary license approval does not meet local zoning and land use laws;
12.27 	(4) the applicant fails to pay the applicable license fee; or
12.28 	(5) the office determines that the applicant is disqualified from holding the license or 
12.29 	would operate in violation of the provisions of this chapter.; or
13.1 	(6) the applicant fails to demonstrate that the proposed cannabis business's location 
13.2 	complies with local zoning ordinances, the State Fire Code, or the State Building Code.
13.3 	(d) Within 90 days of receiving the information required under paragraph (a) and the 
13.4 	results of any required background check, the office shall grant final authorization and issue 
13.5 	the appropriate license or send the applicant a notice of rejection setting forth specific 
13.6 	reasons that the office did not approve the application.

13.7 	Sec. 6. Minnesota Statutes 2025 Supplement, section 342.16, is amended to read:
13.8 	342.16 CANNABIS BUSINESSES; GENERAL OWNERSHIP 
13.9 	DISQUALIFICATIONS AND REQUIREMENTS.
13.10 	(a) A license holder or an applicant must meet each of the following requirements, if 
13.11 	applicable, to hold or receive a cannabis license issued under this chapter:
13.12 	(1) be at least 21 years of age;
13.13 	(2) have completed an application for licensure or application for renewal;
13.14 	(3) have paid the applicable application fee and license fee;
13.15 	(4) if the applicant or license holder is a business entity, be incorporated in the state or 
13.16 	otherwise formed or organized under the laws of the state;
13.17 	(5) not be employed by the office or any state agency with regulatory authority under 
13.18 	this chapter or the rules adopted pursuant to this chapter;
13.19 	(6) not be a licensed peace officer, as defined in section 626.84, subdivision 1, paragraph 
13.20 	(c);
13.21 	(7) never have had a license previously issued under this chapter revoked, and never 
13.22 	have had a cannabis license, a registration, an agreement, or another authorization to operate 
13.23 	a cannabis business issued under the laws of another state revoked;
13.24 	(8) have filed any previously required tax returns for a cannabis business;
13.25 	(9) have paid and remitted any business taxes, gross receipts taxes, interest, or penalties 
13.26 	due relating to the operation of a cannabis business;
13.27 	(10) have fully and truthfully complied with all information requests of the office relating 
13.28 	to license application and renewal;
13.29 	(11) not be disqualified under section 342.15;
14.1 	(12) not employ an individual who is disqualified from working for a cannabis business 
14.2 	under this chapter;
14.3 	(13) meet the ownership and operational requirements for the type of license and, if 
14.4 	applicable, endorsement sought or held; and
14.5 	(14) not have had any confirmed willful labor violation with the Minnesota Department 
14.6 	of Labor, National Labor Relations Board, and Industry or the Occupational Safety and 
14.7 	Health Administration within the last five years, as determined by the office.
14.8 	(b) A health care practitioner who certifies qualifying medical conditions for patients is 
14.9 	prohibited from:
14.10 	(1) holding a direct or indirect economic interest in a cannabis business;
14.11 	(2) serving as a cooperative member, director, manager, general partner, or employee 
14.12 	of a cannabis business; or
14.13 	(3) advertising with a cannabis business in any way.
14.14 	(c) If the license holder or applicant is a business entity, every officer, director, manager, 
14.15 	and general partner of the business entity must meet each of the requirements of this section.
14.16 	(d) The ownership disqualifications and requirements under this section do not apply to 
14.17 	a hemp business license holder or applicant.

14.18 	EFFECTIVE DATE. This section is effective the day following final enactment.

14.19 	Sec. 7. Minnesota Statutes 2024, section 342.20, subdivision 1, is amended to read:
14.20 		Subdivision 1.Not public data. The following data collected, created, or maintained 
14.21 	by the office are classified as nonpublic data, as defined by section 13.02, subdivision 9, or 
14.22 	as private data on individuals, as defined by section 13.02, subdivision 12:
14.23 	(1) application data submitted by an applicant for a cannabis business license or hemp 
14.24 	business license, other than the data listed in subdivision 2;
14.25 	(2) the identity of a complainant who has made a report concerning a license holder or 
14.26 	an applicant that appears in inactive investigative data unless the complainant consents to 
14.27 	the disclosure;
14.28 	(3) data identifying retail or wholesale customers of a cannabis business or hemp business; 
14.29 	and
14.30 	(4) data identifying cannabis workers or hemp workers.; and
15.1 	(5) data reported to the office using the statewide monitoring system established under 
15.2 	section 342.05.

15.3 	Sec. 8. Minnesota Statutes 2024, section 342.20, subdivision 2, is amended to read:
15.4 		Subd. 2.Public data on license applicants. (a) The following application data submitted 
15.5 	by an applicant for a cannabis business license or hemp business license are public data:
15.6 	(1) the applicant's name and designated address;
15.7 	(2) data disclosing the ownership and control of the applicant;
15.8 	(3) proof of trade name registration;
15.9 	(4) data showing the legal possession of the premises where the business will operate;
15.10 	(5) data describing whether the volatile chemicals that will be used in any methods of 
15.11 	extraction or concentration, if applicable;
15.12 	(6) environmental plans;
15.13 	(7) the type and number of other cannabis business licenses or hemp business licenses 
15.14 	held by the applicant; and
15.15 	(8) the name, address, location, dates, and hours of where any proposed cannabis event 
15.16 	will take place.; and
15.17 	(9) the status of the applicant's application, except for an applicant's status as a social 
15.18 	equity applicant.
15.19 	(b) Scoring and other data generated by the office in its review of an applicant for a 
15.20 	cannabis business license or hemp business license are public data.

15.21 	Sec. 9. Minnesota Statutes 2024, section 342.20, subdivision 3, is amended to read:
15.22 		Subd. 3.Public application data on license holders. Once an applicant for a cannabis 
15.23 	business license or hemp business license becomes a license holder, all of the application 
15.24 	or renewal data that the license holder had previously submitted to the office are public data 
15.25 	except that the following data remain classified as nonpublic data or private data on 
15.26 	individuals:
15.27 	(1) data identifying retail or wholesale customers of a cannabis business or hemp business;
15.28 	(2) data identifying cannabis workers or hemp workers;
15.29 	(3) tax returns, bank account statements, and other financial account information;
16.1 	(4) business plans; and, including descriptions of sites, security, and operations of the 
16.2 	license holder;
16.3 	(5) data regarding the license holder's accounting compliance;
16.4 	(6) data contained in vehicle disclosure forms and related documentation required in 
16.5 	section 342.35, subdivision 2, clauses (1) and (2); and
16.6 	(5) (7) data classified as nonpublic data or private data on individuals by chapter 13 or 
16.7 	other applicable law.

16.8 	Sec. 10. Minnesota Statutes 2024, section 342.22, subdivision 4, is amended to read:
16.9 		Subd. 4.Compliance checks. (a) A local unit of government shall conduct compliance 
16.10 	checks of every cannabis business and hemp business with a retail registration issued by 
16.11 	the local unit of government. During a compliance check, a local unit of government shall 
16.12 	assess a business's compliance with age verification requirements and compliance with any 
16.13 	applicable local ordinance established pursuant to section 342.13.
16.14 	(b) A local unit of government must conduct unannounced age verification compliance 
16.15 	checks of every cannabis business and hemp business at least once each calendar year. Age 
16.16 	verification compliance checks must involve persons at least 17 years of age but under the 
16.17 	age of 21 who, with the prior written consent of a parent or guardian if the person is under 
16.18 	the age of 18, attempt to purchase adult-use cannabis flower, adult-use cannabis products, 
16.19 	lower-potency hemp edibles, or hemp-derived consumer products under the direct supervision 
16.20 	of a law enforcement officer or an employee of the local unit of government.
16.21 	(c) A local government with retail registration authority that performs compliance checks 
16.22 	must annually submit data regarding compliance checks to the office. The data must include:
16.23 	(1) the name of the cannabis business and the business's address, license number, and 
16.24 	type of business under chapter 342;
16.25 	(2) the results of the compliance check, including whether the business was compliant 
16.26 	with any applicable local ordinances;
16.27 	(3) the date and time of the compliance check;
16.28 	(4) a description of any specific violation of a local ordinance, including any failure to 
16.29 	request documentation for age verification, an age verification method that violates this 
16.30 	chapter, or any other violation of a local ordinance; and
16.31 	(5) any warnings, fines, suspensions, or other actions taken by the local government in 
16.32 	response to the business's violation of a local ordinance.
17.1 	(d) A local government may provide the office with data from a compliance check before 
17.2 	the annual submission date. A local government may provide the office with data from a 
17.3 	compliance check by notifying the office of a suspended retail registration according to 
17.4 	subdivision 5, paragraph (a).

17.5 	Sec. 11. Minnesota Statutes 2024, section 342.23, subdivision 5, is amended to read:
17.6 		Subd. 5.Financial relationship. (a) Except for the lawful sale of cannabis plants, 
17.7 	cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency hemp 
17.8 	edibles, and hemp-derived consumer products in the ordinary course of business and as 
17.9 	otherwise provided in this subdivision, No cannabis business or hemp business may offer, 
17.10 	give, accept, receive, or borrow money or anything else of value or accept or receive credit 
17.11 	from any other cannabis business. This prohibition applies to or hemp business, including
17.12 	offering or receiving a benefit in exchange for preferential placement by a retailer, including
17.13 	and offering or receiving preferential placement on the retailer's shelves, display cases, or 
17.14 	website. This The prohibition in this paragraph applies to every cooperative member or 
17.15 	every director, manager, and general partner of a cannabis business or hemp business.
17.16 	(b) This Paragraph (a) does not apply to the lawful sale of cannabis plants, cannabis 
17.17 	flower, cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, 
17.18 	and hemp-derived consumer products in the ordinary course of business and as otherwise 
17.19 	provided in this subdivision.
17.20 	(c) The prohibition in paragraph (a) does not apply to merchandising credit in the ordinary 
17.21 	course of business for a period not to exceed 30 days.
17.22 	(c) This (d) The prohibition in paragraph (a) does not apply to free samples of usable 
17.23 	cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer 
17.24 	products packaged in a sample jar protected by a plastic or metal mesh screen to allow 
17.25 	customers to smell the cannabis flower, cannabis product, lower-potency hemp edible, or 
17.26 	hemp-derived consumer product before purchase. A sample jar may not contain more than 
17.27 	eight grams of usable cannabis flower, more than eight grams of a cannabis concentrate, an 
17.28 	edible cannabis product infused with more than 100 milligrams of tetrahydrocannabinol, a 
17.29 	lower-potency hemp edible infused with more than 50 milligrams of tetrahydrocannabinol, 
17.30 	or a hemp-derived consumer product with a total weight of more than eight grams.
17.31 	(d) This (e) The prohibition in paragraph (a) does not apply to free samples of cannabis 
17.32 	flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products 
17.33 	provided to a retailer or cannabis wholesaler for the purposes of quality control and to allow 
17.34 	retailers to determine whether to offer a product for sale. A sample provided for these 
18.1 	purposes may not contain more than eight grams of usable cannabis flower, more than eight 
18.2 	grams of a cannabis concentrate, an edible cannabis product infused with more than 100 
18.3 	milligrams of tetrahydrocannabinol, a lower-potency hemp edible infused with more than 
18.4 	50 milligrams of tetrahydrocannabinol, or a hemp-derived consumer product with a total 
18.5 	weight of more than eight grams.
18.6 	(e) This (f) The prohibition in paragraph (a) does not apply to any fee charged by a 
18.7 	licensed cannabis event organizer to a cannabis business or hemp business for participation 
18.8 	in a cannabis event.
18.9 	(g) The prohibition in paragraph (a) does not apply to any transaction entered into in 
18.10 	good faith by a cannabis business or hemp business for the sale of goods or services at fair 
18.11 	market value.

18.12 	EFFECTIVE DATE. This section is effective the day following final enactment.

18.13 	Sec. 12. Minnesota Statutes 2024, section 342.27, subdivision 2, is amended to read:
18.14 		Subd. 2.Sale of cannabis and cannabinoid products. (a) A cannabis business with a 
18.15 	license or endorsement authorizing the retail sale of cannabis flower or cannabis products 
18.16 	may only sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
18.17 	cannabis products, lower-potency hemp edibles, and hemp-derived consumer products to 
18.18 	individuals who are at least 21 years of age.
18.19 	(b) A cannabis business with a license or endorsement authorizing the retail sale of 
18.20 	adult-use cannabis flower or adult-use cannabis products may sell immature cannabis plants 
18.21 	and seedlings, adult-use cannabis flower, adult-use cannabis products, lower-potency hemp 
18.22 	edibles, and hemp-derived consumer products that:
18.23 	(1) are obtained from a business licensed under this chapter; and
18.24 	(2) meet all applicable packaging and labeling requirements.
18.25 	(c) A cannabis business with a license or endorsement authorizing the retail sale of 
18.26 	cannabis flower or cannabis products may sell up to two ounces of adult-use cannabis flower 
18.27 	or hemp-derived consumer products consisting primarily of hemp plant parts, up to eight 
18.28 	grams of adult-use cannabis concentrate or hemp-derived consumer products consisting 
18.29 	primarily of hemp concentrate or artificially derived cannabinoids, and edible cannabis 
18.30 	products and lower-potency hemp edibles infused with up to 800 milligrams of 
18.31 	tetrahydrocannabinol during a single transaction to a customer.
19.1 	(d) Edible adult-use cannabis products and hemp-derived consumer products intended 
19.2 	to be eaten may not include more than ten milligrams of tetrahydrocannabinol per serving 
19.3 	and a single package may not include more than a total of 200 milligrams of 
19.4 	tetrahydrocannabinol. A package may contain multiple servings of ten milligrams of 
19.5 	tetrahydrocannabinol provided that each serving is indicated by scoring, wrapping, or other 
19.6 	indicators designating the individual serving size.
19.7 	(e) Edible adult-use cannabis products and hemp-derived consumer products intended 
19.8 	to be consumed as beverages may not include more than ten milligrams of 
19.9 	tetrahydrocannabinol per serving. A single beverage container may not contain more than 
19.10 	two servings.

19.11 	EFFECTIVE DATE. This section is effective the day following final enactment.

19.12 	Sec. 13. Minnesota Statutes 2024, section 342.37, subdivision 1, is amended to read:
19.13 		Subdivision 1.Authorized actions. A cannabis testing facility license entitles the license 
19.14 	holder to:
19.15 	(1) obtain and test immature cannabis plants and seedlings, cannabis flower, cannabis 
19.16 	products, hemp plant parts, hemp concentrate, artificially derived cannabinoids, 
19.17 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
19.18 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
19.19 	cannabis wholesalers, lower-potency hemp edible manufacturers, medical cannabis 
19.20 	combination businesses, and industrial hemp growers; and
19.21 	(2) perform other actions approved by the office.

19.22 	EFFECTIVE DATE. This section is effective the day following final enactment.

19.23 	Sec. 14. Minnesota Statutes 2024, section 342.39, subdivision 1, is amended to read:
19.24 		Subdivision 1.Authorized actions. A cannabis event organizer license entitles the 
19.25 	license holder to:
19.26 	(1) organize a temporary cannabis event lasting no more than four days; and
19.27 	(2) perform other actions approved by the office.

19.28 	EFFECTIVE DATE. This section is effective the day following final enactment.

20.1 	Sec. 15. PSILOCYBIN THERAPEUTIC USE PROGRAM REPORT.
 20.2 	(a) The Office of Cannabis Management must regularly analyze the availability of federal 
20.3 	programs to provide funds to support state efforts to establish a psilocybin therapeutic use 
20.4 	program for individuals aged 21 and older who have qualifying medical conditions to access 
20.5 	and use psilocybin under medical supervision.
20.6 	(b) If a federal funding opportunity is identified, the office shall consult with the chairs 
20.7 	and ranking minority members of the legislative committees with jurisdiction over cannabis, 
20.8 	health, and veterans affairs to evaluate the federal funding opportunity and identify options 
20.9 	for participation, guided by recommendations in the Minnesota Psychedelic Medicine Task 
20.10 	Force's legislative report published January 1, 2025, related to a psilocybin therapeutic use 
20.11 	program.
20.12 	(c) The office must report to the legislature by each January 15 if federal funding 
20.13 	opportunities have been identified in the previous calendar year, including the results of 
20.14 	any evaluations.

20.15 	Sec. 16. REPEALER.
 20.16 	(a) Minnesota Statutes 2024, section 151.72, subdivisions 1, 2, 4, 5, 5b, 5c, 6, and 7, are 
20.17 	repealed.
20.18 	(b) Minnesota Statutes 2025 Supplement, section 151.72, subdivisions 3 and 5a, are 
20.19 	repealed.

20.20 	EFFECTIVE DATE. This section is effective the day following final enactment.

20.21 	ARTICLE 2
20.22 	CANNABIS LICENSING AND ENDORSEMENTS

20.23 	Section 1. Minnesota Statutes 2024, section 342.07, subdivision 3, is amended to read:
20.24 		Subd. 3.Edible cannabinoid product handler endorsement. (a) Any person A license 
20.25 	holder seeking to manufacture, process, sell, handle, or store an edible cannabis product or 
20.26 	lower-potency hemp edible, other than an edible cannabis product or lower-potency hemp 
20.27 	edible that has been placed in its final packaging, must firstapply for and obtain an edible 
20.28 	cannabinoid product handler endorsement.
20.29 	(b) In consultation with the commissioner of agriculture, the office shall establish an 
20.30 	edible cannabinoid product handler endorsement.
21.1 	(c) The office must regulate edible cannabinoid product handlers in a manner consistent 
21.2 	with Department of Agriculture regulation of food handlers under chapters 28A, 31, and 
21.3 	34A and associated rules, with the following exceptions:
21.4 	(1) the office must issue an edible cannabinoid product handler endorsement, rather than 
21.5 	a license;
21.6 	(2) eligibility for an edible cannabinoid product handler endorsement is limited to persons 
21.7 	who possess a valid license issued by the office;
21.8 	(3) the office may not charge a fee for issuing or renewing the endorsement;
21.9 	(4) the office must align the term and renewal period for edible cannabinoid product 
21.10 	handler endorsements with the term and renewal period of the license issued by the office; 
21.11 	and
21.12 	(5) an edible cannabis product or a lower-potency hemp edible must not be considered 
21.13 	adulterated solely because the product or edible contains tetrahydrocannabinol, cannabis 
21.14 	concentrate, hemp concentrate, artificially derived cannabinoids, or any other material 
21.15 	extracted or derived from a cannabis plant, cannabis flower, hemp plant, or hemp plant 
21.16 	parts.
21.17 	(d) The An edible cannabinoid product handler endorsement must prohibit prohibits the 
21.18 	manufacture of edible cannabis products at the same premises where food is manufactured, 
21.19 	except for the limited production of edible products produced solely for product development, 
21.20 	sampling, or testing. ThisThe limitation in this paragraph does not apply to the manufacture 
21.21 	of lower-potency hemp edibles.
21.22 	(e) An edible cannabinoid product handler endorsement is available to the following 
21.23 	license holders:
21.24 	(1) cannabis microbusinesses;
21.25 	(2) cannabis mezzobusinesses;
21.26 	(3) cannabis manufacturers;
21.27 	(4) lower-potency hemp edible manufacturers; and
21.28 	(5) cannabis macrobusinesses.
21.29 	(f) A lower-potency hemp edible manufacturer with an edible cannabinoid product 
21.30 	handler endorsement may only manufacture lower-potency hemp edibles and must not add 
21.31 	any cannabis flower, cannabis concentrate, or cannabinoid derived from cannabis flower 
21.32 	or cannabis concentrate to a product consistent with the requirements in section 342.45.

22.1 	Sec. 2. Minnesota Statutes 2024, section 342.15, subdivision 2, is amended to read:
22.2 		Subd. 2.Criminal offenses; disqualifications. (a) The office may by rule determine 
22.3 	whether any felony convictions, including but not limited to convictions for noncannabis 
22.4 	controlled substance crimes in the first or second degree, human trafficking, labor trafficking, 
22.5 	fraud, or financial crimes, disqualify an individual from holding or receiving a cannabis 
22.6 	business license issued under this chapter or working for a cannabis business, and the length 
22.7 	of any such disqualification. In adopting rules pursuant to this subdivision, the office shall 
22.8 	not disqualify an individual for a violation of section 152.025.
22.9 	(b) The office must not issue a cannabis business license to any person or business who 
22.10 	was convicted of illegally selling cannabis after August 1, 2023, unless five years have 
22.11 	passed since the date of conviction.
22.12 	(c) The office must not issue a cannabis business license to any person or business who 
22.13 	violated this chapter after August 1, 2023, unless five years have passed since the date of 
22.14 	violation. The office may set aside the violation if the office finds that the violation occurred 
22.15 	as a result of a mistake made in good faith and the violation did not involve gross negligence, 
22.16 	an illegal sale of cannabis, or cause harm to the public. The office must not issue a license 
22.17 	to any person or business who the office has assessed a fine to under section 342.09, 
22.18 	subdivision 6.

22.19 	Sec. 3. Minnesota Statutes 2024, section 342.15, subdivision 5, is amended to read:
22.20 		Subd. 5.Civil and regulatory offenses; disqualifications. (a) The office may determine 
22.21 	whether any civil or regulatory violations, as determined by another state agency, local unit 
22.22 	of government, or any other jurisdiction, disqualify an individual from holding or receiving 
22.23 	a cannabis business license issued under this chapter or disqualify an individual from working 
22.24 	for a cannabis business, and the length of the disqualification. Upon the office's request, a 
22.25 	state agency, as defined in section 13.02, subdivision 17, except for the Department of 
22.26 	Revenue, may release civil investigative data, including data classified as protected nonpublic 
22.27 	or confidential under section 13.39, subdivision 2, if the request is related to a specific 
22.28 	applicant and the data is necessary to make a determination under this section.
22.29 	(b) The office must not issue a cannabis business license to any person or business who 
22.30 	violated this chapter after August 1, 2023, unless five years have passed since the date of 
22.31 	the violation. The office may set aside the violation if the office finds that the violation:
22.32 	(1) occurred as a result of a mistake made in good faith;
22.33 	(2) did not involve gross negligence;
23.1 	(3) did not involve an illegal sale of cannabis; and
23.2 	(4) did not cause harm to the public.
23.3 	(c) The office must not issue a cannabis business license to any person or business who 
23.4 	was assessed a fine by the office under section 342.09, subdivision 6.
23.5 	(d) The office may determine the length of a disqualification for a true party of interest 
23.6 	who owns or controls more than ten percent of a cannabis business that had a cannabis 
23.7 	business license or hemp business license revoked by the office under section 342.21.

23.8 	Sec. 4. Minnesota Statutes 2024, section 342.19, subdivision 6, is amended to read:
23.9 		Subd. 6.Inspection of unlicensed businesses and facilities. (a) The office may inspect 
23.10 	any commercial premises that is not licensed under this chapter where cultivation, 
23.11 	manufacturing, processing, or sale of cannabis plants, cannabis flower, cannabis concentrate, 
23.12 	artificially derived cannabinoids, hemp-derived consumer products, or edible cannabinoid 
23.13 	products, or lower-potency hemp edibles is taking place.
23.14 	(b) A representative of the office performing an inspection under this subdivision must 
23.15 	present appropriate credentials to the owner, operator, or agent in charge and clearly state 
23.16 	the purpose of the inspection.
23.17 	(c) After providing the notice required under paragraph (b), a representative of the office 
23.18 	may enter the commercial premises and perform any of the following to determine if any 
23.19 	person is engaging in activities that are regulated by this chapter and not authorized without 
23.20 	the possession of a license and to determine the appropriate penalty under section 342.09, 
23.21 	subdivision 6:
23.22 	(1) inspect and investigate the commercial premises;
23.23 	(2) inspect and copy records; and
23.24 	(3) question privately any employer, owner, operator, agent, or employee of the 
23.25 	commercial operation.
23.26 	(d) Entry of a commercial premises must take place during regular working hours or at 
23.27 	other reasonable times.
23.28 	(e) If the office finds any cannabis plant, cannabis flower, cannabis product, artificially 
23.29 	derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product on 
23.30 	the inspected commercial premises, the office may either:
23.31 	(1) immediately seize the item or;
24.1 	(2) affix to the item a tag, withdrawal from distribution order, or other appropriate 
24.2 	marking providing notice that the cannabis plant, cannabis flower, cannabis product, 
24.3 	artificially derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer 
24.4 	product is, or is suspected of being, possessed or distributed in violation of this chapter, and 
24.5 	has been detained or embargoed, and warning all persons not to remove or dispose of the 
24.6 	item by sale or otherwise until permission for removal or disposal is given by the office or 
24.7 	the court; and
24.8 	(3) assess a civil penalty to the business pursuant to section 342.09, subdivision 6, and 
24.9 	may treat the possession of the seized, embargoed, or detained product as having been sold.
24.10 	(f) It is unlawful for a person to remove or dispose of a detained or embargoed cannabis 
24.11 	plant, cannabis flower, cannabis product, artificially derived cannabinoid, lower-potency 
24.12 	hemp edible, or hemp-derived consumer product by sale or otherwise without the office's 
24.13 	or a court's permission and each transaction may be treated as a sale for the purposes of 
24.14 	imposing a penalty pursuant to section 342.09, subdivision 6.
24.15 	(f) (g) If the office has seized, detained, or embargoed any item pursuant to paragraph 
24.16 	(e), the office must:
24.17 	(1) petition the district court in the county in which the item was found for an order 
24.18 	authorizing destruction of the product; and
24.19 	(2) notify the county attorney in the county where the item was found of the office's 
24.20 	actions.
24.21 	(g) (h) If the court finds that the seized, detained, or embargoed cannabis plant, cannabis 
24.22 	flower, cannabis product, artificially derived cannabinoid, lower-potency hemp edible, or 
24.23 	hemp-derived consumer product was possessed or distributed in violation of this chapter 
24.24 	or rules adopted under this chapter, the office may destroy the cannabis plant, cannabis 
24.25 	flower, cannabis product, artificially derived cannabinoid, lower-potency hemp edible, or 
24.26 	hemp-derived consumer product at the expense of the person who possessed or distributed 
24.27 	the item in violation of this chapter and all court costs, fees, storage, and other proper 
24.28 	expenses must be assessed against the person or the person's agent.
24.29 	(h) (i) The provisions of subdivision 2, paragraph (f), apply to any analysis or examination 
24.30 	performed under this subdivision.
24.31 	(i) (j) The authorization under paragraph (e) does not apply to any cannabis flower, 
24.32 	cannabis product, lower-potency hemp edible, or hemp-derived consumer product lawfully 
24.33 	purchased for personal use.

25.1 	Sec. 5. [342.245] ENDORSEMENTS.
25.2 	(a) The office must provide endorsement application forms to applicants.
25.3 	(b) The office may deny an endorsement application if:
25.4 	(1) the license holder has previously had an endorsement suspended, revoked, or canceled 
25.5 	by the office within the last five years;
25.6 	(2) the license holder owes outstanding fines to the office for violations; or
25.7 	(3) the license holder does not meet the requirements to: (i) conduct activities authorized 
25.8 	by the endorsement; or (ii) conduct activities authorized by the endorsement at the specific 
25.9 	location indicated on the application.
25.10 	(c) The office must not charge a fee to an applicant for an endorsement application.
25.11 	(d) The office must align the term and renewal period for an endorsement with the term 
25.12 	and renewal period of the applicant's license.

25.13 	Sec. 6. Minnesota Statutes 2024, section 342.25, subdivision 1, is amended to read:
25.14 		Subdivision 1.Applicability. Every (a) A cannabis business with a license or 
25.15 	endorsement authorizing the cultivation of cannabisseeking to cultivate cannabis must 
25.16 	comply with the requirements of this section apply for and obtain a cannabis cultivation 
25.17 	endorsement.
25.18 	(b) A cannabis cultivation endorsement is available to the following license holders:
25.19 	(1) cannabis microbusinesses;
25.20 	(2) cannabis mezzobusinesses;
25.21 	(3) cannabis cultivators; and
25.22 	(4) cannabis macrobusinesses.

25.23 	Sec. 7. Minnesota Statutes 2024, section 342.25, subdivision 2, is amended to read:
25.24 		Subd. 2.Cultivation records. A business licensed or authorized to cultivate cannabis
25.25 	with a cannabis cultivation endorsement must prepare a cultivation record for each batch 
25.26 	of cannabis plants and cannabis flower in the form required by the office and must maintain 
25.27 	each record for at least five years. The A cultivation record must include the quantity and 
25.28 	timing, where if applicable, of each pesticide, fertilizer, soil amendment, or plant amendment 
25.29 	used to cultivate the batch, as well as any other information required by the office in rule. 
26.1 	The A cannabis business must present provide cultivation records to the office, the 
26.2 	commissioner of agriculture, or the commissioner of health upon request.

26.3 	Sec. 8. Minnesota Statutes 2024, section 342.25, subdivision 3, is amended to read:
26.4 		Subd. 3.Agricultural chemicals and other inputs. A business licensed or authorized 
26.5 	to cultivate cannabis with a cannabis cultivation endorsement is subject to rules promulgated 
26.6 	by the office in consultation with the commissioner of agriculture, subject to subdivision 
26.7 	5, governing the use of pesticides, fertilizers, soil amendments, plant amendments, and other 
26.8 	inputs to cultivate cannabis.

26.9 	Sec. 9. Minnesota Statutes 2024, section 342.25, subdivision 4, is amended to read:
26.10 		Subd. 4.Cultivation plan. A business licensed or authorized to cultivate cannabis with 
26.11 	a cannabis cultivation endorsement must prepare, maintain, and execute an operating plan 
26.12 	and a cultivation plan as directed by the office in rule, which must include but is not limited 
26.13 	to:
26.14 	(1) water usage;
26.15 	(2) recycling;
26.16 	(3) solid waste disposal; and
26.17 	(4) a pest management protocol that incorporates integrated pest management principles 
26.18 	to control or prevent the introduction of pests to the cultivation site.

26.19 	Sec. 10. Minnesota Statutes 2024, section 342.25, subdivision 5, is amended to read:
26.20 		Subd. 5.Agricultural chemicals and other inputs; pollinator protection. (a) A business 
26.21 	licensed or authorized to cultivate cannabis with a cannabis cultivation endorsement must 
26.22 	comply with chapters 18B, 18C, 18D, and any other pesticide, fertilizer, soil amendment, 
26.23 	and plant amendment laws and rules enforced by the commissioner of agriculture.
26.24 	(b) A business licensed or authorized to cultivate cannabis with a cannabis cultivation 
26.25 	endorsement must not apply pesticides when pollinators are present or allow pesticides to 
26.26 	drift to flowering plants that are attractive to pollinators.

26.27 	Sec. 11. Minnesota Statutes 2024, section 342.25, subdivision 6, is amended to read:
26.28 		Subd. 6.Adulteration prohibited. A business licensed or authorized to cultivate cannabis
26.29 	with a cannabis cultivation endorsement must not treat or otherwise adulterate cannabis 
27.1 	plants or cannabis flower with any substance or compound that has the effect or intent of 
27.2 	altering the color, appearance, weight, potency, or odor of the cannabis.

27.3 	Sec. 12. Minnesota Statutes 2024, section 342.25, subdivision 7, is amended to read:
27.4 		Subd. 7.Indoor or outdoor cultivation authorized; security. A business licensed or 
27.5 	authorized to cultivate cannabis with a cannabis cultivation endorsement may cultivate 
27.6 	cannabis plants indoors or outdoors, subject to the security, fencing, lighting, and any other 
27.7 	requirements imposed by the office in rule.

27.8 	Sec. 13. Minnesota Statutes 2024, section 342.26, subdivision 1, is amended to read:
27.9 		Subdivision 1.Applicability. Every (a) A cannabis business with a license or 
27.10 	endorsement authorizing the creation of cannabis concentrate and manufacture of cannabis 
27.11 	products and hemp-derived consumer products for public consumption must comply with 
27.12 	the requirements of this section seeking to manufacture cannabis products must apply for 
27.13 	and obtain the applicable endorsement according to subdivisions 3 and 4.
27.14 	(b) An endorsement under subdivisions 3 and 4 is available to the following license 
27.15 	holders:
27.16 	(1) cannabis microbusinesses;
27.17 	(2) cannabis mezzobusinesses;
27.18 	(3) cannabis manufacturers; and
27.19 	(4) cannabis macrobusinesses.

27.20 	Sec. 14. Minnesota Statutes 2024, section 342.26, subdivision 2, is amended to read:
27.21 		Subd. 2.All manufacturer operations. (a) Cannabis manufacturing must take place in 
27.22 	an enclosed, locked facility that is used exclusively for the manufacture of cannabis products, 
27.23 	creation of hemp concentrate, creation of artificially derived cannabinoids, creation of 
27.24 	lower-potency hemp edibles, or creation of hemp-derived consumer products, except that 
27.25 	a business that also holds a cannabis cultivator license may operate in a facility that shares 
27.26 	general office space, bathrooms, entryways, and walkways.
27.27 	(b) Cannabis manufacturing must take place on equipment that is used exclusively for 
27.28 	the manufacture of cannabis products, creation of hemp concentrate, creation of artificially 
27.29 	derived cannabinoids, creation of lower-potency hemp edibles, or creation of hemp-derived 
27.30 	consumer products.
28.1 	(c) A business licensed or authorized to manufacture cannabis products with an 
28.2 	endorsement under subdivision 3 or 4 must comply with all applicable packaging, labeling, 
28.3 	and health and safety requirements.
28.4 	(d) A cannabis business with a production of consumer product endorsement may not 
28.5 	manufacture, import, export, or sell a cannabinoid product powered by or with a battery 
28.6 	that is not easily removable.

28.7 	EFFECTIVE DATE. Paragraph (d) is effective January 1, 2027.

28.8 	Sec. 15. Minnesota Statutes 2024, section 342.26, subdivision 3, is amended to read:
28.9 		Subd. 3.Cannabis extraction and concentration endorsement, hemp extraction and 
28.10 	concentration endorsement, and creation of artificially derived cannabinoids 
28.11 	endorsement. (a) A cannabis business licensed or authorized seeking to manufacture 
28.12 	cannabis products that creates cannabis concentrate, hemp concentrate, or artificially derived 
28.13 	cannabinoids must apply for and obtain ana cannabis extraction and concentration 
28.14 	endorsement from the office.
28.15 	(b) A cannabis business seeking to manufacture hemp concentrate must apply for and 
28.16 	obtain a hemp extraction and concentration endorsement.
28.17 	(c) A cannabis business seeking to manufacture artificially derived cannabinoids must 
28.18 	apply for and obtain a creation of artificially derived cannabinoids endorsement. A cannabis 
28.19 	business must hold a hemp extraction and concentration endorsement to apply for and obtain 
28.20 	a creation of artificially derived cannabinoids endorsement.
28.21 	(b)(d) A business licensed or authorized to manufacture cannabis products with a 
28.22 	cannabis extraction and concentration endorsement, hemp extraction and concentration 
28.23 	endorsement, or creation of artificially derived cannabinoids endorsement must inform the 
28.24 	office of all methods of extraction and concentration that the manufacturer intends to use 
28.25 	and identify the volatile chemicals, if any, that will be involved in the creation of cannabis 
28.26 	concentrate or hemp concentrate. A cannabis manufacturer business with a cannabis 
28.27 	extraction and concentration endorsement, hemp extraction and concentration endorsement, 
28.28 	or creation of artificially derived cannabinoids endorsement may not use a method of 
28.29 	extraction and concentration or a volatile chemical without approval by the office.
28.30 	(c)(e) A business licensed or authorized to manufacture cannabis products with a cannabis 
28.31 	extraction and concentration endorsement, hemp extraction and concentration endorsement, 
28.32 	or creation of artificially derived cannabinoids endorsement must inform the office of all 
28.33 	methods of conversion that the manufacturer will use, including any specific catalysts that 
29.1 	the manufacturer will employ, to create artificially derived cannabinoids and the molecular 
29.2 	nomenclature of all cannabinoids or other chemical compounds that the manufacturer will 
29.3 	create. A business licensed or authorized to manufacture cannabis products with a cannabis 
29.4 	extraction and concentration endorsement, hemp extraction and concentration endorsement, 
29.5 	or creation of artificially derived cannabinoids endorsement may not use a method of 
29.6 	conversion or a catalyst without approval by the office.
29.7 	(d)(f) A business licensed or authorized to manufacture cannabis products with a cannabis 
29.8 	extraction and concentration endorsement, hemp extraction and concentration endorsement, 
29.9 	or creation of artificially derived cannabinoids endorsement must obtain a certification from 
29.10 	an independent third-party industrial hygienist or professional engineer approving:
29.11 	(1) all electrical, gas, fire suppression, and exhaust systems; and
29.12 	(2) the plan for safe storage and disposal of hazardous substances, including but not 
29.13 	limited to any volatile chemicals.
29.14 	(e)(g) A business licensed or authorized to manufacture cannabis products that 
29.15 	manufactures with a cannabis extraction and concentration endorsement may manufacture
29.16 	cannabis concentrate from cannabis flower received from an unlicensed person who is at 
29.17 	least 21 years of age and must comply with all health and safety requirements established 
29.18 	by the office. At a minimum, the office shall require the manufacturer to:
29.19 	(1) store the cannabis flower in an area that is segregated from cannabis flower and hemp 
29.20 	plant parts received from a licensed cannabis business;
29.21 	(2) perform the extraction and concentration on equipment that is used exclusively for 
29.22 	extraction or concentration of cannabis flower received from unlicensed individuals;
29.23 	(3) store any cannabis concentrate in an area that is segregated from cannabis concentrate, 
29.24 	hemp concentrate, or artificially derived cannabinoids derived or manufactured from cannabis 
29.25 	flower or hemp plant parts received from a licensed cannabis business; and
29.26 	(4) provide any cannabis concentrate only to the person who provided the cannabis 
29.27 	flower.
29.28 	(f)(h) Upon the sale of cannabis concentrate, hemp concentrate, or artificially derived 
29.29 	cannabinoids to any person, cooperative, or business, a business licensed or authorized to 
29.30 	manufacture cannabis products with a cannabis extraction and concentration endorsement, 
29.31 	hemp extraction and concentration endorsement, or creation of artificially derived 
29.32 	cannabinoids endorsement must provide a statement to the buyer that discloses the method 
30.1 	of extraction and concentration or conversion used and any solvents, gases, or catalysts, 
30.2 	including but not limited to any volatile chemicals, involved in that method.

30.3 	Sec. 16. Minnesota Statutes 2024, section 342.26, subdivision 4, is amended to read:
30.4 		Subd. 4.Edible cannabinoid product handler endorsement and production of 
30.5 	consumer products endorsement. (a) A cannabis business licensed or authorized to 
30.6 	manufacture cannabis products that produces edible cannabis products or lower-potency 
30.7 	hemp ediblesseeking to produce edible cannabis products or lower-potency hemp edibles 
30.8 	must apply for and obtain an edible cannabinoid product handler endorsement from the 
30.9 	office.
30.10 	(b) A cannabis business with an edible cannabinoid product handler endorsement must 
30.11 	comply with the requirements in section 342.07, subdivision 3.
30.12 	(b) (c) A cannabis business licensed or authorized to manufacture cannabis products
30.13 	seeking to produce hemp-derived consumer products or cannabis products other than edible 
30.14 	cannabis products must apply for and obtain ana production of consumer products 
30.15 	endorsement from the office to produce:.
30.16 	(1) cannabis products other than edible cannabis products; or
30.17 	(2) hemp-derived consumer products other than lower-potency hemp edibles.
30.18 	(c) (d) A cannabis business with an endorsement under this subdivision must ensure that
30.19 	all areas within the licensed premises of a the business licensed or authorized to manufacture 
30.20 	cannabis products producing cannabis products, lower-potency hemp edibles, or 
30.21 	hemp-derived consumer products must meet the sanitary standards specified in rules adopted 
30.22 	by the office.
30.23 	(d) (e) A cannabis business licensed or authorized to manufacture cannabis products
30.24 	with an endorsement under this subdivision may only add chemicals or compounds approved 
30.25 	by the office to cannabis concentrate, hemp concentrate, or artificially derived cannabinoids.
30.26 	(e) (f) Upon the sale of any cannabis product, lower-potency hemp edible, or 
30.27 	hemp-derived consumer product to a cannabis business or hemp business, a cannabis business 
30.28 	licensed or authorized to manufacture cannabis products with an endorsement under this 
30.29 	subdivision must provide a statement to the buyer that discloses the product's ingredients, 
30.30 	including but not limited to any chemicals or compounds and any major food allergens 
30.31 	declared by name.
31.1 	(f) (g) A business licensed or authorized to manufacture cannabis products shall with 
31.2 	an endorsement under this subdivision must not add any cannabis flower, cannabis 
31.3 	concentrate, artificially derived cannabinoid, hemp plant part, or hemp concentrate to a 
31.4 	product where if the manufacturer of the product holds a trademark to the product's name, 
31.5 	except that a business licensed or authorized to manufacture cannabis products may use a 
31.6 	trademarked food product if the manufacturer uses the product as a component or as part 
31.7 	of a recipe and where if the business licensed or authorized to manufacture cannabis products 
31.8 	does not state or advertise to the customer that the final retail cannabis product, lower-potency 
31.9 	hemp edible, or hemp-derived consumer product contains a trademarked food product.

31.10 	Sec. 17. Minnesota Statutes 2024, section 342.26, subdivision 5, is amended to read:
31.11 		Subd. 5.Exception. Nothing in this section applies to the operations of a lower-potency 
31.12 	hemp edible manufacturer. A lower-potency hemp edible manufacturer must comply with 
31.13 	section 342.45 and applicable rules.

31.14 	Sec. 18. Minnesota Statutes 2024, section 342.27, subdivision 1, is amended to read:
31.15 		Subdivision 1.Applicability. Every (a) A cannabis business with a license or 
31.16 	endorsement authorizing the seeking to conduct retail sale sales of cannabis flower or,
31.17 	cannabis products, hemp-derived consumer products, or lower-potency hemp edible products
31.18 	must comply with the requirements of this section apply for and obtain a cannabis retail 
31.19 	operations endorsement.
31.20 	(b) A cannabis retail operations endorsement is available to the following license holders:
31.21 	(1) cannabis microbusinesses;
31.22 	(2) cannabis mezzobusinesses;
31.23 	(3) cannabis retailers; and
31.24 	(4) cannabis macrobusinesses.

31.25 	Sec. 19. Minnesota Statutes 2024, section 342.27, is amended by adding a subdivision to 
31.26 	read:
31.27 		Subd. 2a.Cannabis flower packaging endorsement. (a) A cannabis business seeking 
31.28 	to package cannabis flower at a point of retail sale must apply for and obtain a cannabis 
31.29 	flower packaging endorsement.
31.30 	(b) A cannabis business with a cannabis flower packaging endorsement must package 
31.31 	cannabis flower in a container that:
32.1 	(1) complies with all packaging requirements in section 342.62;
32.2 	(2) complies with all applicable rules; and
32.3 	(3) includes an affixed label on the container that, at the final point of sale to a customer 
32.4 	or patient, meets all requirements in section 342.63 and applicable rules.
32.5 	(c) A cannabis business with a cannabis flower packaging endorsement may store bulk 
32.6 	cannabis flower intended to be packaged at the point of sale outside of the secure storage 
32.7 	area during operating hours. At the end of operating hours, the business must ensure that 
32.8 	bulk cannabis flower is placed in the secure storage area.
32.9 	(d) A cannabis flower packaging endorsement is available to the following license holders 
32.10 	only if the license holder holds a cannabis retail operations endorsement:
32.11 	(1) cannabis microbusinesses;
32.12 	(2) cannabis mezzobusinesses;
32.13 	(3) cannabis retailers; or
32.14 	(4) cannabis macrobusinesses.

32.15 	Sec. 20. Minnesota Statutes 2024, section 342.28, subdivision 6, is amended to read:
32.16 		Subd. 6.Cannabis cultivation endorsement. A cannabis microbusiness that cultivates 
32.17 	cannabis plants and harvests cannabis flower must apply for and obtain a cannabis cultivation 
32.18 	endorsement and comply with the requirements in section 342.25.

32.19 	Sec. 21. Minnesota Statutes 2024, section 342.28, subdivision 7, is amended to read:
32.20 		Subd. 7.Cannabis extraction and concentration endorsement, hemp extraction and 
32.21 	concentration endorsement, and creation of artificially derived cannabinoids 
32.22 	endorsement. (a) A cannabis microbusiness that creates seeking to manufacture cannabis 
32.23 	concentrate must apply for and obtain a cannabis extraction and concentration endorsement 
32.24 	and comply with the requirements in section 342.26, subdivisions 2 and 3.
32.25 	(b) A cannabis microbusiness seeking to manufacture hemp concentrate must apply for 
32.26 	and obtain a hemp extraction and concentration endorsement and comply with the 
32.27 	requirements in section 342.26, subdivisions 2 and 3.
32.28 	(c) A cannabis microbusiness seeking to manufacture artificially derived cannabinoids 
32.29 	must apply for and obtain a creation of artificially derived cannabinoids endorsement and 
32.30 	comply with the requirements in section 342.26, subdivisions 2 and 3.

33.1 	Sec. 22. Minnesota Statutes 2025 Supplement, section 342.28, subdivision 8, is amended 
33.2 	to read:
33.3 		Subd. 8.Production of consumer products endorsement and edible cannabinoid 
33.4 	product handler endorsement. (a) A cannabis microbusiness that manufactures edible
33.5 	seeking to manufacture cannabis products, lower-potency hemp products, or hemp-derived 
33.6 	consumer products must apply for and obtain a production of consumer products endorsement 
33.7 	and comply with the requirements in section 342.26, subdivisions 2 and 4.
33.8 	(b) A cannabis microbusiness seeking to manufacture edible cannabis products or 
33.9 	lower-potency hemp edibles must apply for and obtain an edible cannabinoid product handler 
33.10 	endorsement and comply with the requirements in section 342.26, subdivisions 2 and 4.

33.11 	Sec. 23. Minnesota Statutes 2024, section 342.28, subdivision 9, is amended to read:
33.12 		Subd. 9.Retail operations endorsement. (a) A cannabis microbusiness that operates
33.13 	seeking to operate a retail location must apply for and obtain a cannabis retail operations 
33.14 	endorsement and comply with the requirements in section 342.27.
33.15 	(b) A cannabis microbusiness with a cannabis retail operations endorsement may apply 
33.16 	for and obtain a cannabis flower packaging endorsement subject to the requirements in 
33.17 	section 342.27, subdivision 2a.

33.18 	Sec. 24. Minnesota Statutes 2024, section 342.28, subdivision 11, is amended to read:
33.19 		Subd. 11.Transportation between facilitiesInternal transporter endorsement. A 
33.20 	cannabis microbusiness may seeking to transport immature cannabis plants and seedlings, 
33.21 	cannabis flower, cannabis products, artificially derived cannabinoids, hemp plant parts, 
33.22 	hemp concentrate, lower-potency hemp edibles, and hemp-derived consumer products 
33.23 	between facilities operated by the cannabis microbusiness if must apply for and obtain an 
33.24 	internal transporter endorsement. To obtain an internal transporter endorsement, the cannabis 
33.25 	microbusiness must:
33.26 	(1) provides provide the office with the information described in section 342.35, 
33.27 	subdivision 2; and
33.28 	(2) complies comply with the requirements of section 342.36.

34.1 	Sec. 25. Minnesota Statutes 2024, section 342.28, is amended by adding a subdivision to 
34.2 	read:
34.3 		Subd. 12.Medical cannabis cultivation endorsement. (a) A cannabis microbusiness 
34.4 	with a cultivation endorsement may apply for and obtain a medical cannabis cultivation 
34.5 	endorsement described in section 342.51, subdivision 1b.
34.6 	(b) A cannabis microbusiness with a medical cannabis cultivation endorsement that 
34.7 	cultivates cannabis at an indoor facility and meets the requirements of section 342.51, 
34.8 	subdivision 1b, may cultivate up to 1,000 square feet of plant canopy in addition to the 
34.9 	limits in section 342.28, subdivision 2, paragraph (a).
34.10 	(c) A cannabis microbusiness with a medical cannabis cultivation endorsement that 
34.11 	cultivates cannabis at an outdoor location and meets the requirements of section 342.51, 
34.12 	subdivision 1b, may cultivate up to one-quarter acre of mature flowering plants in addition 
34.13 	to the limits in section 342.28, subdivision 2, paragraph (b).

34.14 	Sec. 26. Minnesota Statutes 2024, section 342.28, is amended by adding a subdivision to 
34.15 	read:
34.16 		Subd. 13.Medical cannabis manufacturer endorsement. (a) A cannabis microbusiness 
34.17 	may apply for and obtain a medical cannabis manufacturer endorsement as described in 
34.18 	section 342.51, subdivision 1c.
34.19 	(b) A cannabis microbusiness with a medical cannabis manufacturer endorsement that 
34.20 	meets the requirements of section 342.51, subdivision 1c, may manufacture cannabis 
34.21 	products, lower-potency hemp edibles, hemp-derived consumer products, or medical 
34.22 	cannabinoid products up to 25 percent above the limit established in rule for the 
34.23 	manufacturing capacity of a cannabis microbusiness.

34.24 	Sec. 27. Minnesota Statutes 2024, section 342.28, is amended by adding a subdivision to 
34.25 	read:
34.26 		Subd. 14.Medical cannabis retail endorsement. (a) A cannabis microbusiness with a 
34.27 	retail endorsement may apply for and obtain a medical cannabis retail endorsement described 
34.28 	in section 342.51, subdivision 1d.
34.29 	(b) A cannabis microbusiness with a medical cannabis retail endorsement that meets the 
34.30 	requirements of section 342.51, subdivision 1d, may operate one additional retail location 
34.31 	in excess of the limit in section 342.28, subdivision 2, paragraph (d), if at least one retail 
34.32 	location is located in an area identified by the office as a high medical need area.

35.1 	Sec. 28. Minnesota Statutes 2024, section 342.28, is amended by adding a subdivision to 
35.2 	read:
35.3 		Subd. 15.External transporter endorsement. A cannabis microbusiness with at least 
35.4 	two medical cannabis endorsements as described in section 342.51, subdivisions 1b, 1c, 
35.5 	and 1d, may apply for and obtain an external transporter endorsement as described in section 
35.6 	342.51, subdivision 1e.

35.7 	Sec. 29. Minnesota Statutes 2024, section 342.28, is amended by adding a subdivision to 
35.8 	read:
35.9 		Subd. 16.Medical cannabis delivery endorsement. A cannabis microbusiness with a 
35.10 	medical cannabis retail endorsement may apply for and obtain a medical cannabis delivery 
35.11 	endorsement as described in section 342.51, subdivision 1e.

35.12 	Sec. 30. Minnesota Statutes 2024, section 342.29, subdivision 5, is amended to read:
35.13 		Subd. 5.Cannabis cultivation endorsement. A cannabis mezzobusiness that cultivates
35.14 	seeking to cultivate cannabis plants and harvestsharvest cannabis flower must apply for 
35.15 	and obtain a cannabis cultivation endorsement and comply with the requirements in section 
35.16 	342.25.

35.17 	Sec. 31. Minnesota Statutes 2024, section 342.29, subdivision 6, is amended to read:
35.18 		Subd. 6.Cannabis extraction and concentration endorsement, hemp extraction and 
35.19 	concentration endorsement, and creation of artificially derived cannabinoids 
35.20 	endorsement. (a) A cannabis mezzobusiness that creates seeking to manufacture cannabis 
35.21 	concentrate must apply for and obtain a cannabis extraction and concentration endorsement 
35.22 	and comply with the requirements in section 342.26, subdivisions 2 and 3.
35.23 	(b) A cannabis mezzobusiness seeking to manufacture hemp concentrate must apply for 
35.24 	and obtain a hemp extraction and concentration endorsement and comply with the 
35.25 	requirements in section 342.26, subdivisions 2 and 3.
35.26 	(c) A cannabis mezzobusiness seeking to manufacture artificially derived cannabinoids 
35.27 	must apply for and obtain a creation of artificially derived cannabinoids endorsement and 
35.28 	comply with the requirements in section 342.26, subdivisions 2 and 3.

36.1 	Sec. 32. Minnesota Statutes 2025 Supplement, section 342.29, subdivision 7, is amended 
36.2 	to read:
36.3 		Subd. 7.Production of consumer products endorsement and edible cannabinoid 
36.4 	product handler endorsement. (a) A cannabis mezzobusiness that manufactures edible
36.5 	seeking to manufacture cannabis products, lower-potency hemp products, or hemp-derived 
36.6 	consumer products must apply for and obtain a production of consumer products endorsement 
36.7 	and comply with the requirements in section 342.26, subdivisions 2 and 4.
36.8 	(b) A cannabis mezzobusiness seeking to manufacture edible cannabis products or 
36.9 	lower-potency hemp edibles must apply for and obtain an edible cannabinoid product handler 
36.10 	endorsement and comply with the requirements in section 342.26, subdivisions 2 and 4.

36.11 	Sec. 33. Minnesota Statutes 2024, section 342.29, subdivision 8, is amended to read:
36.12 		Subd. 8.Retail operations endorsement. (a) A cannabis mezzobusiness that operates
36.13 	seeking to operate a retail location must apply for and obtain a cannabis retail operations 
36.14 	endorsement and comply with the requirements in section 342.27.
36.15 	(b) A cannabis mezzobusiness with a cannabis retail operations endorsement may apply 
36.16 	for and obtain a cannabis flower packaging endorsement subject to the requirements in 
36.17 	section 342.27, subdivision 2a.

36.18 	Sec. 34. Minnesota Statutes 2024, section 342.29, subdivision 8a, is amended to read:
36.19 		Subd. 8a.Multiple endorsements required. (a) Within 18 months of receiving a cannabis 
36.20 	mezzobusiness license, a cannabis mezzobusiness must apply for and obtain at least two of 
36.21 	the following endorsements identified in subdivisions 5, 6, 7, and 8.:
36.22 	(1) a cannabis cultivation endorsement under section 342.25;
36.23 	(2) a cannabis extraction and concentration endorsement under section 342.26;
36.24 	(3) a hemp extraction and concentration endorsement under section 342.26;
36.25 	(4) a creation of artificially derived cannabinoids endorsement under section 342.26;
36.26 	(5) an edible cannabinoid product handler endorsement under section 342.26;
36.27 	(6) a production of consumer products endorsement under section 342.26; or
36.28 	(7) a cannabis retail operations endorsement under section 342.27.
36.29 	(b) If a cannabis mezzobusiness fails to obtain multiple endorsements within 18 months, 
36.30 	the office may suspend, revoke, or not renew the license as provided in section 342.21.

37.1 	Sec. 35. Minnesota Statutes 2024, section 342.29, subdivision 10, is amended to read:
37.2 		Subd. 10.Transportation between facilitiesInternal transporter endorsement. A 
37.3 	cannabis mezzobusiness may seeking to transport immature cannabis plants and seedlings, 
37.4 	cannabis flower, cannabis products, artificially derived cannabinoids, hemp plant parts, 
37.5 	hemp concentrate, lower-potency hemp edibles, and hemp-derived consumer products 
37.6 	between facilities operated by the cannabis mezzobusiness if must apply for and obtain an 
37.7 	internal transporter endorsement. To obtain an internal transporter endorsement, the cannabis 
37.8 	mezzobusiness must:
37.9 	(1) provides provide the office with the information described in section 342.35, 
37.10 	subdivision 2; and
37.11 	(2) complies comply with the requirements of section 342.36.

37.12 	Sec. 36. Minnesota Statutes 2024, section 342.29, is amended by adding a subdivision to 
37.13 	read:
37.14 		Subd. 11.Medical cannabis cultivation endorsement. (a) A cannabis mezzobusiness 
37.15 	with a cultivation endorsement may apply for and obtain a medical cannabis cultivation 
37.16 	endorsement described in section 342.51, subdivision 1b.
37.17 	(b) A cannabis mezzobusiness with a medical cannabis cultivation endorsement that 
37.18 	cultivates cannabis at an indoor facility and meets the requirements of section 342.51, 
37.19 	subdivision 1b, may cultivate up to 3,000 square feet of plant canopy in addition to the 
37.20 	limits in section 342.29, subdivision 2, paragraph (a).
37.21 	(c) A cannabis mezzobusiness with a medical cannabis cultivation endorsement that 
37.22 	cultivates cannabis at an outdoor location and meets the requirements of section 342.51, 
37.23 	subdivision 1b, may cultivate up to one-half acre of mature flowering plants in addition to 
37.24 	the limits in section 342.29, subdivision 2, paragraph (b).

37.25 	Sec. 37. Minnesota Statutes 2024, section 342.29, is amended by adding a subdivision to 
37.26 	read:
37.27 		Subd. 12.Medical cannabis manufacturer endorsement. (a) A cannabis mezzobusiness 
37.28 	may apply for and obtain a medical cannabis manufacturer endorsement as described in 
37.29 	section 342.51, subdivision 1c.
37.30 	(b) A cannabis mezzobusiness with a medical cannabis manufacturer endorsement that 
37.31 	meets the requirements of section 342.51, subdivision 1c, may manufacture cannabis 
37.32 	products, lower-potency hemp edibles, hemp-derived consumer products, or medical 
38.1 	cannabinoid products up to 25 percent above the limit established in rule for the 
38.2 	manufacturing capacity of a cannabis mezzobusiness.

38.3 	Sec. 38. Minnesota Statutes 2024, section 342.29, is amended by adding a subdivision to 
38.4 	read:
38.5 		Subd. 13.Medical cannabis retail endorsement. (a) A cannabis mezzobusiness with 
38.6 	a retail endorsement may apply for and obtain a medical cannabis retail endorsement 
38.7 	described in section 342.51, subdivision 1d.
38.8 	(b) A cannabis mezzobusiness with a medical cannabis retail endorsement that meets 
38.9 	the requirements of section 342.51, subdivision 1d, may operate up to two additional retail 
38.10 	locations in excess of the limit in section 342.29, subdivision 2, paragraph (d), if at least 
38.11 	two retail locations are located in an area identified by the office as a high medical need 
38.12 	area.

38.13 	Sec. 39. Minnesota Statutes 2024, section 342.29, is amended by adding a subdivision to 
38.14 	read:
38.15 		Subd. 14.External transporter endorsement. A cannabis mezzobusiness with at least 
38.16 	two medical cannabis endorsements as described in section 342.51, subdivisions 1b, 1c, 
38.17 	and 1d, may apply for and obtain an external transporter endorsement as described in section 
38.18 	342.51, subdivision 1e.

38.19 	Sec. 40. Minnesota Statutes 2024, section 342.29, is amended by adding a subdivision to 
38.20 	read:
38.21 		Subd. 15.Medical cannabis delivery endorsement. A cannabis mezzobusiness with 
38.22 	a medical cannabis retail endorsement may apply for and obtain a medical cannabis delivery 
38.23 	endorsement as described in section 342.51, subdivision 1e.

38.24 	Sec. 41. Minnesota Statutes 2025 Supplement, section 342.30, subdivision 1, is amended 
38.25 	to read:
38.26 		Subdivision 1.Authorized actions. (a) A cannabis cultivator seeking to cultivate cannabis 
38.27 	must apply for and obtain a cannabis cultivation endorsement.
38.28 	(b) A cannabis cultivator license entitles the license holder to with a cannabis cultivation 
38.29 	endorsement may:
39.1 	(1) grow cannabis plants within the approved amount of space from seed or immature 
39.2 	plant to mature plant;
39.3 	(2) harvest cannabis flower from a mature plant;
39.4 	(3) package and label immature cannabis plants and seedlings and cannabis flower for 
39.5 	sale to other cannabis businesses;
39.6 	(4) sell immature cannabis plants and seedlings and cannabis flower to other cannabis 
39.7 	businesses;
39.8 	(5) transport cannabis flower to a cannabis manufacturer located on the same premises; 
39.9 	and
39.10 	(6) perform other actions approved by the office.

39.11 	Sec. 42. Minnesota Statutes 2024, section 342.30, subdivision 3, is amended to read:
39.12 		Subd. 3.Additional information required. In addition to the information required to 
39.13 	be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, 
39.14 	a person, cooperative, or business seeking a cannabis cultivator license cultivation 
39.15 	endorsement must submit the following information in a form approved by the office:
39.16 	(1) an operating plan demonstrating the proposed size and layout of the cultivation 
39.17 	facility; plans for wastewater and waste disposal for the cultivation facility; plans for 
39.18 	providing electricity, water, and other utilities necessary for the normal operation of the 
39.19 	cultivation facility; and plans for compliance with the applicable building code and federal 
39.20 	and state environmental and workplace safety requirements;
39.21 	(2) a cultivation plan demonstrating the proposed size and layout of the cultivation 
39.22 	facility that will be used exclusively for cultivation including the total amount of plant 
39.23 	canopy; and
39.24 	(3) evidence that the business will comply with the applicable operation requirements 
39.25 	for the license being sought.

39.26 	Sec. 43. Minnesota Statutes 2024, section 342.30, is amended by adding a subdivision to 
39.27 	read:
39.28 		Subd. 6.Medical cannabis cultivation endorsement. (a) A cannabis cultivator with a 
39.29 	cultivation endorsement may apply for and obtain a medical cannabis cultivation endorsement 
39.30 	described in section 342.51, subdivision 1b.
40.1 	(b) A cannabis cultivator with a medical cannabis cultivation endorsement that cultivates 
40.2 	cannabis at an indoor facility and meets the requirements of section 342.51, subdivision 1b, 
40.3 	may cultivate up to 6,000 square feet of plant canopy in addition to the limits in section 
40.4 	342.30, subdivision 2, paragraph (a).
40.5 	(c) A cannabis cultivator with a medical cannabis cultivation endorsement that cultivates 
40.6 	cannabis at an outdoor location and meets the requirements of section 342.51, subdivision 
40.7 	1b, may cultivate up to one acre of mature flowering plants in addition to the limits in section 
40.8 	342.30, subdivision 2, paragraph (b).

40.9 	Sec. 44. Minnesota Statutes 2024, section 342.31, subdivision 3, is amended to read:
40.10 		Subd. 3.Additional information required. In addition to the information required to 
40.11 	be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, 
40.12 	a person, cooperative, or business seeking a cannabis manufacturer license extraction and 
40.13 	concentration endorsement, a hemp extraction and concentration endorsement, a creation 
40.14 	of artificially derived cannabinoids endorsement, a production of consumer products 
40.15 	endorsement, or an edible product handler endorsement must submit the following 
40.16 	information in a form approved by the office:
40.17 	(1) an operating plan demonstrating the proposed layout of the facility, including a 
40.18 	diagram of ventilation and filtration systems; plans for wastewater and waste disposal for 
40.19 	the manufacturing facility; plans for providing electricity, water, and other utilities necessary 
40.20 	for the normal operation of the manufacturing facility; and plans for compliance with 
40.21 	applicable building code and federal and state environmental and workplace safety 
40.22 	requirements; and
40.23 	(2) evidence that the business will comply with the applicable operation requirements 
40.24 	for the endorsement being sought.

40.25 	Sec. 45. Minnesota Statutes 2024, section 342.31, subdivision 5, is amended to read:
40.26 		Subd. 5.Manufacturing operations and endorsements. (a) A cannabis manufacturer 
40.27 	must comply with the requirements in section 342.26. A cannabis manufacturer must apply 
40.28 	for and obtain a cannabis extraction and concentration endorsement, a hemp extraction and 
40.29 	concentration endorsement, a creation of artificially derived cannabinoids endorsement, a 
40.30 	production of consumer products endorsement, or an edible product handler endorsement 
40.31 	before conducting activities authorized only under the applicable endorsement.
41.1 	(b) A cannabis manufacturer may apply for and obtain a medical cannabis manufacturer 
41.2 	endorsement as described in section 342.51, subdivision 1c.

41.3 	Sec. 46. Minnesota Statutes 2025 Supplement, section 342.32, subdivision 1, is amended 
41.4 	to read:
41.5 		Subdivision 1.Authorized actions. (a) A cannabis retailer seeking to conduct retail 
41.6 	sales of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
41.7 	consumer products must apply for and obtain a cannabis retail operations endorsement.
41.8 	(b) A cannabis retailer license entitles the license holder to with a cannabis retail 
41.9 	operations endorsement may:
41.10 	(1) purchase immature cannabis plants and seedlings, cannabis flower, cannabis products, 
41.11 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
41.12 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
41.13 	cannabis wholesalers, and medical cannabis combination businesses;
41.14 	(2) purchase lower-potency hemp edibles from a licensed lower-potency hemp edible 
41.15 	manufacturer or lower-potency hemp edible wholesaler;
41.16 	(3) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
41.17 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
41.18 	other products authorized by law to customers; and
41.19 	(4) perform other actions approved by the office.

41.20 	Sec. 47. Minnesota Statutes 2024, section 342.32, subdivision 3, is amended to read:
41.21 		Subd. 3.Additional information required. In addition to the information required to 
41.22 	be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, 
41.23 	a person, cooperative, or business seeking a cannabis retail license operations endorsement
41.24 	must submit the following information in a form approved by the office:
41.25 	(1) a list of every retail license held by the applicant and, if the applicant is a business, 
41.26 	every retail license held, either as an individual or as part of another business, by each 
41.27 	officer, director, manager, and general partner of the cannabis business;
41.28 	(2) an operating plan demonstrating the proposed layout of the facility, including a 
41.29 	diagram of ventilation and filtration systems; policies to avoid sales to individuals who are 
41.30 	under 21 years of age; identification of a restricted area for storage; and plans to prevent 
42.1 	the visibility of cannabis flower, cannabis products, lower-potency hemp edibles, and 
42.2 	hemp-derived consumer products to individuals outside the retail location; and
42.3 	(3) evidence that the business will comply with the applicable operation requirements 
42.4 	for the license being sought.

42.5 	Sec. 48. Minnesota Statutes 2024, section 342.32, is amended by adding a subdivision to 
42.6 	read:
42.7 		Subd. 6.Medical cannabis retail endorsement and medical cannabis delivery 
42.8 	endorsement. (a) A cannabis retailer with a retail endorsement may apply for and obtain 
42.9 	a medical cannabis retail endorsement described in section 342.51, subdivision 1d.
42.10 	(b) A cannabis retailer with a medical cannabis retail endorsement that meets the 
42.11 	requirements of section 342.51, subdivision 1d, may operate up to three additional retail 
42.12 	locations in excess of the limit in subdivision 2, if three retail locations are located in an 
42.13 	area identified by the office as a high medical need area.
42.14 	(c) A cannabis retailer with a medical cannabis retail endorsement may apply for and 
42.15 	obtain a medical cannabis delivery endorsement as described in section 342.51, subdivision 
42.16 	1e.

42.17 	Sec. 49. Minnesota Statutes 2025 Supplement, section 342.43, subdivision 2, is amended 
42.18 	to read:
42.19 		Subd. 2.Multiple licenses; limits. (a) A person, cooperative, or business may hold any 
42.20 	combination of a lower-potency hemp edible manufacturer, a lower-potency hemp edible 
42.21 	wholesaler, and a lower-potency hemp edible retailer license.
42.22 	(b) Nothing in this section prohibits a person, cooperative, or business from holding a 
42.23 	lower-potency hemp edible manufacturer license, a lower-potency hemp edible wholesaler 
42.24 	license, a lower-potency hemp edible retailer license, or any combination of those licenses, 
42.25 	and also holding a license to cultivate industrial hemp issued pursuant to chapter 18K.
42.26 	(c) Nothing in this section prohibits a person, cooperative, or business from holding a 
42.27 	lower-potency hemp edible manufacturer license, a lower-potency hemp edible wholesaler 
42.28 	license, a lower-potency hemp edible retailer license, or any combination of those licenses, 
42.29 	and also holding any other license, including but not limited to a license to prepare or sell 
42.30 	food; sell tobacco, tobacco-related devices, electronic delivery devices as defined in section 
42.31 	609.685, subdivision 1, and nicotine and lobelia delivery products as described in section 
43.1 	609.6855; or manufacture or sell alcoholic beverages as defined in section 340A.101, 
43.2 	subdivision 2.
43.3 	(d) A person, cooperative, or business holding a lower-potency hemp edible manufacturer 
43.4 	license, a lower-potency hemp edible wholesaler license, a lower-potency hemp edible 
43.5 	retailer license, or any combination of those licenses, may not hold a cannabis business 
43.6 	license.

43.7 	Sec. 50. Minnesota Statutes 2025 Supplement, section 342.44, subdivision 1, is amended 
43.8 	to read:
43.9 		Subdivision 1.Application; contents. (a) Except as otherwise provided in this 
43.10 	subdivision, the provisions of this chapter relating to license applications, license selection 
43.11 	criteria, general ownership disqualifications and requirements, and general operational 
43.12 	requirements do not apply to hemp businesses.
43.13 	(b) The office shall establish forms and procedures for the processing of hemp licenses 
43.14 	issued under this chapter. At a minimum, any application to obtain or renew a hemp license 
43.15 	shall include the following information, if applicable:
43.16 	(1) the name, address, and date of birth of the applicant;
43.17 	(2) the address and legal property description of the business;
43.18 	(3) proof of trade name registration;
43.19 	(4) certification that the applicant will comply with the requirements of this chapter 
43.20 	relating to the ownership and operation of a hemp business;
43.21 	(5) identification of one or more controlling persons or managerial employees as agents 
43.22 	who shall be responsible for dealing with the office on all matters; and
43.23 	(6) a statement that the applicant agrees to respond to the office's supplemental requests 
43.24 	for information.
43.25 	(c) An applicant for a lower-potency hemp edible manufacturer license must submit an 
43.26 	attestation signed by a bona fide labor organization stating that the applicant has entered 
43.27 	into a labor peace agreement. A labor peace agreement entered into on or after August 15, 
43.28 	2025, must address the duration of the election.
43.29 	(d) The office may determine whether any civil or regulatory violation as determined 
43.30 	by the office, another state agency, a local government, or any other jurisdiction disqualifies 
43.31 	an individual or business from receiving a hemp business license issued under this chapter. 
43.32 	The office may determine the length of the disqualification.

44.1 	Sec. 51. Minnesota Statutes 2024, section 342.44, subdivision 2, is amended to read:
44.2 		Subd. 2.Issuance; eligibility; prohibition on transfer. (a) The office may issue a hemp 
44.3 	business license to an applicant who:
44.4 	(1) is at least 21 years of age;
44.5 	(2) has completed an application for licensure or application for renewal and has fully 
44.6 	and truthfully complied with all information requests relating to license application and 
44.7 	renewal;
44.8 	(3) has paid the applicable application and license fees pursuant to section 342.11; and
44.9 	(4) is not employed by the office or any state agency with regulatory authority over this 
44.10 	chapter; and.
44.11 	(5) does not hold any cannabis business license.
44.12 	(b) Licenses must be renewed annually.
44.13 	(c) Licenses may not be transferred.

44.14 	Sec. 52. Minnesota Statutes 2024, section 342.45, subdivision 3, is amended to read:
44.15 		Subd. 3.Extraction and concentration. (a) A lower-potency hemp edible manufacturer 
44.16 	that creates seeking to create hemp concentrate or must apply for and obtain a lower-potency 
44.17 	hemp extraction and concentration endorsement. A lower-potency hemp edible manufacturer 
44.18 	seeking to create artificially derived cannabinoids must apply for and obtain an a 
44.19 	lower-potency hemp creation of artificially derived cannabinoid endorsement from the 
44.20 	office.
44.21 	(b) A lower-potency hemp edible manufacturer seeking an with a lower-potency hemp 
44.22 	extraction and concentration endorsement to create hemp concentrate must inform the office 
44.23 	of all methods of extraction and concentration that the manufacturer intends to use and 
44.24 	identify the volatile chemicals, if any, that will be involved in the creation of hemp 
44.25 	concentrate. A lower-potency hemp edible manufacturer may not use a method of extraction 
44.26 	and concentration or a volatile chemical without approval by the office.
44.27 	(c) A lower-potency hemp edible manufacturer seeking an with a lower-potency hemp 
44.28 	creation of artificially derived cannabinoid endorsement to create artificially derived 
44.29 	cannabinoids must inform the office of all methods of conversion that the manufacturer will 
44.30 	use, including any specific catalysts that the manufacturer will employ, to create artificially 
44.31 	derived cannabinoids and the molecular nomenclature of all cannabinoids or other chemical 
44.32 	compounds that the manufacturer will create. A business licensed or authorized to 
45.1 	manufacture lower-potency hemp edibles lower-potency hemp edible manufacturer may 
45.2 	not use a method of conversion or a catalyst without approval by the office.
45.3 	(d) A lower-potency hemp edible manufacturer with a lower-potency hemp extraction 
45.4 	and concentration endorsement or a lower-potency hemp creation of artificially derived 
45.5 	cannabinoid endorsement must obtain a certification from an independent third-party 
45.6 	industrial hygienist or professional engineer approving:
45.7 	(1) all electrical, gas, fire suppression, and exhaust systems; and
45.8 	(2) the plan for safe storage and disposal of hazardous substances, including but not 
45.9 	limited to any volatile chemicals.
45.10 	(e) Upon the sale of hemp concentrate or artificially derived cannabinoids to any person, 
45.11 	cooperative, or business, a lower-potency hemp edible manufacturer must provide a statement 
45.12 	to the buyer that discloses the method of extraction and concentration or conversion used 
45.13 	and any solvents, gases, or catalysts, including but not limited to any volatile chemicals 
45.14 	involved in that method.

45.15 	Sec. 53. Minnesota Statutes 2025 Supplement, section 342.62, subdivision 2, is amended 
45.16 	to read:
45.17 		Subd. 2.Packaging requirements. (a) Except as provided in paragraph (b), All cannabis 
45.18 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products 
45.19 	sold to customers or patients must be:
45.20 	(1) prepackaged in packaging or a container that is child-resistant, tamper-evident, and 
45.21 	opaque; or.
45.22 	(2) placed in packaging or a container that is plain, child-resistant, tamper-evident, and 
45.23 	opaque at the final point of sale to a customer.
45.24 	(b) All cannabis flower sold to customers or patients must be prepackaged unless the 
45.25 	business selling the cannabis flower holds a cannabis flower packaging endorsement.
45.26 	(b) (c) The requirement that packaging be child-resistant does not apply to a 
45.27 	lower-potency hemp edible that is intended to be consumed as a beverage.
45.28 	(c) (d) If a cannabis product, lower-potency hemp edible, or a hemp-derived consumer 
45.29 	product is packaged in a manner that includes more than a single serving, each serving must 
45.30 	be indicated by scoring, wrapping, or other indicators designating the individual serving 
45.31 	size.
46.1 	(d) (e) Notwithstanding paragraph (c) (d), any edible cannabinoid products that are 
46.2 	intended to be combined with food or beverage products before consumption must indicate 
46.3 	a single serving using one of the following methods:
46.4 	(1) the product is packaged in individual servings;
46.5 	(2) the product indicates a single serving by scoring or use of another indicator that 
46.6 	appears on the product; or
46.7 	(3) the product is sold with a calibrated dropper, measuring spoon, or similar device for 
46.8 	measuring a single serving.
46.9 	(e) (f) A package containing multiple servings of a lower-potency hemp edible that is 
46.10 	not intended to be consumed as a beverage must not contain:
46.11 	(1) more than 50 milligrams of delta-9 tetrahydrocannabinol;
46.12 	(2) more than 1,000 milligrams of cannabidiol, cannabigerol, cannabinol, or 
46.13 	cannabichromene:;
46.14 	(3) more than the established limit of any other cannabinoid authorized by the office; 
46.15 	or
46.16 	(4) any combination of those cannabinoids that exceeds the identified amounts for the 
46.17 	applicable product category.
46.18 	(f) (g) A single container containing a lower-potency hemp edible product that is intended 
46.19 	to be consumed as a beverage must not contain:
46.20 	(1) more than ten milligrams of delta-9 tetrahydrocannabinol;
46.21 	(2) more than 200 milligrams of cannabidiol, cannabigerol, cannabinol, or 
46.22 	cannabichromene;
46.23 	(3) more than the established limit of any other cannabinoid authorized by the office; 
46.24 	or
46.25 	(4) any combination of those cannabinoids that exceeds the identified amounts for the 
46.26 	applicable product category.
46.27 	(g) (h) Edible cannabis products and lower-potency hemp edibles containing more than 
46.28 	a single serving must be prepackaged or placed at the final point of sale in packaging or a 
46.29 	container that is resealable.

47.1 	Sec. 54. Minnesota Statutes 2025 Supplement, section 342.63, subdivision 2, is amended 
47.2 	to read:
47.3 		Subd. 2.Content of label; cannabis. All cannabis flower and hemp-derived consumer 
47.4 	products that consist of hemp plant parts sold to customers or patients must have affixed 
47.5 	on the packaging or container of the cannabis flower or hemp-derived consumer product a 
47.6 	label that contains at least the following information:
47.7 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
47.8 	cannabis cultivator, medical cannabis combination business, or industrial hemp grower 
47.9 	where the cannabis flower or hemp plant part was cultivated;
47.10 	(2) the net weight of cannabis flower or hemp plant parts in the package or container;
47.11 	(3) the batch number;
47.12 	(4) the cannabinoid profile;
47.13 	(5) a universal symbol established by the office indicating that the package or container 
47.14 	contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
47.15 	hemp-derived consumer product;
47.16 	(6) verification that the cannabis flower or hemp plant part was tested according to 
47.17 	section 342.61 and that the cannabis flower or hemp plant part complies with the applicable 
47.18 	standards;
47.19 	(7) information on the usage of the cannabis flower or hemp-derived consumer product
47.20 	the type of product, including directions on usage;
47.21 	(8) the following statement: "Keep this product out of reach of children." the warning 
47.22 	symbol established by the office indicating that the product is not for children and information 
47.23 	about the Minnesota Poison Control Center; and
47.24 	(9) any other statements or information required by the office.

47.25 	Sec. 55. Minnesota Statutes 2025 Supplement, section 342.63, subdivision 3, is amended 
47.26 	to read:
47.27 		Subd. 3.Content of label; cannabinoid products excluding lower-potency hemp 
47.28 	edibles. (a) All cannabis products, lower-potency hemp edibles, hemp concentrate, 
47.29 	hemp-derived consumer products other than products subject to the requirements under 
47.30 	subdivision 2, and medical cannabinoid products, and hemp-derived topical products sold 
47.31 	to customers or patients must have affixed to the packaging or container of the cannabis
47.32 	product a label that contains at least the following information:
48.1 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
48.2 	cannabis cultivator, medical cannabis combination business, or industrial hemp grower that 
48.3 	cultivated the cannabis flower or hemp plant parts used in the cannabis product, 
48.4 	lower-potency hemp edible, hemp-derived consumer product, or medical cannabinoid 
48.5 	product;
48.6 	(2) (1) the name and license number of the cannabis microbusiness, cannabis 
48.7 	mezzobusiness, cannabis manufacturer, lower-potency hemp edible manufacturer, medical 
48.8 	cannabis combination business, or industrial hemp grower that manufactured the cannabis 
48.9 	concentrate, hemp concentrate, or artificially derived cannabinoid and, if different, the name 
48.10 	and license number of the cannabis microbusiness, cannabis mezzobusiness, cannabis 
48.11 	manufacturer, lower-potency hemp edible manufacturer, or medical cannabis combination 
48.12 	business that manufactured the product;
48.13 	(3) (2) the net weight of the cannabis product, lower-potency hemp edible, or 
48.14 	hemp-derived consumer product in the package or container;
48.15 	(4) (3) the type of cannabis product, lower-potency hemp edible, or hemp-derived 
48.16 	consumer product including directions on usage;
48.17 	(5) (4) the batch number;
48.18 	(6) (5) the serving size;
48.19 	(7) (6) the cannabinoid profile per serving and in total;
48.20 	(8) (7) a list of ingredients;
48.21 	(9) (8) a universal symbol established by the office indicating that the package or 
48.22 	container contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
48.23 	hemp-derived consumer product;
48.24 	(10)(9) a warning symbol developed by the office in consultation with the commissioner 
48.25 	of health and the Minnesota Poison Control System that: established by the office indicating 
48.26 	that the product is not for children and information about the Minnesota Poison Control 
48.27 	Center;
48.28 	(i) is at least three-quarters of an inch tall and six-tenths of an inch wide;
48.29 	(ii) is in a highly visible color;
48.30 	(iii) includes a visual element that is commonly understood to mean a person should 
48.31 	stop;
48.32 	(iv) indicates that the product is not for children; and
49.1 	(v) includes the phone number of the Minnesota Poison Control System;
49.2 	(11) (10) verification that the cannabis product, lower-potency hemp edible, hemp-derived 
49.3 	consumer product, or medical cannabinoid product was tested according to section 342.61 
49.4 	and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product, 
49.5 	or medical cannabinoid product complies with the applicable standards; and
49.6 	(12) information on the usage of the product;
49.7 	(13) the following statement: "Keep this product out of reach of children."; and
49.8 	(14) (11) any other statements or information required by the office.
49.9 	(b) The office may by rule establish alternative labeling requirements for lower-potency 
49.10 	hemp edibles that are imported into the state if those requirements provide consumers with 
49.11 	information that is substantially similar to the information described in paragraph (a).

49.12 	Sec. 56. Minnesota Statutes 2024, section 342.63, subdivision 4, is amended to read:
49.13 		Subd. 4.Additional content of label; medical cannabis flower and medical 
49.14 	cannabinoid products. In addition to the applicable requirements for labeling under 
49.15 	subdivision 2 or 3, all medical cannabis flower and medical cannabinoid products must 
49.16 	include at least the following information on the label affixed to the packaging or container 
49.17 	of the medical cannabis flower or medical cannabinoid product:
49.18 	(1) the patient's name and date of birth;
49.19 	(2) if applicable, the name and date of birth of the patient's registered designated caregiver 
49.20 	or, if listed on the registry verification, the name of the patient's parent, legal guardian, or 
49.21 	spouse, if applicable; and
49.22 	(3) the patient's registry identification number.

49.23 	Sec. 57. Minnesota Statutes 2025 Supplement, section 342.63, subdivision 5, is amended 
49.24 	to read:
49.25 		Subd. 5.Content of label; hemp-derived topical products. (a) All hemp-derived topical 
49.26 	products sold to customers must have affixed to the packaging or container of the product 
49.27 	a label that contains includes at least the following information:
49.28 	(1) the manufacturer name, location, phone number, and website;
49.29 	(2) the name and address of the independent, accredited laboratory used by the 
49.30 	manufacturer to test the product;
50.1 	(3) the net weight or volume of the product in the package or container;
50.2 	(4) the type of topical product;
50.3 	(5) the amount or percentage of cannabidiol, cannabigerol, or any other cannabinoid, 
50.4 	derivative, or extract of hemp, per serving and in total;
50.5 	(6) a list of ingredients;
50.6 	(7) a statement that the product does not claim to diagnose, treat, cure, or prevent any 
50.7 	disease and that the product has not been evaluated or approved by the United States Food 
50.8 	and Drug Administration, unless the product has been so approved; and
50.9 	(8) any other statements or information required by the office.
50.10 	(b) All hemp-derived topical products that contain THC must have affixed to the product's 
50.11 	packaging or container a label that includes at least the following information:
50.12 	(1) the information required in paragraph (a);
50.13 	(2) the amount or percentage of THC per serving and the total THC;
50.14 	(3) the universal symbol established by the office indicating that the package or container 
50.15 	contains a product containing THC;
50.16 	(4) the warning symbol established by the office indicating that the product is not for 
50.17 	children and information about the Minnesota Poison Control Center; and
50.18 	(5) information that the product was tested according to section 342.61, subdivision 4.

50.19 	Sec. 58. Minnesota Statutes 2024, section 342.63, is amended by adding a subdivision to 
50.20 	read:
50.21 		Subd. 7.Labeling of lower-potency hemp edibles. (a) All lower-potency hemp edible 
50.22 	products must have affixed to the packaging or container a label that includes at least the 
50.23 	following information:
50.24 	(1) information about the business that cultivated the hemp parts used in the product, 
50.25 	including either:
50.26 	(i) the business's name, the business's address, and the country and state, if applicable, 
50.27 	where the business operates; or
50.28 	(ii) the business's name and business's license number;
50.29 	(2) information about the business that manufactured the hemp concentrate and artificially 
50.30 	derived cannabinoids used in the product, including either:
51.1 	(i) the business's name, the business's address, and the country and state, if applicable, 
51.2 	where the business operates; or
51.3 	(ii) the business's name and the business's license number;
51.4 	(3) the net weight of the lower-potency hemp edible product in the package or container;
51.5 	(4) the batch number;
51.6 	(5) the serving size;
51.7 	(6) the cannabinoid profile per serving and total THC;
51.8 	(7) a list of ingredients;
51.9 	(8) the universal symbol established by the office indicating that the package or container 
51.10 	contains a product containing THC;
51.11 	(9) the warning symbol established by the office indicating that the product is not for 
51.12 	children and information about the Minnesota Poison Control Center;
51.13 	(10) verification that the lower-potency hemp edible was tested according to section 
51.14 	342.61;
51.15 	(11) directions on the usage of the product; and
51.16 	(12) any other statements or information required by the office.
51.17 	(b) A cannabis or hemp business selling lower-potency hemp edibles to customers may 
51.18 	provide customers with the required information in paragraph (a), clauses (1), (2), and (4), 
51.19 	through the use of a scannable barcode affixed to the label of the product if the barcode is 
51.20 	accurate and active at all times.
51.21 	(c) The label of a lower-potency hemp edible product that contains only nonintoxicating 
51.22 	cannabinoids approved by the office and that does not include THC is not required to include 
51.23 	the universal symbol in paragraph (a), clause (8).

51.24 	Sec. 59. Minnesota Statutes 2024, section 342.66, subdivision 3, is amended to read:
51.25 		Subd. 3.Approved cannabinoids. (a) Products manufactured, marketed, distributed, 
51.26 	and sold under this section may contain cannabidiol or cannabigerol. Except as provided 
51.27 	in paragraph (c), products may not contain any other cannabinoid unless approved by the 
51.28 	office.
52.1 	(b) The office may approve any cannabinoid, other than any tetrahydrocannabinol, and 
52.2 	authorize its use in manufacturing, marketing, distribution, and sales under this section if 
52.3 	the office determines that the cannabinoid is a nonintoxicating cannabinoid.
52.4 	(c) A product manufactured, marketed, distributed, and sold under this section may 
52.5 	contain cannabinoids other than cannabidiol, cannabigerol, or any other cannabinoid approved 
52.6 	by the office provided that the cannabinoids arehemp concentrate that is naturally occurring 
52.7 	in hemp plants or hemp plant parts and the total of all other cannabinoids present in a product 
52.8 	does not exceed one milligram per package must not contain more than 0.3 percent total 
52.9 	THC.

52.10 	ARTICLE 3
52.11 	ADULT-USE AND MEDICAL CANNABIS STREAMLINING

52.12 	Section 1. Minnesota Statutes 2024, section 342.01, subdivision 14, is amended to read:
52.13 		Subd. 14.Cannabis business. "Cannabis business" means any of the following licensed 
52.14 	under this chapter:
52.15 	(1) cannabis microbusiness;
52.16 	(2) cannabis mezzobusiness;
52.17 	(3) cannabis cultivator;
52.18 	(4) cannabis manufacturer;
52.19 	(5) cannabis retailer;
52.20 	(6) cannabis wholesaler;
52.21 	(7) cannabis transporter;
52.22 	(8) cannabis testing facility;
52.23 	(9) cannabis event organizer;
52.24 	(10) cannabis delivery service; and
52.25 	(11) medical cannabis combination business macrobusiness.

52.26 	Sec. 2. Minnesota Statutes 2024, section 342.01, subdivision 20, is amended to read:
52.27 		Subd. 20.Cannabis product. (a) "Cannabis product" means any of the following:
52.28 	(1) cannabis concentrate;
53.1 	(2) a product infused with cannabinoids, including but not limited to tetrahydrocannabinol, 
53.2 	extracted or derived from cannabis plants or cannabis flower;
53.3 	(3) a ratio hemp-infused cannabis product; or
53.4 	(3) (4) any other product that contains cannabis concentrate.
53.5 	(b) Cannabis product includes adult-use cannabis products, including but not limited to 
53.6 	edible cannabis products and medical cannabinoid products. Cannabis product does not 
53.7 	include cannabis flower, artificially derived cannabinoid, lower-potency hemp edibles, 
53.8 	hemp-derived consumer products, or hemp-derived topical products.

53.9 	Sec. 3. Minnesota Statutes 2025 Supplement, section 342.01, subdivision 48, is amended 
53.10 	to read:
53.11 		Subd. 48.License holder. "License holder" means a person, cooperative, or business 
53.12 	that holds any of the following licenses:
53.13 	(1) cannabis microbusiness;
53.14 	(2) cannabis mezzobusiness;
53.15 	(3) cannabis cultivator;
53.16 	(4) cannabis manufacturer;
53.17 	(5) cannabis retailer;
53.18 	(6) cannabis wholesaler;
53.19 	(7) cannabis transporter;
53.20 	(8) cannabis testing facility;
53.21 	(9) cannabis event organizer;
53.22 	(10) cannabis delivery service;
53.23 	(11) lower-potency hemp edible manufacturer;
53.24 	(12) lower-potency hemp edible wholesaler;
53.25 	(13) lower-potency hemp edible retailer; or
53.26 	(14) medical cannabis combination business macrobusiness.

54.1 	Sec. 4. Minnesota Statutes 2024, section 342.01, subdivision 52, is amended to read:
54.2 		Subd. 52.Medical cannabinoid product. (a) "Medical cannabinoid product" means a 
54.3 	cannabis product that:
54.4 	(1) consists of or contains cannabis concentrate or hemp concentrate or is infused with 
54.5 	cannabinoids, including but not limited to artificially derived cannabinoids; and
54.6 	(2) is provided to a patient enrolled in the registry program; a visiting patient; a registered 
54.7 	designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient, by a 
54.8 	registered designated caregiver, cannabis retailer, or cannabis business with a medical 
54.9 	cannabis retail endorsement to treat or alleviate the symptoms of a qualifying medical 
54.10 	condition.
54.11 	(b) A medical cannabinoid product must be in the form of:
54.12 	(1) liquid, including but not limited to oil;
54.13 	(2) pill;
54.14 	(3) liquid or oil for use with a vaporized delivery method;
54.15 	(4) water-soluble cannabinoid multiparticulate, including granules, powder, and sprinkles;
54.16 	(5) orally dissolvable product, including lozenges, gum, mints, buccal tablets, and 
54.17 	sublingual tablets;
54.18 	(6) edible products in the form of gummies and chews;
54.19 	(7) topical formulation; or
54.20 	(8) any allowable form or delivery method approved by the office.
54.21 	(c) Medical cannabinoid product does not include adult-use cannabis products or 
54.22 	hemp-derived consumer products.
54.23 	(b) A medical cannabinoid product may contain or be infused with cannabinoids derived 
54.24 	from hemp that have been approved by the office as nonintoxicating.

54.25 	Sec. 5. Minnesota Statutes 2024, section 342.01, subdivision 54, is amended to read:
54.26 		Subd. 54.Medical cannabis flower. "Medical cannabis flower" means cannabis flower 
54.27 	provided to a patient enrolled in the registry program or a visiting patient; a registered 
54.28 	designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient by a 
54.29 	registered designated caregiver, cannabis retailer, or cannabis business with a medical 
55.1 	cannabis retail endorsement to treat or alleviate the symptoms of a qualifying medical 
55.2 	condition. Medical cannabis flower does not include adult-use cannabis flower.

55.3 	Sec. 6. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to 
55.4 	read:
55.5 		Subd. 63a.Ratio hemp-infused cannabis product. (a) "Ratio hemp-infused cannabis 
55.6 	product" means a product that:
55.7 	(1) contains cannabis extracts in combination with cannabinoids derived from hemp as 
55.8 	defined in United States Code, title 7, section 1639o(1), that are not artificially derived 
55.9 	cannabinoids and have been approved by the office as nonintoxicating, in the same or 
55.10 	different concentrations than naturally occur in the plant; and
55.11 	(2) is a product category approved by the office.
55.12 	(b) Ratio hemp-infused cannabis products must not include more than 100 milligrams 
55.13 	of cannabidiol, cannabigerol, cannabinol, or cannabichromene per serving.
55.14 	(c) If the ratio hemp-infused cannabis product is meant to be eaten, the product must 
55.15 	not include more than ten milligrams of THC per serving and 200 milligrams of THC per 
55.16 	package.
55.17 	(d) If the ratio hemp-infused cannabis product is meant to be consumed as a beverage, 
55.18 	the product must not include more than ten milligrams of THC per serving, and a single 
55.19 	beverage container may not contain more than two servings.
55.20 	(e) If the ratio hemp-infused cannabis product is meant to be used as a transdermal or 
55.21 	topical product, the product must not include more than the limit approved by the office in 
55.22 	rule.
55.23 	(f) If the ratio hemp-infused cannabis product is designed for a vaporized delivery 
55.24 	method, the product must not exceed the limit approved by the office in rule.

55.25 	Sec. 7. Minnesota Statutes 2024, section 342.09, subdivision 3, is amended to read:
55.26 		Subd. 3.Home extraction of cannabis concentrate by use of volatile solvent 
55.27 	prohibited. No person may use a volatile solvent to separate or extract cannabis concentrate 
55.28 	or hemp concentrate without a cannabis microbusiness, cannabis mezzobusiness, cannabis 
55.29 	macrobusiness, cannabis manufacturer, medical cannabis combination business, or 
55.30 	lower-potency hemp edible manufacturer license issued under this chapter.

56.1 	Sec. 8. Minnesota Statutes 2025 Supplement, section 342.10, is amended to read:
56.2 	342.10 LICENSES; TYPES.
56.3 	The office shall issue the following types of license:
56.4 	(1) cannabis microbusiness;
56.5 	(2) cannabis mezzobusiness;
56.6 	(3) cannabis cultivator;
56.7 	(4) cannabis manufacturer;
56.8 	(5) cannabis retailer;
56.9 	(6) cannabis wholesaler;
56.10 	(7) cannabis transporter;
56.11 	(8) cannabis testing facility;
56.12 	(9) cannabis event organizer;
56.13 	(10) cannabis delivery service;
56.14 	(11) lower-potency hemp edible manufacturer;
56.15 	(12) lower-potency hemp edible wholesaler;
56.16 	(13) lower-potency hemp edible retailer; and
56.17 	(14) medical cannabis combination business macrobusiness.

56.18 	Sec. 9. Minnesota Statutes 2025 Supplement, section 342.11, is amended to read:
56.19 	342.11 LICENSES; FEES.
56.20 	(a) The office shall require the payment of application fees, initial licensing fees, and 
56.21 	renewal licensing fees as provided in this section. The initial license fee shall include the 
56.22 	fee for initial issuance of the license and the first annual renewal. The renewal fee shall be 
56.23 	charged at the time of the second renewal and each subsequent annual renewal thereafter. 
56.24 	Nothing in this section prohibits a local unit of government from charging the retailer 
56.25 	registration fee established in section 342.22. Application fees, initial licensing fees, and 
56.26 	renewal licensing fees are nonrefundable.
56.27 	(b) Application and licensing fees shall be as follows:
56.28 	(1) for a cannabis microbusiness:
57.1 	(i) an application fee of $500;
57.2 	(ii) an initial license fee of $0; and
57.3 	(iii) a renewal license fee of $2,000;
57.4 	(2) for a cannabis mezzobusiness:
57.5 	(i) an application fee of $5,000;
57.6 	(ii) an initial license fee of $5,000; and
57.7 	(iii) a renewal license fee of $10,000;
57.8 	(3) for a cannabis cultivator:
57.9 	(i) an application fee of $10,000;
57.10 	(ii) an initial license fee of $20,000; and
57.11 	(iii) a renewal license fee of $30,000;
57.12 	(4) for a cannabis manufacturer:
57.13 	(i) an application fee of $10,000;
57.14 	(ii) an initial license fee of $10,000; and
57.15 	(iii) a renewal license fee of $20,000;
57.16 	(5) for a cannabis retailer:
57.17 	(i) an application fee of $2,500;
57.18 	(ii) an initial license fee of $2,500; and
57.19 	(iii) a renewal license fee of $5,000;
57.20 	(6) for a cannabis wholesaler:
57.21 	(i) an application fee of $5,000;
57.22 	(ii) an initial license fee of $5,000; and
57.23 	(iii) a renewal license fee of $10,000;
57.24 	(7) for a cannabis transporter:
57.25 	(i) an application fee of $250;
57.26 	(ii) an initial license fee of $500; and
57.27 	(iii) a renewal license fee of $1,000;
58.1 	(8) for a cannabis testing facility:
58.2 	(i) an application fee of $5,000;
58.3 	(ii) an initial license fee of $5,000; and
58.4 	(iii) a renewal license fee of $10,000;
58.5 	(9) for a cannabis delivery service:
58.6 	(i) an application fee of $250;
58.7 	(ii) an initial license fee of $500; and
58.8 	(iii) a renewal license fee of $1,000;
58.9 	(10) for a cannabis event organizer:
58.10 	(i) an application fee of $750; and
58.11 	(ii) an initial license fee of $750;
58.12 	(11) for a lower-potency hemp edible manufacturer:
58.13 	(i) an application fee of $250;
58.14 	(ii) an initial license fee of $1,000; and
58.15 	(iii) a renewal license fee of $1,000;
58.16 	(12) for a lower-potency hemp edible wholesaler:
58.17 	(i) an application fee of $250;
58.18 	(ii) an initial license fee of $10,000; and
58.19 	(iii) a renewal license fee of $10,000;
58.20 	(13) for a lower-potency hemp edible retailer:
58.21 	(i) an application fee of $250 or, if the lower-potency hemp retailer operates more than 
58.22 	one retail location, $250 per retail location;
58.23 	(ii) an initial license fee of $250 or, if the lower-potency hemp retailer operates more 
58.24 	than one retail location, $250 per retail location; and
58.25 	(iii) a renewal license fee of $250 or, if the lower-potency hemp retailer operates more 
58.26 	than one retail location, $250 per retail location; and
58.27 	(14) for a medical cannabis combination business macrobusiness:
58.28 	(i) an application fee of $10,000;
59.1 	(ii) an initial license fee of $20,000; and
59.2 	(iii) a renewal license fee of $70,000.

59.3 	Sec. 10. Minnesota Statutes 2025 Supplement, section 342.12, is amended to read:
59.4 	342.12 LICENSES; TRANSFERS; ADJUSTMENTS.
59.5 		Subdivision 1.Transfer of licenses. (a) Licenses issued under this chapter that are 
59.6 	available to all applicants pursuant to section 342.14, subdivision 1b, paragraph (c), may 
59.7 	be freely transferred subject to the prior written approval of the office unless the license 
59.8 	holder has not received a final site inspection or the license holder is a social equity applicant.
59.9 	(b) Licenses issued as social equity licenses pursuant to either section 342.14, subdivision 
59.10 	1b, paragraph (b), or section 342.175, paragraph (b), may only be transferred to another 
59.11 	social equity applicant for three years after the date on which the office issues the license. 
59.12 	Three years after the date of issuance, a license holder may transfer a license to any entity. 
59.13 	Transfer of a license that was issued as a social equity license must be reviewed by the 
59.14 	Division of Social Equity and is subject to the prior written approval of the office.
59.15 	(c) Preliminary license approval issued pursuant to section 342.14, subdivision 5, may 
59.16 	not be transferred.
59.17 	(d) A new license must be obtained when:
59.18 	(1) the form of the licensee's legal business structure converts or changes to a different 
59.19 	type of legal business structure; or
59.20 	(2) the licenseelicense holder dissolves; consolidates; reorganizes; undergoes bankruptcy, 
59.21 	insolvency, or receivership proceedings; merges with another legal organization; or assigns 
59.22 	all or substantially all of its assets for the benefit of creditors.
59.23 	(e) Licenses must be renewed annually.
59.24 	(f) License holders may petition the office to adjust the tier of a license issued within a 
59.25 	license category if the license holder meets all applicable requirements.
59.26 	(g) The office by rule may permit the relocation of a licensed cannabis business; permit 
59.27 	the relocation of an approved operational location, including a cultivation, manufacturing, 
59.28 	processing, or retail location; adopt requirements for the submission of a license relocation 
59.29 	application; establish standards for the approval of a relocation application; and charge a 
59.30 	fee not to exceed $250 for reviewing and processing applications. Relocation of a licensed 
59.31 	premises pursuant to this paragraph does not extend or otherwise modify the license term 
59.32 	of the license subject to relocation.
60.1 		Subd. 2.License availability. (a) Beginning January 1, 2030, the office may determine 
60.2 	whether licenses are available for a license holder that is a cannabis microbusiness or 
60.3 	cannabis mezzobusiness to petition to reclassify the license holder as another type of business, 
60.4 	either as a cannabis mezzobusiness or cannabis macrobusiness.
60.5 	(b) If the office determines that licenses are available, subject to section 342.14, 
60.6 	subdivision 1a, the office must announce the date on which the office will begin accepting 
60.7 	petitions from applicants seeking reclassification. When approving reclassification of a 
60.8 	license, the office must give priority to:
60.9 	(1) any cannabis microbusiness with a medical retail endorsement that is seeking 
60.10 	reclassification; or
60.11 	(2) any cannabis mezzobusiness with a medical endorsement that is seeking 
60.12 	reclassification.
60.13 	(c) The office shall establish procedures for the processing of petitions to reclassify 
60.14 	under this subdivision. A license holder that seeks to reclassify its license as a cannabis 
60.15 	mezzobusiness or cannabis macrobusiness must include in its petition to reclassify at least 
60.16 	the following information, if applicable:
60.17 	(1) its status as a social equity license holder;
60.18 	(2) the number of medical endorsements held and a description of the manner in which 
60.19 	medical patients are provided services;
60.20 	(3) financial statements exhibiting the ability to operate a larger license;
60.21 	(4) a transition plan that describes how the license holder will comply with all statutes 
60.22 	and rules applicable to the reclassified license; and
60.23 	(5) a description of the planned growth of the license holder up to the limits of the new 
60.24 	license type.
60.25 	(d) After a license holder submits a petition to reclassify that contains all required 
60.26 	information, the office must review the petition. The office may deny a petition if:
60.27 	(1) the petition is incomplete;
60.28 	(2) the petition contains a materially false statement about the applicant or omits 
60.29 	information required under this subdivision;
60.30 	(3) the license holder does not meet the qualifications under section 342.16;
61.1 	(4) the license holder is prohibited from holding the license under section 342.18, 
61.2 	subdivision 2;
61.3 	(5) the license holder does not meet the minimum requirements under section 342.18, 
61.4 	subdivision 3;
61.5 	(6) the petition was not submitted by the petition deadline;
61.6 	(7) the license holder has unpaid fines or fees or has engaged in substantial noncompliance 
61.7 	with this chapter; or
61.8 	(8) the office determines that the applicant would be prohibited from holding a license 
61.9 	for any other reason.
61.10 	(e) The office may request additional information from any license holder if the office 
61.11 	determines that the information is necessary to review or process the petition. If the license 
61.12 	holder does not provide the additional requested information within 14 calendar days of the 
61.13 	office's request for information, the office may deny the petition.
61.14 	(f) If the office denies a petition, the office must notify the license holder of the denial 
61.15 	and the basis for the denial.
61.16 	(g) A license holder whose petition is not denied under this subdivision is a qualified 
61.17 	petitioner. The office shall reclassify the license of all qualified petitioners holding a social 
61.18 	equity license. The number of reclassified licenses approved for social equity applicants 
61.19 	must be equal to or greater than the number of reclassified licenses approved for all 
61.20 	applicants. In the event the number of qualified petitioners not classified as social equity 
61.21 	license holders exceeds the number of qualified petitioners classified as social equity license 
61.22 	holders, the office shall select qualified petitioners using the methods in section 342.14, 
61.23 	subdivision 4.
61.24 	(h) Reclassification according to this subdivision must not remove the social equity 
61.25 	license status from a social equity license.
61.26 	(i) A license holder that submits a petition to reclassify its license may continue operations 
61.27 	pending office determination on the petition. A license holder that submits a petition to 
61.28 	reclassify its license that is denied retains their existing license.

62.1 	Sec. 11. Minnesota Statutes 2025 Supplement, section 342.13, is amended to read:
62.2 	342.13 LOCAL CONTROL.
62.3 	(a) A local unit of government may not prohibit the possession, transportation, or use 
62.4 	of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
62.5 	consumer products authorized under this chapter.
62.6 	(b) Except as provided in section 342.22, a local unit of government may not prohibit 
62.7 	the establishment or operation of a cannabis business or hemp business licensed under this 
62.8 	chapter.
62.9 	(c) A local unit of government may adopt reasonable restrictions on the time, place, and 
62.10 	manner of the operation of a cannabis business provided that such restrictions do not prohibit 
62.11 	the establishment or operation of cannabis businesses. A local unit of government may 
62.12 	prohibit the operation of a cannabis business within 1,000 feet of a school, or 500 feet of a 
62.13 	day care, residential treatment facility, or an attraction within a public park that is regularly 
62.14 	used by minors, including a playground or athletic field.
62.15 	(d) The office shall work with local units of government to:
62.16 	(1) develop model ordinances for reasonable restrictions on the time, place, and manner 
62.17 	of the operation of a cannabis business;
62.18 	(2) develop standardized forms and procedures for the issuance of a retail registration 
62.19 	pursuant to section 342.22; and
62.20 	(3) develop model policies and procedures for the performance of compliance checks 
62.21 	required under section 342.22.
62.22 	(e) If a local unit of government is conducting studies or has authorized a study to be 
62.23 	conducted or has held or has scheduled a hearing for the purpose of considering adoption 
62.24 	or amendment of reasonable restrictions on the time, place, and manner of the operation of 
62.25 	a cannabis business, the governing body of the local unit of government may adopt an 
62.26 	interim ordinance applicable to all or part of its jurisdiction for the purpose of protecting 
62.27 	the planning process and the health, safety, and welfare of its citizens. Before adopting the 
62.28 	interim ordinance, the governing body must hold a public hearing. The interim ordinance 
62.29 	may regulate, restrict, or prohibit the operation of a cannabis business within the jurisdiction 
62.30 	or a portion thereof until January 1, 2025.
62.31 	(f) Within 30 days of receiving a copy of an application from the office, a local unit of 
62.32 	government shall certify on a form provided by the office whether a proposed cannabis 
62.33 	business complies with local zoning ordinances and, if applicable, whether the proposed 
63.1 	business complies with the state fire code and building code. The office may not issue a 
63.2 	license if the local unit of government informs the office that the cannabis business does 
63.3 	not meet local zoning and land use laws. If the local unit of government does not provide 
63.4 	the certification to the office within 30 days of receiving a copy of an application from the 
63.5 	office, the office may issue a license.
63.6 	(g) The office by rule shall establish an expedited complaint process to receive, review, 
63.7 	and respond to complaints made by a local unit of government about a cannabis business. 
63.8 	At a minimum, the expedited complaint process shall require the office to provide an initial 
63.9 	response to the complaint within seven days and perform any necessary inspections within 
63.10 	30 days. Nothing in this paragraph prohibits a local unit of government from enforcing a 
63.11 	local ordinance. If a local unit of government notifies the office that a cannabis business 
63.12 	other than a cannabis retailer, cannabis microbusiness, cannabis mezzobusiness, cannabis 
63.13 	macrobusiness, or lower-potency hemp edible retailer with a retail operations endorsement, 
63.14 	or medical cannabis combination business operating a retail location poses an immediate 
63.15 	threat to the health or safety of the public, the office must respond within one business day 
63.16 	and may take any action described in section 342.19 or 342.21.
63.17 	(h) A local government unit that issues a cannabis retailer registration under section 
63.18 	342.22 may, by ordinance, limit the number of licensed cannabis retailers, cannabis 
63.19 	macrobusinesses with a retail operations endorsement, cannabis mezzobusinesses with a 
63.20 	retail operations endorsement, and cannabis microbusinesses with a retail operations 
63.21 	endorsement to no fewer than one registration for every 12,500 residents.
63.22 	(i) If a county has one active registration for every 12,500 residents, a city or town within 
63.23 	the county is not obligated to register a cannabis business.
63.24 	(j) Nothing in this section shall prohibit a local government unit from allowing licensed 
63.25 	cannabis retailers in excess of the minimums set in paragraph (h).
63.26 	(k) Notwithstanding the foregoing provisions, the state shall not issue a license to any 
63.27 	cannabis business to operate in Indian country, as defined in United States Code, title 18, 
63.28 	section 1151, of a Minnesota Tribal government without the consent of the Tribal 
63.29 	government.

63.30 	Sec. 12. Minnesota Statutes 2024, section 342.175, is amended to read:
63.31 	342.175 SOCIAL EQUITY LICENSE CLASSIFICATION.
63.32 	(a) The office must classify licenses listed in section 342.10, clauses (1) to (10) and (13)
63.33 	(14) as:
64.1 	(1) available to social equity applicants who meet the requirements of section 342.17; 
64.2 	and
64.3 	(2) available to all applicants.
64.4 	(b) The office must classify any license issued to a social equity applicant as a social 
64.5 	equity license.

64.6 	Sec. 13. Minnesota Statutes 2025 Supplement, section 342.18, subdivision 2, is amended 
64.7 	to read:
64.8 		Subd. 2.Vertical integration prohibited; exceptions. (a) Except as otherwise provided 
64.9 	in this subdivision, the office shall not issue licenses to a single applicant that would result 
64.10 	in the applicant being vertically integrated in violation of the provisions of this chapter.
64.11 	(b) Nothing in this section prohibits or limits the issuance of microbusiness licenses, 
64.12 	mezzobusiness licenses, or medical cannabis combination business macrobusiness licenses, 
64.13 	or the issuance of lower-potency hemp edible manufacturer, lower-potency hemp edible 
64.14 	wholesaler, and lower-potency hemp edible retailer licenses to the same person or entity.

64.15 	Sec. 14. Minnesota Statutes 2024, section 342.22, subdivision 1, is amended to read:
64.16 		Subdivision 1.Registration required. Before making retail sales to customers or patients, 
64.17 	a cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, medical cannabis 
64.18 	combination business macrobusiness, or lower-potency hemp edible retailer must register 
64.19 	with the city, town, or county in which the retail establishment is located. A county may 
64.20 	issue a registration in cases where a city or town has provided consent for the county to 
64.21 	issue the registration for the jurisdiction.

64.22 	Sec. 15. Minnesota Statutes 2025 Supplement, section 342.22, subdivision 3, is amended 
64.23 	to read:
64.24 		Subd. 3.Issuance of registration. (a) A local unit of government shall issue a retail 
64.25 	registration to a cannabis microbusiness with a retail operations endorsement, cannabis 
64.26 	mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis 
64.27 	combination business macrobusiness operating a retail location, or lower-potency hemp 
64.28 	edible retailer that:
64.29 	(1) has a valid license or preliminary license approval issued by the office;
64.30 	(2) has paid the registration fee or renewal fee pursuant to subdivision 2;
65.1 	(3) is found to be in compliance with the requirements of this chapter at any preliminary 
65.2 	compliance check that the local unit of government performs; and
65.3 	(4) if applicable, is current on all property taxes and assessments at the location where 
65.4 	the retail establishment is located.
65.5 	(b) Before issuing a retail registration, the local unit of government may conduct a 
65.6 	preliminary compliance check to ensure that the cannabis business or hemp business is in 
65.7 	compliance with any applicable local ordinance established pursuant to section 342.13.
65.8 	(c) A local unit of government shall renew the retail registration of a cannabis business 
65.9 	or hemp business when the office renews the license of the cannabis business or hemp 
65.10 	business.
65.11 	(d) A retail registration issued under this section may not be transferred.

65.12 	Sec. 16. Minnesota Statutes 2024, section 342.22, subdivision 5, is amended to read:
65.13 		Subd. 5.Registration suspension and cancellation; notice to office; penalties. (a) If 
65.14 	a local unit of government determines that a cannabis business or hemp business with a 
65.15 	retail registration issued by the local unit of government is not operating in compliance with 
65.16 	the requirements of a local ordinance authorized under section 342.13 or that the operation 
65.17 	of the business poses an immediate threat to the health or safety of the public, the local unit 
65.18 	of government may suspend the retail registration of the cannabis business or hemp business. 
65.19 	The local unit of government must immediately notify the office of the suspension and shall 
65.20 	include a description of the grounds for the suspension.
65.21 	(b) The office shall review the retail registration suspension and may order reinstatement 
65.22 	of the retail registration or take any action described in section 342.19 or 342.21.
65.23 	(c) The retail registration suspension must be for up to 30 days unless the office suspends 
65.24 	the license and operating privilege of the cannabis business or hemp business for a longer 
65.25 	period or revokes the license.
65.26 	(d) The local unit of government may reinstate the retail registration if the local unit of 
65.27 	government determines that any violation has been cured. The local unit of government 
65.28 	must reinstate the retail registration if the office orders reinstatement.
65.29 	(e) No cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, medical
65.30 	cannabis combination business macrobusiness, or lower-potency hemp edible retailer may 
65.31 	make any sale to a customer or patient without a valid retail registration with a local unit 
65.32 	of government and a valid license with any applicable endorsement from the office. A local 
66.1 	unit of government may impose a civil penalty of up to $2,000 for each violation of this 
66.2 	paragraph.

66.3 	Sec. 17. Minnesota Statutes 2024, section 342.27, subdivision 12, is amended to read:
66.4 		Subd. 12.Prohibitions. A cannabis business with a license or endorsement authorizing 
66.5 	the retail sale of cannabis flower or cannabis products shall not:
66.6 	(1) sell cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
66.7 	consumer products to a person who is visibly intoxicated;
66.8 	(2) knowingly sell more cannabis flower, cannabis products, lower-potency hemp edibles, 
66.9 	or hemp-derived consumer products than a customer is legally permitted to possess;
66.10 	(3) give away immature cannabis plants or seedlings, cannabis flower, cannabis products, 
66.11 	lower-potency hemp edibles, or hemp-derived consumer products;
66.12 	(4) operate a drive-through window;
66.13 	(5) allow for the dispensing of cannabis plants, cannabis flower, cannabis products, 
66.14 	lower-potency hemp edibles, or hemp-derived consumer products in vending machines; or
66.15 	(6) sell cannabis plants, cannabis flower, or cannabis products if the cannabis retailer 
66.16 	knows that any required security or statewide monitoring systems are not operational.; or
66.17 	(7) sell medical cannabinoid products to a person who is not registered in the patient 
66.18 	registry or is not enrolled in the registry program as a patient or caregiver.

66.19 	Sec. 18. Minnesota Statutes 2024, section 342.35, subdivision 1, is amended to read:
66.20 		Subdivision 1.Authorized actions. A cannabis transporter license entitles the license 
66.21 	holder to transport immature cannabis plants and seedlings, cannabis flower, cannabis 
66.22 	products, artificially derived cannabinoids, hemp plant parts, hemp concentrate, 
66.23 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
66.24 	microbusinesses, cannabis mezzobusinesses, cannabis macrobusinesses, cannabis cultivators, 
66.25 	cannabis manufacturers, cannabis wholesalers, lower-potency hemp edible manufacturers, 
66.26 	and industrial hemp growers to cannabis microbusinesses, cannabis mezzobusinesses, 
66.27 	cannabis macrobusinesses, cannabis manufacturers, cannabis testing facilities, cannabis 
66.28 	wholesalers, cannabis retailers, and lower-potency hemp edible retailers, and medical 
66.29 	cannabis combination businesses and perform other actions approved by the office.

67.1 	Sec. 19. Minnesota Statutes 2024, section 342.37, subdivision 1, is amended to read:
67.2 		Subdivision 1.Authorized actions. A cannabis testing facility license entitles the license 
67.3 	holder to obtain and test immature cannabis plants and seedlings, cannabis flower, cannabis 
67.4 	products, hemp plant parts, hemp concentrate, artificially derived cannabinoids, 
67.5 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
67.6 	microbusinesses, cannabis mezzobusinesses, cannabis macrobusinesses, cannabis cultivators, 
67.7 	cannabis manufacturers, cannabis wholesalers, lower-potency hemp edible manufacturers, 
67.8 	medical cannabis combination businesses, and industrial hemp growers.

67.9 	Sec. 20. Minnesota Statutes 2025 Supplement, section 342.40, subdivision 7, is amended 
67.10 	to read:
67.11 		Subd. 7.Cannabis event sales. (a) Cannabis microbusinesses with a retail endorsement, 
67.12 	cannabis mezzobusinesses with a retail endorsement, cannabis retailers, medical cannabis 
67.13 	combination businesses macrobusinesses operating a retail location, and lower-potency 
67.14 	hemp edible retailers, including the cannabis event organizer, may be authorized to sell 
67.15 	cannabis plants, adult-use cannabis flower, adult-use cannabis products, lower-potency 
67.16 	hemp edibles, and hemp-derived consumer products to customers at a cannabis event.
67.17 	(b) All sales of cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
67.18 	lower-potency hemp edibles, and hemp-derived consumer products at a cannabis event must 
67.19 	take place in a retail area as designated in the premises diagram.
67.20 	(c) Authorized retailers may only conduct sales within their specifically assigned area.
67.21 	(d) Authorized retailers must verify the age of all customers pursuant to section 342.27, 
67.22 	subdivision 4, before completing a sale and may not sell cannabis plants, adult-use cannabis 
67.23 	flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer 
67.24 	products to an individual under 21 years of age.
67.25 	(e) Authorized retailers may display one sample of each type of cannabis plant, adult-use 
67.26 	cannabis flower, adult-use cannabis product, lower-potency hemp edible, and hemp-derived 
67.27 	consumer product available for sale. Samples of adult-use cannabis and adult-use cannabis 
67.28 	products must be stored in a sample jar or display case and be accompanied by a label or 
67.29 	notice containing the information required to be affixed to the packaging or container 
67.30 	containing adult-use cannabis flower and adult-use cannabis products sold to customers. A 
67.31 	sample may not consist of more than eight grams of adult-use cannabis flower or adult-use 
67.32 	cannabis concentrate, or an edible cannabis product infused with more than 100 milligrams 
68.1 	of tetrahydrocannabinol. A cannabis retailer may allow customers to smell the adult-use 
68.2 	cannabis flower or adult-use cannabis product before purchase.
68.3 	(f) The notice requirements under section 342.27, subdivision 6, apply to authorized 
68.4 	retailers offering cannabis plants, adult-use cannabis flower, adult-use cannabinoid products, 
68.5 	and hemp-derived consumer products for sale at a cannabis event.
68.6 	(g) Authorized retailers may not:
68.7 	(1) sell adult-use cannabis flower, adult-use cannabis products, lower-potency hemp 
68.8 	edibles, or hemp-derived consumer products to a person who is visibly intoxicated;
68.9 	(2) knowingly sell more cannabis plants, adult-use cannabis flower, adult-use cannabis 
68.10 	products, lower-potency hemp edibles, or hemp-derived consumer products than a customer 
68.11 	is legally permitted to possess;
68.12 	(3) sell medical cannabis flower or medical cannabinoid products; or
68.13 	(4) allow for the dispensing of cannabis plants, cannabis flower, cannabis products, 
68.14 	lower-potency hemp edibles, or hemp-derived consumer products in vending machines.
68.15 	(h) Except for samples of a cannabis plant, adult-use cannabis flower, adult-use cannabis 
68.16 	product, lower-potency hemp edible, and hemp-derived consumer product, all cannabis 
68.17 	plants, adult-use cannabis flower, adult-use cannabis products, lower-potency hemp edibles, 
68.18 	and hemp-derived consumer products for sale at a cannabis event must be stored in a secure, 
68.19 	locked container that is not accessible to the public. Such items being stored at a cannabis 
68.20 	event shall not be left unattended.
68.21 	(i) All cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
68.22 	lower-potency hemp edibles, and hemp-derived consumer products for sale at a cannabis 
68.23 	event must comply with this chapter and rules adopted pursuant to this chapter regarding 
68.24 	the testing, packaging, and labeling of those items.
68.25 	(j) All cannabis plants, adult-use cannabis flower, and adult-use cannabis products sold, 
68.26 	damaged, or destroyed at a cannabis event must be recorded in the statewide monitoring 
68.27 	system.

68.28 	Sec. 21. Minnesota Statutes 2024, section 342.41, subdivision 1, is amended to read:
68.29 		Subdivision 1.Authorized actions. A cannabis delivery service license entitles the 
68.30 	license holder to purchase cannabis flower, cannabis products, lower-potency hemp edibles, 
68.31 	and hemp-derived consumer products from licensed cannabis microbusinesses with a retail 
68.32 	endorsement, cannabis mezzobusinesses with a retail endorsement, cannabis retailers, and 
69.1 	medical cannabis combination businesses macrobusinesses; transport and deliver cannabis 
69.2 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumable 
69.3 	products to customers; and perform other actions approved by the office.

69.4 	Sec. 22. Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to 
69.5 	read:
69.6 		Subd. 1a.Types of medical cannabis endorsements; authorized actions. The office 
69.7 	may issue the following types of medical cannabis endorsements to a license holder:
69.8 	(1) a medical cannabis cultivation endorsement;
69.9 	(2) a medical cannabis manufacturer endorsement; or
69.10 	(3) a medical cannabis retail endorsement.

69.11 	Sec. 23. Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to 
69.12 	read:
69.13 		Subd. 1b.Medical cannabis cultivation endorsement. (a) A cannabis microbusiness, 
69.14 	cannabis mezzobusiness, cannabis macrobusiness, or cannabis cultivator with a cannabis 
69.15 	cultivation endorsement may apply for and obtain a medical cannabis cultivation 
69.16 	endorsement.
69.17 	(b) A cannabis business with a medical cannabis cultivation endorsement must:
69.18 	(1) comply with the requirements of section 342.25; and
69.19 	(2) otherwise meet all applicable requirements established by the office.
69.20 	(c) A medical cannabis cultivation endorsement entitles the license holder to perform 
69.21 	the actions authorized in section 342.30, subdivision 1.
69.22 	(d) A cannabis microbusiness with a medical cannabis cultivation endorsement that 
69.23 	cultivates cannabis at an indoor facility may cultivate cannabis using up to 1,000 square 
69.24 	feet of plant canopy in addition to the limits in section 342.28, subdivision 2, paragraph (a). 
69.25 	A cannabis microbusiness with a medical cannabis cultivation endorsement that cultivates 
69.26 	cannabis at an outdoor location may cultivate up to one-quarter acre of mature flowering 
69.27 	plants in addition to the limits in section 342.28, subdivision 2, paragraph (b).
69.28 	(e) A cannabis mezzobusiness with a medical cannabis cultivation endorsement that 
69.29 	cultivates cannabis at an indoor facility may cultivate cannabis using up to 3,000 square 
69.30 	feet of plant canopy in addition to the limits in section 342.29, subdivision 2, paragraph (a). 
69.31 	A cannabis mezzobusiness with a medical cannabis cultivation endorsement that cultivates 
70.1 	cannabis at an outdoor location may cultivate up to one-half acre of mature flowering plants 
70.2 	in addition to the limits in section 342.29, subdivision 2, paragraph (b).
70.3 	(f) A cannabis cultivator with a medical cannabis cultivation endorsement that cultivates 
70.4 	cannabis at an indoor facility may cultivate cannabis using up to an additional 6,000 square 
70.5 	feet of plant canopy in addition to the limits in section 342.30, subdivision 2, paragraph (a). 
70.6 	A cannabis cultivator with a medical cannabis cultivation endorsement that cultivates 
70.7 	cannabis at an outdoor location may cultivate up to one acre of mature flowering plants in 
70.8 	addition to the limits in section 342.30, subdivision 2, paragraph (b).
70.9 	(g) Annually, at least one quarter of all cannabis flower cultivated by a cannabis business 
70.10 	with a medical cannabis cultivation endorsement must be sold by the license holder to a 
70.11 	cannabis business with a medical cannabis endorsement, including the license holder if the 
70.12 	license holder has a medical cannabis manufacturing endorsement or medical cannabis retail 
70.13 	endorsement.

70.14 	Sec. 24. Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to 
70.15 	read:
70.16 		Subd. 1c.Medical cannabis manufacturer endorsement. (a) A cannabis microbusiness, 
70.17 	cannabis mezzobusiness, cannabis macrobusiness, or cannabis manufacturer with a 
70.18 	manufacturing endorsement may apply for and obtain a medical cannabis manufacturer 
70.19 	endorsement.
70.20 	(b) A cannabis business with a medical cannabis manufacturer endorsement must:
70.21 	(1) comply with the requirements of section 342.26;
70.22 	(2) manufacture high medical need products identified by the office; and
70.23 	(3) otherwise meet all applicable requirements established by the office.
70.24 	(c) A medical cannabis manufacturer endorsement entitles a license holder to:
70.25 	(1) manufacture medical cannabinoid products; and
70.26 	(2) sell medical cannabinoid products only to other cannabis businesses with a medical 
70.27 	cannabis manufacturer endorsement or medical cannabis retail endorsement.
70.28 	(d) A medical cannabinoid product must be labeled with a "Minnesota Medical Cannabis" 
70.29 	warning symbol and must only be sold to a person, patient, or caregiver enrolled in the 
70.30 	registry program or a visiting patient.
71.1 	(e) A medical cannabis manufacturer endorsement held by a cannabis microbusiness 
71.2 	entitles the license holder to increase the use of cannabis by dry weight up to 25 percent 
71.3 	above the limit established by the office in rule.
71.4 	(f) A medical cannabis manufacturer endorsement held by a cannabis mezzobusiness 
71.5 	entitles the license holder to increase the use of cannabis by dry weight up to 25 percent 
71.6 	above the limit established by the office in rule.

71.7 	Sec. 25. Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to 
71.8 	read:
71.9 		Subd. 1d.Medical cannabis retail endorsement. (a) A cannabis microbusiness, cannabis 
71.10 	mezzobusiness, cannabis macrobusiness, or cannabis retailer with a retail operations 
71.11 	endorsement may apply for and obtain a medical cannabis retail endorsement.
71.12 	(b) A cannabis business with a medical cannabis retail endorsement must:
71.13 	(1) comply with all requirements of this section and section 342.27;
71.14 	(2) have at least one member of staff who has earned a medical cannabis consultant 
71.15 	certificate issued by the office and completed the required training or have at least one 
71.16 	member of staff who is a licensed pharmacist under chapter 151;
71.17 	(3) ensure availability of patient consultations as required under this section;
71.18 	(4) ensure that patients and caregivers enrolled in the registry program receive priority 
71.19 	service;
71.20 	(5) carry all products identified by the office as high medical need; and
71.21 	(6) otherwise meet all applicable requirements established by the office.
71.22 	(c) The office must identify high medical need products and publish a list of all high 
71.23 	medical need products on the office's publicly accessible website.
71.24 	(d) A medical cannabis retail endorsement held by a cannabis business entitles the license 
71.25 	holder to perform the actions authorized in section 342.32, subdivision 1.
71.26 	(e) A cannabis microbusiness with a medical retail endorsement may operate one 
71.27 	additional retail location in excess of the limit in section 342.28, subdivision 2, paragraph 
71.28 	(d), if at least one retail location is located in an area identified by the office as a high medical 
71.29 	need area.
71.30 	(f) A cannabis mezzobusiness with a medical cannabis retail endorsement may operate 
71.31 	up to two additional retail locations in excess of the limit in section 342.29, subdivision 2, 
72.1 	paragraph (d), if at least two retail locations are located in an area identified by the office 
72.2 	as a high medical need area.
72.3 	(g) A cannabis retailer with a medical cannabis retail endorsement may operate up to 
72.4 	three additional retail locations in excess of the limit established in section 342.32, 
72.5 	subdivision 2, if at least three retail locations are located in an area identified by the office 
72.6 	as a high medical need area.

72.7 	Sec. 26. Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to 
72.8 	read:
72.9 		Subd. 1e.Additional authorized actions; external transporter endorsement and 
72.10 	medical cannabis delivery endorsement. (a) A cannabis microbusiness or cannabis 
72.11 	mezzobusiness with at least two medical cannabis endorsements may apply for and obtain 
72.12 	an external transporter endorsement to transport immature cannabis plants and seedlings, 
72.13 	cannabis flower, cannabis products, artificially derived cannabinoids, hemp plant parts, 
72.14 	hemp concentrate, lower-potency hemp edibles, and hemp-derived consumer products to  
72.15 	and from other cannabis microbusinesses, cannabis mezzobusinesses, cannabis 
72.16 	macrobusinesses, cannabis cultivators, cannabis manufacturers, cannabis wholesalers, 
72.17 	cannabis retailers, and hemp businesses if the cannabis business:
72.18 	(1) provides the office with the information required in section 342.35, subdivision 2; 
72.19 	and
72.20 	(2) complies with the requirements of section 342.36.
72.21 	(b) A cannabis business with a medical cannabis retail endorsement may apply for and 
72.22 	obtain a medical cannabis delivery endorsement to deliver medical cannabis flower and 
72.23 	medical cannabinoid products to patients enrolled in the registry program; registered 
72.24 	designated caregivers; and parents, legal guardians, and spouses of an enrolled patient if 
72.25 	the cannabis business:
72.26 	(1) provides the office with the information required in section 342.41, subdivision 2; 
72.27 	and
72.28 	(2) complies with the requirements of subdivisions 2 and 3 and section 342.42.

73.1 	Sec. 27. Minnesota Statutes 2025 Supplement, section 342.51, subdivision 2, is amended 
73.2 	to read:
73.3 		Subd. 2.Distribution requirements. (a) Prior to distribution of medical cannabis flower 
73.4 	or medical cannabinoid products to a person enrolled in the registry program, an employee 
73.5 	of a cannabis business must:
73.6 	(1) review and confirm the patient's enrollment in the registry program;
73.7 	(2) verify that the person requesting the distribution of medical cannabis flower or 
73.8 	medical cannabinoid products is the patient,; the patient's registered designated caregiver,;
73.9 	or the patient's parent, legal guardian, or spouse using the procedures established by the 
73.10 	office;
73.11 	(3) confirm that the patient had a consultation with: (i) an employee with a valid medical 
73.12 	cannabis consultant certificate issued by the office; or (ii) an employee who is a licensed 
73.13 	pharmacist under chapter 151 to determine the proper medical cannabis flower or medical 
73.14 	cannabinoid product, dosage, and paraphernalia for the patient if required under subdivision 
73.15 	3;
73.16 	(4) apply a patient-specific label on the medical cannabis flower or medical cannabinoid 
73.17 	product that includes recommended dosage requirements and other information as required 
73.18 	by the office; and
73.19 	(5) provide the patient with any other information required by the office.
73.20 	(b) A cannabis business with a medical cannabis retail endorsement may not deliver 
73.21 	medical cannabis flower or medical cannabinoid products to a person enrolled in the registry 
73.22 	program unless the cannabis business with a medical cannabis retail endorsement also holds 
73.23 	a cannabis delivery service license. The delivery of medical cannabis flower and medical 
73.24 	cannabinoid products are subject to the provisions of section 342.42.

73.25 	Sec. 28. Minnesota Statutes 2024, section 342.515, as amended by Laws 2025, chapter 
73.26 	31, sections 89 and 90, is amended to read:
73.27 	342.515 MEDICAL CANNABIS COMBINATION BUSINESSES
73.28 	MACROBUSINESSES.
73.29 		Subdivision 1.Authorized actions. (a) A person, cooperative, or business holding a 
73.30 	medical cannabis combination business license is prohibited from owning or operating any 
73.31 	other cannabis business or hemp business or holding an active registration agreement under 
73.32 	section 152.25, subdivision 1.
74.1 	(b) A person or business may hold only one medical cannabis combination business 
74.2 	license.
74.3 	(c) (a) A medical cannabis combination businessmacrobusiness license, consistent with 
74.4 	the requirements of specific license endorsements approved by the office, entitles the license 
74.5 	holder to perform any or all of the following within the limits established by this section
74.6 	actions:
74.7 	(1) grow cannabis plants from seed or immature plant to mature plant and, harvest 
74.8 	adult-use cannabis flower and medical cannabis flower from a mature plant, package and 
74.9 	label cannabis flower for sale to other cannabis businesses, and sell immature cannabis 
74.10 	plants and seedlings and cannabis flower to other cannabis businesses;
74.11 	(2) make cannabis concentrate;
74.12 	(3) make hemp concentrate, including hemp concentrate with a delta-9 
74.13 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
74.14 	(4) manufacture artificially derived cannabinoids;
74.15 	(5) manufacture medical cannabinoid products;
74.16 	(6) (5) manufacture, package, and label adult-use cannabis products, lower-potency 
74.17 	hemp edibles, and hemp-derived consumer products for public consumption;
74.18 	(7) (6) purchase immature cannabis plants and seedlings and cannabis flower from a 
74.19 	cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a cannabis 
74.20 	wholesaler, or another medical cannabis combination business macrobusiness;
74.21 	(8) (7) purchase hemp plant parts and propagules from an industrial hemp grower licensed 
74.22 	under chapter 18K;
74.23 	(9) (8) purchase cannabis concentrate, hemp concentrate, and artificially derived 
74.24 	cannabinoids from a cannabis microbusiness, a cannabis mezzobusiness, a cannabis 
74.25 	manufacturer, a cannabis wholesaler, or another medical cannabis combination business
74.26 	macrobusiness;
74.27 	(10) (9) purchase hemp concentrate from an industrial hemp processor licensed under 
74.28 	chapter 18K;
74.29 	(11) manufacture, package, and label medical cannabis flower and medical cannabinoid 
74.30 	products for sale to cannabis businesses with a medical cannabis processor endorsement, 
74.31 	cannabis businesses with a medical cannabis retail endorsement, other medical cannabis 
74.32 	combination businesses, and persons in the registry program;
75.1 	(12) transport and deliver medical cannabis flower and medical cannabinoid products 
75.2 	to medical cannabis processors, medical cannabis retailers, other medical cannabis 
75.3 	combination businesses, patients enrolled in the registry program, registered designated 
75.4 	caregivers, and parents, legal guardians, and spouses of an enrolled patient;
75.5 	(13) manufacture, package, and label adult-use cannabis flower, adult-use cannabis 
75.6 	products, lower-potency hemp edibles, and hemp-derived consumer products for sale to 
75.7 	customers and other cannabis businesses;
75.8 	(14) sell medical cannabis flower and medical cannabinoid products to other cannabis 
75.9 	businesses with a medical endorsement, other medical cannabis combination businesses, 
75.10 	and patients enrolled in the registry program, registered designated caregivers, and parents, 
75.11 	legal guardians, and spouses of an enrolled patient;
75.12 	(15) (10) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
75.13 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
75.14 	other products authorized by law to other cannabis businesses and to customers;
75.15 	(16) transport immature cannabis plants and seedlings, adult-use cannabis flower, 
75.16 	adult-use cannabis products, lower-potency hemp edibles, hemp-derived consumer products, 
75.17 	and other products authorized by law to other cannabis businesses;
75.18 	(17) (11) sell and transport lower-potency hemp edibles to lower-potency hemp edible 
75.19 	retailers and lower-potency hemp edible wholesalers; and
75.20 	(18) (12) perform other actions approved by the office.
75.21 	(d) A medical cannabis combination business is not required to obtain a medical cannabis 
75.22 	endorsement to perform any actions authorized under this section.
75.23 	(b) A cannabis macrobusiness must apply for and obtain a medical cannabis manufacturer 
75.24 	endorsement and at least one other medical cannabis endorsement identified in section 
75.25 	342.51.
75.26 		Subd. 2.Cultivation endorsement; size limitations. (a) A cannabis macrobusiness 
75.27 	seeking to cultivate cannabis plants and harvest cannabis flower must obtain a cannabis 
75.28 	cultivation endorsement and comply with section 342.25.
75.29 	(b) A cannabis macrobusiness that obtains a cannabis cultivation endorsement must 
75.30 	apply for and obtain a medical cannabis cultivation endorsement and comply with section 
75.31 	342.51, subdivision 1b.
76.1 	(a) (c) A medical cannabis combination business may cultivate cannabis to be sold as 
76.2 	medical cannabis flower or used in medical cannabinoid products in an area of up to 60,000 
76.3 	square feet of plant canopy subject to the limits on adult-use cannabis cultivation in paragraph 
76.4 	(c). A medical cannabis combination business may cultivate cannabis and manufacture 
76.5 	cannabis in more than one location, except the aggregate total of plant canopy in all locations 
76.6 	must count toward the business' canopy limit. macrobusiness with a cultivation endorsement 
76.7 	and a medical cannabis cultivation endorsement that cultivates cannabis at an indoor facility 
76.8 	may cultivate up to 30,000 square feet of plant canopy.
76.9 	(b) (d) A medical cannabis combination businessmay cultivate cannabis to be sold as 
76.10 	adult-use cannabis flower or used in adult-use cannabis products in an area authorized by 
76.11 	the office as described in paragraph (c). macrobusiness that cultivates cannabis at an outdoor 
76.12 	location may cultivate up to one acre of mature, flowering plants.
76.13 	(c) The office shall authorize a medical cannabis combination business to cultivate 
76.14 	cannabis for sale in the adult-use market in an area of plant canopy that is equal to one-half 
76.15 	of the area the business used to cultivate cannabis sold in the medical market in the preceding 
76.16 	year. The office shall establish an annual verification and authorization procedure. The 
76.17 	office may increase the area of plant canopy in which a medical cannabis combination 
76.18 	business is authorized to cultivate cannabis for sale in the adult-use market between 
76.19 	authorization periods if the business demonstrates a significant increase in the sale of medical 
76.20 	cannabis and medical cannabis products.
76.21 	(e) A cannabis macrobusiness with a cannabis cultivation endorsement and a retail 
76.22 	operations endorsement may package and label adult-use cannabis flower, adult-use cannabis 
76.23 	products, lower-potency hemp edibles, and hemp-derived consumer products for sale to 
76.24 	customers.
76.25 	(f) A cannabis macrobusiness with a medical cannabis cultivation endorsement and a 
76.26 	medical cannabis retail endorsement may package and label medical cannabis flower and 
76.27 	medical cannabinoid products for sale to patients enrolled in the registry program; registered 
76.28 	designated caregivers; and parents, legal guardians, and spouses of an enrolled patient.
76.29 	(g) A cannabis macrobusiness may choose to engage in outdoor or indoor cultivation, 
76.30 	but a cannabis macrobusiness may not engage in both outdoor and indoor cultivation.
76.31 		Subd. 3.Manufacturing Manufacturer endorsement; size limitations. (a) By rule, 
76.32 	the office may establish limits on cannabis manufacturing that are consistent with the area 
76.33 	of plant canopy a business is authorized to cultivate. Until the office establishes limits by 
77.1 	rule, a cannabis macrobusiness must not use more than 90,000 pounds of cannabis or its 
77.2 	dry-weight equivalent of raw concentrates to manufacture cannabis products.
77.3 	(b) A cannabis macrobusiness must apply for and obtain a medical cannabis manufacturer 
77.4 	endorsement and must comply with section 342.51, subdivision 1c.
77.5 	(c) A cannabis macrobusiness may apply for and obtain one or more cannabis 
77.6 	manufacturer endorsements identified in section 342.26.
77.7 		Subd. 4.Retail operations endorsement; locations. (a) A medical cannabis combination 
77.8 	business macrobusiness with a retail operations endorsement may operate up to one retail 
77.9 	location in each congressional district. A medical cannabis combination business must offer 
77.10 	medical cannabis flower, medical cannabinoid products, or both at every retail location.
77.11 	eight retail locations and, if operating more than five retail locations, must ensure that at 
77.12 	least three retail locations are located in areas identified by the office as high medical need 
77.13 	areas.
77.14 	(b) A cannabis macrobusiness may apply for and obtain a retail operations endorsement 
77.15 	and must comply with section 342.27.
77.16 	(c) A cannabis macrobusiness with a retail operations endorsement must apply for and 
77.17 	obtain a medical cannabis retail operations endorsement and comply with section 342.51, 
77.18 	subdivision 1d.
77.19 	(d) A cannabis macrobusiness with a retail operations endorsement and a medical cannabis 
77.20 	retail operations endorsement must carry and make available for sale, at each retail location, 
77.21 	all high medical need products identified by the office.
77.22 		Subd. 5.Failure to participate; suspension or revocation of license. The office may 
77.23 	suspend or revoke a medical cannabis combination businessmacrobusiness license if the 
77.24 	office determines that the business is no longer actively participating in the medical cannabis 
77.25 	market. The office may, by rule, establish minimum requirements related to cannabis 
77.26 	cultivation, manufacturing of medical cannabinoid products, retail sales of medical cannabis 
77.27 	flower and medical cannabinoid products, and other relevant criteria to demonstrate active 
77.28 	participation in the medical cannabis market. If a cannabis macrobusiness fails to obtain or 
77.29 	operate under a medical cannabis manufacturer endorsement or fails to carry and make 
77.30 	available for sale, at each retail location, high medical need products identified by the office, 
77.31 	the office may suspend or revoke the cannabis macrobusiness's license under this subdivision.
77.32 		Subd. 6.Operations. A medical cannabis combination business must comply with the 
77.33 	relevant requirements of sections 342.25, 342.26, 342.27, and 342.51, subdivisions 2 to 5.
78.1 		Subd. 7.Transportation Internal transporter endorsement and external transporter 
78.2 	endorsement. (a) A medical cannabis combination business macrobusiness may obtain an 
78.3 	internal transporter endorsement to transport immature cannabis plants and seedlings, 
78.4 	cannabis flower, cannabis products, artificially derived cannabinoids, hemp plant parts, 
78.5 	hemp concentrate, lower-potency hemp edibles, and hemp-derived consumer products
78.6 	between facilities owned by the license holder if the medical cannabis combination business
78.7 	macrobusiness:
78.8 	(1) provides the office with the information described in section 342.35, subdivision 2; 
78.9 	and
78.10 	(2) complies with the requirements of section 342.36.
78.11 	(b) A cannabis macrobusiness with at least two medical cannabis endorsements may 
78.12 	apply for and obtain an external transporter endorsement to transport immature cannabis 
78.13 	plants and seedlings, cannabis flower, cannabis products, artificially derived cannabinoids, 
78.14 	hemp plant parts, hemp concentrate, lower-potency hemp edibles, and hemp-derived 
78.15 	consumer products to and from other cannabis microbusinesses, cannabis mezzobusinesses, 
78.16 	cannabis macrobusinesses, cannabis cultivators, cannabis manufacturers, cannabis 
78.17 	wholesalers, cannabis retailers, and hemp businesses if the cannabis macrobusiness:
78.18 	(1) provides the office with the information required under section 342.35, subdivision 
78.19 	2; and
78.20 	(2) complies with the requirements of section 342.36.
78.21 		Subd. 8.Multiple licenses. (a) A person, cooperative, or business holding a cannabis 
78.22 	macrobusiness license may also hold a cannabis event organizer license.
78.23 	(b) Except as provided in paragraph (a),  a person, cooperative, or business holding a 
78.24 	cannabis macrobusiness license is prohibited from owning or operating any other cannabis 
78.25 	business or hemp business or holding more than one cannabis macrobusiness license.
78.26 	(c) For purposes of this subdivision, a restriction on the number or type of licenses that 
78.27 	a business may hold applies to every cooperative member or every director, manager, and 
78.28 	general partner of a cannabis business.
78.29 		Subd. 9.Conversion of licenses. (a) On or after January 1, 2027, the office must convert 
78.30 	any existing medical cannabis combination business licenses to cannabis macrobusiness 
78.31 	licenses.
78.32 	(b) Beginning January 1, 2030, the office may determine the number of available cannabis 
78.33 	macrobusiness licenses for applicants who do not have an existing license under this chapter. 
79.1 	The office must make the determination under this paragraph according to the requirements 
79.2 	of section 342.14, subdivision 1a. If the office is accepting applications for cannabis 
79.3 	macrobusiness licenses from applicants without an existing license under this chapter, the 
79.4 	office must announce the number of cannabis macrobusiness licenses available and the date 
79.5 	on which applications will be accepted. The number of licenses available to social equity 
79.6 	applicants must be equal to or greater than the number of licenses available to all applicants. 
79.7 	Applicants for cannabis macrobusiness licenses must comply with the application and 
79.8 	licensing requirements of this chapter.
79.9 		Subd. 10.Additional canopy. (a) After each annual renewal, the office shall authorize 
79.10 	an additional 5,000 square feet of plant canopy for a cannabis macrobusiness license holder 
79.11 	with a medical cultivation endorsement that cultivates cannabis at an indoor facility. The 
79.12 	cannabis macrobusiness must be in good standing with the office to be eligible for an 
79.13 	authorization of additional canopy. The office shall not authorize any macrobusiness license 
79.14 	holder with a medical cultivation endorsement that cultivates cannabis at an indoor facility 
79.15 	to cultivate more than 45,000 square feet of plant canopy.
79.16 	(b) After each annual renewal, the office shall authorize an additional 1/2 acre of plant 
79.17 	canopy for a cannabis macrobusiness license holder with a medical cultivation endorsement 
79.18 	that cultivates cannabis at an outdoor location. The cannabis macrobusiness must be in good 
79.19 	standing with the office to be eligible for an authorization of additional canopy. The office 
79.20 	shall not authorize any macrobusiness license holder with a medical cultivation endorsement 
79.21 	that cultivates cannabis at an outdoor location to cultivate more than four acres of mature 
79.22 	flowering plants.

79.23 	Sec. 29. Minnesota Statutes 2025 Supplement, section 342.61, subdivision 4, is amended 
79.24 	to read:
79.25 		Subd. 4.Testing of samples; disclosures. (a) On a schedule determined by the office, 
79.26 	every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
79.27 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
79.28 	hemp edible manufacturer, or medical cannabis combination business macrobusiness shall 
79.29 	make each batch of cannabis flower, cannabis products, artificially derived cannabinoids, 
79.30 	lower-potency hemp edibles, or hemp-derived consumer products grown, manufactured, or 
79.31 	imported by the cannabis business or hemp business available to a cannabis testing facility.
79.32 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
79.33 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
79.34 	hemp edible manufacturer, or medical cannabis combination business macrobusiness must 
80.1 	disclose all known information regarding pesticides, fertilizers, solvents, or other foreign 
80.2 	materials, including but not limited to catalysts used in creating artificially derived 
80.3 	cannabinoids, applied or added to the batch of cannabis flower, cannabis products, artificially 
80.4 	derived cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products 
80.5 	subject to testing. Disclosure must be made to the cannabis testing facility and must include 
80.6 	information about all applications by any person, whether intentional or accidental.
80.7 	(c) A cannabis business license holder shall select one or more representative samples 
80.8 	from each batch, test the samples for the presence of contaminants, and test the samples for 
80.9 	potency and homogeneity and to allow the cannabis flower, cannabis product, artificially 
80.10 	derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product to be 
80.11 	accurately labeled with its cannabinoid profile. Testing for contaminants must include testing 
80.12 	for residual solvents, foreign material, microbiological contaminants, heavy metals, pesticide 
80.13 	residue, mycotoxins, and any items identified pursuant to paragraph (b), and may include 
80.14 	testing for other contaminants. A cannabis testing facility must destroy or return to the 
80.15 	cannabis business or hemp business license holder any part of the sample that remains after 
80.16 	testing.

80.17 	Sec. 30. Minnesota Statutes 2024, section 342.61, subdivision 5, is amended to read:
80.18 		Subd. 5.Test results. (a) If a sample meets the applicable testing standards, a cannabis 
80.19 	testing facility shall issue a certification to a cannabis microbusiness, cannabis 
80.20 	mezzobusiness, cannabis cultivator, cannabis manufacturer, cannabis wholesaler with an 
80.21 	endorsement to import products, lower-potency hemp edible manufacturer, or medical
80.22 	cannabis combination business macrobusiness and the cannabis business or hemp business 
80.23 	may then sell or transfer the batch of cannabis flower, cannabis products, artificially derived 
80.24 	cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products from which 
80.25 	the sample was taken to another cannabis business or hemp business, or offer the cannabis 
80.26 	flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products 
80.27 	for sale to customers or patients. If a sample does not meet the applicable testing standards 
80.28 	or if the testing facility is unable to test for a substance identified pursuant to subdivision 
80.29 	4, paragraph (b), the batch from which the sample was taken shall be subject to procedures 
80.30 	established by the office for such batches, including destruction, remediation, or retesting.
80.31 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
80.32 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
80.33 	hemp edible manufacturer, or medical cannabis combination business macrobusiness must 
80.34 	maintain the test results for cannabis flower, cannabis products, artificially derived 
81.1 	cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products grown, 
81.2 	manufactured, or imported by that cannabis business or hemp business for at least five years 
81.3 	after the date of testing.
81.4 	(c) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
81.5 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
81.6 	hemp edible manufacturer, or medical cannabis combination business macrobusiness shall 
81.7 	make test results maintained by that cannabis business or hemp business available for review 
81.8 	by any member of the public, upon request. Test results made available to the public must 
81.9 	be in plain language.

81.10 	Sec. 31. Minnesota Statutes 2025 Supplement, section 342.63, subdivision 2, is amended 
81.11 	to read:
81.12 		Subd. 2.Content of label; cannabis. All cannabis flower and hemp-derived consumer 
81.13 	products that consist of hemp plant parts sold to customers or patients must have affixed 
81.14 	on the packaging or container of the cannabis flower or hemp-derived consumer product a 
81.15 	label that contains at least the following information:
81.16 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
81.17 	cannabis cultivator, medical cannabis combination business macrobusiness, or industrial 
81.18 	hemp grower where the cannabis flower or hemp plant part was cultivated;
81.19 	(2) the net weight of cannabis flower or hemp plant parts in the package or container;
81.20 	(3) the batch number;
81.21 	(4) the cannabinoid profile;
81.22 	(5) a universal symbol established by the office indicating that the package or container 
81.23 	contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
81.24 	hemp-derived consumer product;
81.25 	(6) verification that the cannabis flower or hemp plant part was tested according to 
81.26 	section 342.61 and that the cannabis flower or hemp plant part complies with the applicable 
81.27 	standards;
81.28 	(7) information on the usage of the cannabis flower or hemp-derived consumer product;
81.29 	(8) the following statement: "Keep this product out of reach of children."; and
81.30 	(9) any other statements or information required by the office.

82.1 	Sec. 32. Minnesota Statutes 2025 Supplement, section 342.63, subdivision 3, is amended 
82.2 	to read:
82.3 		Subd. 3.Content of label; cannabinoid products. (a) All cannabis products, 
82.4 	lower-potency hemp edibles, hemp concentrate, hemp-derived consumer products other 
82.5 	than products subject to the requirements under subdivision 2, medical cannabinoid products, 
82.6 	and hemp-derived topical products sold to customers or patients must have affixed to the 
82.7 	packaging or container of the cannabis product a label that contains at least the following 
82.8 	information:
82.9 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
82.10 	cannabis cultivator, medical cannabis combination business macrobusiness, or industrial 
82.11 	hemp grower that cultivated the cannabis flower or hemp plant parts used in the cannabis 
82.12 	product, lower-potency hemp edible, hemp-derived consumer product, or medical 
82.13 	cannabinoid product;
82.14 	(2) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
82.15 	cannabis manufacturer, lower-potency hemp edible manufacturer, medical cannabis 
82.16 	combination business macrobusiness, or industrial hemp grower that manufactured the 
82.17 	cannabis concentrate, hemp concentrate, or artificially derived cannabinoid and, if different, 
82.18 	the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
82.19 	cannabis manufacturer, lower-potency hemp edible manufacturer, or medical cannabis 
82.20 	combination business macrobusiness that manufactured the product;
82.21 	(3) the net weight of the cannabis product, lower-potency hemp edible, or hemp-derived 
82.22 	consumer product in the package or container;
82.23 	(4) the type of cannabis product, lower-potency hemp edible, or hemp-derived consumer 
82.24 	product;
82.25 	(5) the batch number;
82.26 	(6) the serving size;
82.27 	(7) the cannabinoid profile per serving and in total;
82.28 	(8) a list of ingredients;
82.29 	(9) a universal symbol established by the office indicating that the package or container 
82.30 	contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
82.31 	hemp-derived consumer product;
83.1 	(10) a warning symbol developed by the office in consultation with the commissioner 
83.2 	of health and the Minnesota Poison Control System that:
83.3 	(i) is at least three-quarters of an inch tall and six-tenths of an inch wide;
83.4 	(ii) is in a highly visible color;
83.5 	(iii) includes a visual element that is commonly understood to mean a person should 
83.6 	stop;
83.7 	(iv) indicates that the product is not for children; and
83.8 	(v) includes the phone number of the Minnesota Poison Control System;
83.9 	(11) verification that the cannabis product, lower-potency hemp edible, hemp-derived 
83.10 	consumer product, or medical cannabinoid product was tested according to section 342.61 
83.11 	and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product, 
83.12 	or medical cannabinoid product complies with the applicable standards;
83.13 	(12) information on the usage of the product;
83.14 	(13) the following statement: "Keep this product out of reach of children."; and
83.15 	(14) any other statements or information required by the office.
83.16 	(b) The office may by rule establish alternative labeling requirements for lower-potency 
83.17 	hemp edibles that are imported into the state if those requirements provide consumers with 
83.18 	information that is substantially similar to the information described in paragraph (a).
83.19 	(c) A ratio hemp-infused cannabis product as defined in section 342.01, subdivision 63a, 
83.20 	must include on the label the following statement: "This product contains nonintoxicating 
83.21 	cannabinoids derived from hemp."

83.22 	Sec. 33. Minnesota Statutes 2024, section 342.63, subdivision 4, is amended to read:
83.23 		Subd. 4.Additional content of label; medical cannabis flower and medical 
83.24 	cannabinoid products. In addition to the applicable requirements for labeling under 
83.25 	subdivision 2 or 3, all medical cannabis flower and medical cannabinoid products must 
83.26 	include at least the following information on the label affixed to the packaging or container 
83.27 	of the medical cannabis flower or medical cannabinoid product:
83.28 	(1) the patient's name and date of birth;
83.29 	(2) if applicable, the name and date of birth of the patient's registered designated caregiver 
83.30 	or, if listed on the registry verification, the name of the patient's parent, legal guardian, or 
83.31 	spouse, if applicable; and
84.1 	(3) the patient's registry identification number.

84.2 	Sec. 34. Minnesota Statutes 2025 Supplement, section 342.63, subdivision 6, is amended 
84.3 	to read:
84.4 		Subd. 6.Additional information. (a) A cannabis microbusiness, cannabis mezzobusiness, 
84.5 	cannabis retailer, or medical cannabis combination business macrobusiness must provide 
84.6 	customers and patients with the following information:
84.7 	(1) factual information about impairment effects and the expected timing of impairment 
84.8 	effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products, 
84.9 	lower-potency hemp edibles, and hemp-derived consumer products;
84.10 	(2) a statement that customers and patients must not operate a motor vehicle or heavy 
84.11 	machinery while under the influence of cannabis flower, cannabis products, lower-potency 
84.12 	hemp edibles, and hemp-derived consumer products;
84.13 	(3) resources customers and patients may consult to answer questions about cannabis 
84.14 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
84.15 	products, and any side effects and adverse effects;
84.16 	(4) contact information for the poison control center and a safety hotline or website for 
84.17 	customers to report and obtain advice about side effects and adverse effects of cannabis 
84.18 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
84.19 	products;
84.20 	(5) substance use disorder treatment options; and
84.21 	(6) any other information specified by the office.
84.22 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or medical
84.23 	cannabis combination business macrobusiness may include the information described in 
84.24 	paragraph (a) by:
84.25 	(1) including the information on the label affixed to the packaging or container of cannabis 
84.26 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
84.27 	products;
84.28 	(2) posting the information in the premises of the cannabis microbusiness, cannabis 
84.29 	mezzobusiness, cannabis retailer, or medical cannabis combination business macrobusiness; 
84.30 	or
85.1 	(3) providing the information on a separate document or pamphlet provided to customers 
85.2 	or patients when the customer purchases cannabis flower, a cannabis product, a lower-potency 
85.3 	hemp edible, or a hemp-derived consumer product.

85.4 	Sec. 35. Minnesota Statutes 2024, section 342.80, is amended to read:
85.5 	342.80 LAWFUL ACTIVITIES.
85.6 	(a) Notwithstanding any law to the contrary, the cultivation, manufacturing, possessing, 
85.7 	and selling of cannabis flower, cannabis products, artificially derived cannabinoids, 
85.8 	lower-potency hemp edibles, and hemp-derived consumer products by a licensed cannabis 
85.9 	business or hemp business in conformity with the rights granted by a cannabis business 
85.10 	license or hemp business license is lawful and may not be the grounds for the seizure or 
85.11 	forfeiture of property, arrest or prosecution, or search or inspections except as provided by 
85.12 	this chapter.
85.13 	(b) A person acting as an agent of a cannabis microbusiness, cannabis mezzobusiness, 
85.14 	cannabis retailer, medical cannabis combination business macrobusiness, or lower-potency 
85.15 	hemp edible retailer who sells or otherwise transfers cannabis flower, cannabis products, 
85.16 	lower-potency hemp edibles, or hemp-derived consumer products to a person under 21 years 
85.17 	of age is not subject to arrest, prosecution, or forfeiture of property if the person complied 
85.18 	with section 342.27, subdivision 4, and any rules promulgated pursuant to this chapter.

85.19 	Sec. 36. REVISOR INSTRUCTION.
 85.20 	The revisor of statutes must renumber Minnesota Statutes, section 342.515, as Minnesota 
85.21 	Statutes, section 342.295, and make any necessary cross-reference changes consistent with 
85.22 	this renumbering.

85.23 	EFFECTIVE DATE. This section is effective January 1, 2027.

85.24 	Sec. 37. REPEALER.
 85.25 	Minnesota Statutes 2024, section 342.51, subdivision 1, is repealed.

86.1 	ARTICLE 4
86.2 	CANNABIS EVENT ORGANIZER LICENSE MODIFICATIONS

86.3 	Section 1. Minnesota Statutes 2025 Supplement, section 342.11, is amended to read:
86.4 	342.11 LICENSES; FEES.
86.5 	(a) The office shall require the payment of application fees, initial licensing fees, and 
86.6 	renewal licensing fees as provided in this section. The initial license fee shall include the 
86.7 	fee for initial issuance of the license and the first annual renewal. The renewal fee shall be 
86.8 	charged at the time of the second renewal and each subsequent annual renewal thereafter. 
86.9 	Nothing in this section prohibits a local unit of government from charging the retailer 
86.10 	registration fee established in section 342.22. Application fees, initial licensing fees, and 
86.11 	renewal licensing fees are nonrefundable.
86.12 	(b) Application and licensing fees shall be as follows:
86.13 	(1) for a cannabis microbusiness:
86.14 	(i) an application fee of $500;
86.15 	(ii) an initial license fee of $0; and
86.16 	(iii) a renewal license fee of $2,000;
86.17 	(2) for a cannabis mezzobusiness:
86.18 	(i) an application fee of $5,000;
86.19 	(ii) an initial license fee of $5,000; and
86.20 	(iii) a renewal license fee of $10,000;
86.21 	(3) for a cannabis cultivator:
86.22 	(i) an application fee of $10,000;
86.23 	(ii) an initial license fee of $20,000; and
86.24 	(iii) a renewal license fee of $30,000;
86.25 	(4) for a cannabis manufacturer:
86.26 	(i) an application fee of $10,000;
86.27 	(ii) an initial license fee of $10,000; and
86.28 	(iii) a renewal license fee of $20,000;
86.29 	(5) for a cannabis retailer:
87.1 	(i) an application fee of $2,500;
87.2 	(ii) an initial license fee of $2,500; and
87.3 	(iii) a renewal license fee of $5,000;
87.4 	(6) for a cannabis wholesaler:
87.5 	(i) an application fee of $5,000;
87.6 	(ii) an initial license fee of $5,000; and
87.7 	(iii) a renewal license fee of $10,000;
87.8 	(7) for a cannabis transporter:
87.9 	(i) an application fee of $250;
87.10 	(ii) an initial license fee of $500; and
87.11 	(iii) a renewal license fee of $1,000;
87.12 	(8) for a cannabis testing facility:
87.13 	(i) an application fee of $5,000;
87.14 	(ii) an initial license fee of $5,000; and
87.15 	(iii) a renewal license fee of $10,000;
87.16 	(9) for a cannabis delivery service:
87.17 	(i) an application fee of $250;
87.18 	(ii) an initial license fee of $500; and
87.19 	(iii) a renewal license fee of $1,000;
87.20 	(10) for a cannabis event organizer:
87.21 	(i) an application fee of $750; and
87.22 	(ii) an initial license fee of $750 $0;
87.23 	(iii) a renewal license fee of $750; and
87.24 	(iv) a temporary cannabis event application fee of $750;
87.25 	(11) for a lower-potency hemp edible manufacturer:
87.26 	(i) an application fee of $250;
87.27 	(ii) an initial license fee of $1,000; and
88.1 	(iii) a renewal license fee of $1,000;
88.2 	(12) for a lower-potency hemp edible wholesaler:
88.3 	(i) an application fee of $250;
88.4 	(ii) an initial license fee of $10,000; and
88.5 	(iii) a renewal license fee of $10,000;
88.6 	(13) for a lower-potency hemp edible retailer:
88.7 	(i) an application fee of $250 or, if the lower-potency hemp retailer operates more than 
88.8 	one retail location, $250 per retail location;
88.9 	(ii) an initial license fee of $250 or, if the lower-potency hemp retailer operates more 
88.10 	than one retail location, $250 per retail location; and
88.11 	(iii) a renewal license fee of $250 or, if the lower-potency hemp retailer operates more 
88.12 	than one retail location, $250 per retail location; and
88.13 	(14) for a medical cannabis combination business:
88.14 	(i) an application fee of $10,000;
88.15 	(ii) an initial license fee of $20,000; and
88.16 	(iii) a renewal license fee of $70,000.

88.17 	Sec. 2. Minnesota Statutes 2024, section 342.39, as amended by Laws 2025, chapter 31, 
88.18 	section 66, is amended to read:
88.19 	342.39 CANNABIS EVENT ORGANIZER LICENSING.
88.20 		Subdivision 1.Authorized actions. (a) A cannabis event organizer license entitles the 
88.21 	license holder to organize a temporary cannabis events, with each event lasting no more 
88.22 	than four days, and perform other actions approved by the office.
88.23 	(b) For each temporary cannabis event, the license holder is required to submit additional 
88.24 	information pursuant to section 342.40.
88.25 		Subd. 2.Additional information required. (a) In addition to the information required 
88.26 	to be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that 
88.27 	section, a person, cooperative, or business seeking a cannabis event organizer license must 
88.28 	submit the following information in a form approved by the office:
88.29 	(1) the type and number of any other cannabis business license held by the applicant;
89.1 	(2) the address and location where the temporary cannabis event will take place;
89.2 	(3) the name of the temporary cannabis event;
89.3 	(4) a diagram of the physical layout of the temporary cannabis event showing where the 
89.4 	event will take place on the grounds, all entrances and exits that will be used by participants 
89.5 	during the event, all cannabis consumption areas, all cannabis retail areas where cannabis 
89.6 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products 
89.7 	will be sold, the location where cannabis waste will be stored, and any location where 
89.8 	cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
89.9 	products will be stored;
89.10 	(5) a list of the name, number, and type of cannabis businesses and hemp businesses 
89.11 	that will sell cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
89.12 	lower-potency hemp edibles, and hemp-derived consumer products at the event, which may 
89.13 	be supplemented or amended within 72 hours of the time at which the cannabis event begins;
89.14 	(6) the dates and hours during which the cannabis event will take place;
89.15 	(7) proof of local approval for the cannabis event; and
89.16 	(8) evidence that the business will comply with the applicable operation requirements 
89.17 	for the license being sought.
89.18 	(b) A person, cooperative, or business seeking a cannabis event organizer license may 
89.19 	also disclose whether the person or any officer, director, manager, and general partner of a 
89.20 	cannabis business is serving or has previously served in the military.
89.21 	(2) a description of the applicant's process for planning and organizing cannabis events, 
89.22 	including:
89.23 	(i) the applicant's method of selecting a venue;
89.24 	(ii) the applicant's method of coordinating with and overseeing vendors that participate 
89.25 	in cannabis events; and
89.26 	(iii) criteria that the applicant will use for selecting cannabis and hemp businesses to 
89.27 	participate in cannabis events;
89.28 	(3) a description of security measures and protocols that the applicant will use, including:
89.29 	(i) the process that the applicant will use for hiring and contracting with licensed security 
89.30 	personnel;
90.1 	(ii) the method that the applicant will use to ensure that security personnel do not consume 
90.2 	cannabis or hemp products before or during cannabis events;
90.3 	(iii) the method that the applicant will use for managing and controlling crowds at 
90.4 	cannabis events;
90.5 	(iv) the method that the applicant will use to ensure that access to an event is limited to 
90.6 	individuals who are at least 21 years of age; and
90.7 	(v) the method that the applicant will use for managing access to consumption and retail 
90.8 	areas;
90.9 	(4) a description of how the applicant will comply with state and local laws and rules at 
90.10 	each cannabis event, including:
90.11 	(i) the applicant's method of verifying that each participating business has a valid license 
90.12 	issued by the office;
90.13 	(ii) the applicant's method for ensuring that cannabis products are only sold by licensed 
90.14 	retailers in designated retail areas; and
90.15 	(iii) the applicant's methods for handling any violations of this chapter or Minnesota 
90.16 	Rules at cannabis events;
90.17 	(5) the applicant's procedures for protecting the health and safety of event participants, 
90.18 	including:
90.19 	(i) emergency response plans, fire safety protocols, and the availability of medical 
90.20 	assistance devices in the case of a medical emergency; and
90.21 	(ii) guidelines for managing consumption areas to prevent over-intoxication and other 
90.22 	health risks;
90.23 	(6) the applicant's procedures for working with licensed cannabis transporters to handle 
90.24 	the transportation of cannabis plants, products, and related items to and from events;
90.25 	(7) the applicant's management and disposal of cannabis waste in compliance with state 
90.26 	laws and rules, including methods for securely collecting, storing, and transporting cannabis 
90.27 	waste from each event site; and
90.28 	(8) the applicant's methods for reporting and documenting cannabis events to regulators 
90.29 	for inspections and post-event evaluations.
91.1 	(b) Any commitment or statement that the applicant makes in an application to the office 
91.2 	is an ongoing material condition of maintaining and renewing the applicant's cannabis event 
91.3 	organizer license.
91.4 	(c) An application for a cannabis event organizer license is not required to include the 
91.5 	information required under section 342.14, subdivision 1, paragraph (a), clauses (5), (6), 
91.6 	(9), and (10).
91.7 		Subd. 2a.Attestation required. When renewing a cannabis event organizer license, a 
91.8 	cannabis event organizer license holder with ten or more full-time equivalent employees 
91.9 	must submit to the office an attestation signed by a bona fide labor organization stating that 
91.10 	the applicant has entered into a labor peace agreement.
91.11 		Subd. 3.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
91.12 	cannabis event organizer license may not hold a cannabis testing facility license, a 
91.13 	lower-potency hemp edible manufacturer license, a lower-potency hemp edible wholesaler 
91.14 	license, or a lower-potency hemp edible retailer license.
91.15 	(b) The office by rule may limit the number of cannabis event licenses that a person or 
91.16 	business may hold.
91.17 	(c) For purposes of this subdivision, restrictions on the number or type of license that a 
91.18 	business may hold apply to every cooperative member or every director, manager, and 
91.19 	general partner of a cannabis business.

91.20 	Sec. 3. Minnesota Statutes 2024, section 342.40, subdivision 1, is amended to read:
91.21 		Subdivision 1.Local Temporary event approval. (a) To host a temporary cannabis 
91.22 	event under this section, a cannabis event organizer must receive submit a site registration 
91.23 	with the following information to the office in a form approved by the office:
91.24 	(1) proof that the event has received local approval, including obtaining proof that the 
91.25 	cannabis event organizer has obtained any necessary permits or licenses issued by a local 
91.26 	unit of government, before holding a cannabis event.;
91.27 	(2) the address and location where the temporary cannabis event will take place;
91.28 	(3) the name of the temporary cannabis event;
91.29 	(4) a diagram of the physical layout of the temporary cannabis event showing where the 
91.30 	event will take place on the grounds; all entrances and exits that will be used by participants 
91.31 	during the event; all cannabis consumption areas; all cannabis retail areas where cannabis 
91.32 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products 
92.1 	will be sold; the location where cannabis waste will be stored; and any location where 
92.2 	cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
92.3 	products will be stored;
92.4 	(5) a list that includes: (i) the name of each cannabis business and hemp business that 
92.5 	will sell cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
92.6 	lower-potency hemp edibles, and hemp-derived consumer products at the temporary cannabis 
92.7 	event; (ii) the type of each business participating in the temporary cannabis event; and (iii) 
92.8 	the number of businesses participating in the temporary cannabis event. The list may be 
92.9 	amended up to 72 hours before the temporary cannabis event begins;
92.10 	(6) the dates and hours during which the temporary cannabis event will take place; and
92.11 	(7) evidence that the cannabis event organizer will comply with all applicable operation 
92.12 	requirements.
92.13 	(b) Upon review of the temporary cannabis event application materials submitted by the 
92.14 	license holder, the office may deny a temporary cannabis event if:
92.15 	(1) the application is incomplete;
92.16 	(2) the temporary cannabis event does not have local approval;
92.17 	(3) the application contains a materially false statement about the applicant or omits 
92.18 	information required under subdivision 1;
92.19 	(4) the license holder fails to pay the applicable application fee in section 342.11, 
92.20 	paragraph (b), clause (10), item (iv); and
92.21 	(5) the license holder fails to pass any applicable site inspection for the temporary 
92.22 	cannabis event.
92.23 	(c) The office may request additional information from any applicant if the office 
92.24 	determines that the information is necessary to review or process the application. If the 
92.25 	applicant does not provide the additional requested information within seven calendar days 
92.26 	of the office's request for information, the office may deny the application.

92.27 	Sec. 4. Minnesota Statutes 2025 Supplement, section 342.40, subdivision 7, is amended 
92.28 	to read:
92.29 		Subd. 7.Cannabis event sales. (a) Cannabis microbusinesses with a retail endorsement, 
92.30 	cannabis mezzobusinesses with a retail endorsement, cannabis retailers, medical cannabis 
92.31 	combination businesses operating a retail location, and lower-potency hemp edible retailers, 
92.32 	including the cannabis event organizer, may be authorized to sell cannabis plants, adult-use 
93.1 	cannabis flower, adult-use cannabis products, lower-potency hemp edibles, and hemp-derived 
93.2 	consumer products to customers at a cannabis event.
93.3 	(b) All sales of cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
93.4 	lower-potency hemp edibles, and hemp-derived consumer products at a cannabis event must 
93.5 	take place in a retail area as designated in the premises diagram.
93.6 	(c) Authorized retailers may only conduct sales within their specifically assigned area.
93.7 	(d) Authorized retailers must verify the age of all customers pursuant to section 342.27, 
93.8 	subdivision 4, before completing a sale and may not sell cannabis plants, adult-use cannabis 
93.9 	flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer 
93.10 	products to an individual under 21 years of age.
93.11 	(e) Authorized retailers may display one sample of each type of cannabis plant, adult-use 
93.12 	cannabis flower, adult-use cannabis product, lower-potency hemp edible, and hemp-derived 
93.13 	consumer product available for sale. Display samples of adult-use cannabis and adult-use 
93.14 	cannabis products must be stored in a sample jar or display case and be accompanied by a 
93.15 	label or notice containing the information required to be affixed to the packaging or container 
93.16 	containing adult-use cannabis flower and adult-use cannabis products sold to customers. A 
93.17 	display sample may not consist of more than eight grams of adult-use cannabis flower or 
93.18 	adult-use cannabis concentrate, or an edible cannabis product infused with more than 100 
93.19 	milligrams of tetrahydrocannabinol. A cannabis retailer may allow customers to smell the 
93.20 	adult-use cannabis flower or adult-use cannabis product before purchase.
93.21 	(f) The notice requirements under section 342.27, subdivision 6, apply to authorized 
93.22 	retailers offering cannabis plants, adult-use cannabis flower, adult-use cannabinoid products, 
93.23 	and hemp-derived consumer products for sale at a cannabis event.
93.24 	(g) Authorized retailers may not:
93.25 	(1) sell adult-use cannabis flower, adult-use cannabis products, lower-potency hemp 
93.26 	edibles, or hemp-derived consumer products to a person who is visibly intoxicated;
93.27 	(2) knowingly sell more cannabis plants, adult-use cannabis flower, adult-use cannabis 
93.28 	products, lower-potency hemp edibles, or hemp-derived consumer products than a customer 
93.29 	is legally permitted to possess;
93.30 	(3) sell medical cannabis flower or medical cannabinoid products; or
93.31 	(4) allow for the dispensing of cannabis plants, cannabis flower, cannabis products, 
93.32 	lower-potency hemp edibles, or hemp-derived consumer products in vending machines.
94.1 	(h) Except for display samples of a cannabis plant, adult-use cannabis flower, adult-use 
94.2 	cannabis product, lower-potency hemp edible, and hemp-derived consumer product, all 
94.3 	cannabis plants, adult-use cannabis flower, adult-use cannabis products, lower-potency 
94.4 	hemp edibles, and hemp-derived consumer products for sale at a cannabis event must be 
94.5 	stored in a secure, locked container that is not accessible to the public. Such items being 
94.6 	stored at a cannabis event shall not be left unattended.
94.7 	(i) All cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
94.8 	lower-potency hemp edibles, and hemp-derived consumer products for sale at a cannabis 
94.9 	event must comply with this chapter and rules adopted pursuant to this chapter regarding 
94.10 	the testing, packaging, and labeling of those items.
94.11 	(j) Authorized retailers must record in the statewide monitoring system all cannabis 
94.12 	plants, adult-use cannabis flower, and adult-use cannabis products sold, distributed, damaged, 
94.13 	or destroyed at a the cannabis event must be recorded in the statewide monitoring system.

94.14 	Sec. 5. Minnesota Statutes 2025 Supplement, section 342.46, subdivision 8, is amended 
94.15 	to read:
94.16 		Subd. 8.On-site consumption. (a) A lower-potency hemp edible retailer may permit 
94.17 	on-site consumption of lower-potency hemp edibles on a portion of its premises if it has an 
94.18 	on-site consumption endorsement.
94.19 	(b) The office shall issue an on-site consumption endorsement to any lower-potency 
94.20 	hemp edible retailer that also holds an on-sale license issued under chapter 340A.
94.21 	(c) A lower-potency hemp edible retailer must ensure that lower-potency hemp edibles 
94.22 	sold for on-site consumption comply with this chapter and rules adopted pursuant to this 
94.23 	chapter regarding testing.
94.24 	(d) Lower-potency hemp edibles sold for on-site consumption, other than lower-potency 
94.25 	hemp edibles that are intended to be consumed as a beverage, must be served in the required 
94.26 	packaging, but may be removed from the products' packaging by customers and consumed 
94.27 	on site.
94.28 	(e) Lower-potency hemp edibles that are intended to be consumed as a beverage may 
94.29 	be served outside of the edibles' packaging if the information that is required to be contained 
94.30 	on the label of a lower-potency hemp edible is posted or otherwise displayed by the 
94.31 	lower-potency hemp edible retailer. Hemp workers who serve beverages under this paragraph 
94.32 	are not required to obtain an edible cannabinoid product handler endorsement under section 
94.33 	342.07, subdivision 3.
95.1 	(f) Food and beverages not otherwise prohibited by this subdivision may be prepared 
95.2 	and sold on site if the lower-potency hemp edible retailer complies with all relevant state 
95.3 	and local laws, ordinances, licensing requirements, and zoning requirements.
95.4 	(g) A lower-potency hemp edible retailer may offer recorded or live entertainment if the 
95.5 	lower-potency hemp edible retailer complies with all relevant state and local laws, ordinances, 
95.6 	licensing requirements, and zoning requirements.
95.7 	(h) In addition to the prohibitions under subdivision 7, a lower-potency hemp edible 
95.8 	retailer with an on-site consumption endorsement may not:
95.9 	(1) sell, give, furnish, or in any way procure for another lower-potency hemp edibles 
95.10 	for the use of an obviously intoxicated person;
95.11 	(2) sell lower-potency hemp edibles that are designed or reasonably expected to be mixed 
95.12 	with an alcoholic beverage; or
95.13 	(3) permit lower-potency hemp edibles that have been removed from the products' 
95.14 	packaging to be removed from the premises of the lower-potency hemp edible retailer.
95.15 	(i) A lower-potency hemp edible retailer is permitted to sell and may permit the 
95.16 	consumption of lower-potency hemp edibles that are intended to be consumed as a beverage
95.17 	at an event hosted off site if:
95.18 	(1) the event has been authorized by the local unit of government exercising jurisdiction 
95.19 	over the location;
95.20 	(2) the event organizer holds an on-sale license issued under chapter 340A; and
95.21 	(3) the event does not exceed four days.

	ARTICLE 1	OFFICE OF CANNABIS MANAGEMENT POLICY AND TECHNICAL PROVISIONS........	Page.Ln 2.2	
	ARTICLE 2	CANNABIS LICENSING AND ENDORSEMENTS........	Page.Ln 20.21	
	ARTICLE 3	ADULT-USE AND MEDICAL CANNABIS STREAMLINING........	Page.Ln 52.10	
	ARTICLE 4	CANNABIS EVENT ORGANIZER LICENSE MODIFICATIONS........	Page.Ln 86.1	

APPENDIX 

Repealed Minnesota Statutes: S4401-2 

151.72 SALE OF CERTAIN CANNABINOID PRODUCTS.Subdivision 1.Definitions. 
For the purposes of this section, the following terms have the meanings given. 

(a) "Artificially derived cannabinoid" means a cannabinoid extracted from a hemp plant or hemp plant parts with a chemical makeup that is changed after extraction to create a different cannabinoid or other chemical compound by applying a catalyst other than heat or light. Artificially derived cannabinoid includes but is not limited to any tetrahydrocannabinol created from cannabidiol. 

(b) "Batch" means a specific quantity of a specific product containing cannabinoids derived from hemp, including an edible cannabinoid product, that is manufactured at the same time and using the same methods, equipment, and ingredients that is uniform and intended to meet specifications for identity, strength, purity, and composition, and that is manufactured, packaged, and labeled according to a single batch production record executed and documented. 

(c) "Certified hemp" means hemp plants that have been tested and found to meet the requirements of chapter 18K and the rules adopted thereunder. 

(d) "Distributor" means a person who sells, arranges a sale, or delivers a product containing cannabinoids derived from hemp, including an edible cannabinoid product, that the person did not manufacture to a retail establishment for sale to consumers. Distributor does not include a common carrier used only to complete delivery to a retailer. 

(e) "Edible cannabinoid product" means any product that is intended to be eaten or consumed as a beverage by humans, contains a cannabinoid in combination with food ingredients, and is not a drug. 

(f) "Hemp" has the meaning given to "industrial hemp" in section 18K.02, subdivision 3. 

(g) "Label" has the meaning given in section 151.01, subdivision 18. 

(h) "Labeling" means all labels and other written, printed, or graphic matter that are: 

(1) affixed to the immediate container in which a product regulated under this section is sold; 

(2) provided, in any manner, with the immediate container, including but not limited to outer containers, wrappers, package inserts, brochures, or pamphlets; or 

(3) provided on that portion of a manufacturer's website that is linked by a scannable barcode or matrix barcode. 

(i) "Matrix barcode" means a code that stores data in a two-dimensional array of geometrically shaped dark and light cells capable of being read by the camera on a smartphone or other mobile device. 

(j) "Nonintoxicating cannabinoid" means substances extracted from certified hemp plants that do not produce intoxicating effects when consumed by any route of administration. 

(k) "Office" means the director of the Office of Cannabis Management. 

(l) "Synthetic cannabinoid" means a substance with a similar chemical structure and pharmacological activity to a cannabinoid, but which is not extracted or derived from hemp plants, or hemp plant parts and is instead created or produced by chemical or biochemical synthesis. 

Subd. 2.Scope. 
(a) This section applies to the sale of any product that contains cannabinoids extracted from hemp and that is an edible cannabinoid product or is intended for human or animal consumption by any route of administration. 

(b) This section does not apply to any product dispensed by a registered medical cannabis manufacturer pursuant to sections 152.22 to 152.37. 

(c) The office must have no authority over food products, as defined in section 34A.01, subdivision 4, that do not contain cannabinoids extracted or derived from hemp. 

Subd. 3.Sale of cannabinoids derived from hemp. 
(a) Notwithstanding any other section of this chapter, a product containing nonintoxicating cannabinoids, including an edible cannabinoid product, may be sold for human or animal consumption only if all of the requirements of this section are met. A product sold for human or animal consumption must not contain more than 0.3 percent of any tetrahydrocannabinol and an edible cannabinoid product must not contain an amount of any tetrahydrocannabinol that exceeds the limits established in subdivision 5a, paragraph (f). 

(b) A product containing nonintoxicating cannabinoids, other than an edible cannabinoid product, may be sold for human or animal consumption only if it is intended for application externally to a part of the body of a human or animal. Such a product must not be manufactured, marketed, distributed, or intended to be consumed: 

(1) by combustion or vaporization of the product and inhalation of smoke, aerosol, or vapor from the product; 

(2) through chewing, drinking, or swallowing; or 

(3) through injection or application to nonintact skin or a mucous membrane, except for products applied sublingually. 

(c) No other substance extracted or otherwise derived from hemp may be sold for human consumption if the substance is intended: 

(1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention of disease in humans or other animals; or 

(2) to affect the structure or any function of the bodies of humans or other animals. 

(d) No product containing any cannabinoid or tetrahydrocannabinol extracted or otherwise derived from hemp may be sold to any individual who is under the age of 21. 

(e) Products that meet the requirements of this section are not controlled substances under section 152.02. 

(f) Products may be sold for on-site consumption if all of the following conditions are met: 

(1) the retailer must also hold an on-sale license issued under chapter 340A; 

(2) products, other than products that are intended to be consumed as a beverage, must be served in original packaging, but may be removed from the products' packaging by customers and consumed on site; 

(3) products must not be sold to a customer who the retailer knows or reasonably should know is intoxicated; 

(4) products must not be permitted to be mixed with an alcoholic beverage; and 

(5) products that have been removed from packaging must not be removed from the premises. 

(g) Edible cannabinoid products that are intended to be consumed as a beverage may be served outside of the products' packaging if the information that is required to be contained on the label of an edible cannabinoid product is posted or otherwise displayed by the retailer. 

Subd. 4.Testing requirements. 
(a) A manufacturer of a product regulated under this section must submit representative samples of each batch of the product to an independent, accredited laboratory in order to certify that the product complies with the standards adopted by the office. Testing must be consistent with generally accepted industry standards for herbal and botanical substances, and, at a minimum, the testing must confirm that the product: 

(1) contains the amount or percentage of cannabinoids that is stated on the label of the product; 

(2) does not contain more than trace amounts of any mold, residual solvents or other catalysts, pesticides, fertilizers, or heavy metals; and 

(3) does not contain more than 0.3 percent of any tetrahydrocannabinol. 

(b) A manufacturer of a product regulated under this section must disclose all known information regarding pesticides, fertilizers, solvents, or other foreign materials applied to industrial hemp or added to industrial hemp during any production or processing stages of any batch from which a representative sample has been sent for testing, including any catalysts used to create artificially derived cannabinoids. The disclosure must be made to the laboratory performing testing or sampling and, upon request, to the office. The disclosure must include all information known to the manufacturer regardless of whether the application or addition was made intentionally or accidentally, or by the manufacturer or any other person. 

(c) Upon the request of the office, the manufacturer of the product must provide the office with the results of the testing required in this section. 

(d) The office may determine that any testing laboratory that does not operate formal management systems under the International Organization for Standardization is not an accredited laboratory and require that a representative sample of a batch of the product be retested by a testing laboratory that meets this requirement. 

(e) Testing of the hemp from which the nonintoxicating cannabinoid was derived, or possession of a certificate of analysis for such hemp, does not meet the testing requirements of this section. 

Subd. 5.Labeling requirements. 
(a) A product regulated under this section must bear a label that contains, at a minimum: 

(1) the name, location, contact phone number, and website of the manufacturer of the product; 

(2) the name and address of the independent, accredited laboratory used by the manufacturer to test the product; 

(3) the batch number; and 

(4) an accurate statement of the amount or percentage of cannabinoids found in each unit of the product meant to be consumed. 

(b) The information in paragraph (a) may be provided on an outer package if the immediate container that holds the product is too small to contain all of the information. 

(c) The information required in paragraph (a) may be provided through the use of a scannable barcode or matrix barcode that links to a page on the manufacturer's website if that page contains all of the information required by this subdivision. 

(d) The label must also include a statement stating that the product does not claim to diagnose, treat, cure, or prevent any disease and has not been evaluated or approved by the United States Food and Drug Administration (FDA) unless the product has been so approved. 

(e) The information required by this subdivision must be prominently and conspicuously placed on the label or displayed on the website in terms that can be easily read and understood by the consumer. 

(f) The labeling must not contain any claim that the product may be used or is effective for the prevention, treatment, or cure of a disease or that it may be used to alter the structure or function of human or animal bodies, unless the claim has been approved by the FDA. 

Subd. 5a.Additional requirements for edible cannabinoid products. 
(a) In addition to the testing and labeling requirements under subdivisions 4 and 5, an edible cannabinoid must meet the requirements of this subdivision. 

(b) An edible cannabinoid product must not: 

(1) bear the likeness or contain cartoon-like characteristics of a real or fictional person, animal, or fruit that appeals to children; 

(2) be modeled after a brand of products primarily consumed by or marketed to children; 

(3) be made by applying an extracted or concentrated hemp-derived cannabinoid to a commercially available candy or snack food item; 

(4) be substantively similar to a meat food product; poultry food product as defined in section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision 7; 

(5) contain an ingredient, other than a hemp-derived cannabinoid, that is not approved by the United States Food and Drug Administration for use in food; 

(6) be packaged in a way that resembles the trademarked, characteristic, or product-specialized packaging of any commercially available food product; or 

(7) be packaged in a container that includes a statement, artwork, or design that could reasonably mislead any person to believe that the package contains anything other than an edible cannabinoid product. 

(c) An edible cannabinoid product must be prepackaged in packaging or a container that is child-resistant, tamper-evident, and opaque or placed in packaging or a container that is child-resistant, tamper-evident, and opaque at the final point of sale to a customer. The requirement that packaging be child-resistant does not apply to an edible cannabinoid product that is intended to be consumed as a beverage. 

(d) If an edible cannabinoid product, other than a product that is intended to be consumed as a beverage, is intended for more than a single use or contains multiple servings, each serving must be indicated by scoring, wrapping, or other indicators designating the individual serving size that appear on the edible cannabinoid product. If it is not possible to indicate a single serving by scoring or use of another indicator that appears on the product, the edible cannabinoid product may not be packaged in a manner that includes more than a single serving in each container, except that a calibrated dropper, measuring spoon, or similar device for measuring a single serving, when sold with the product, may be used for any edible cannabinoid products that are intended to be combined with food or beverage products prior to consumption. 

(e) A label containing at least the following information must be affixed to the packaging or container of all edible cannabinoid products sold to consumers: 

(1) the serving size; 

(2) the cannabinoid profile per serving and in total; 

(3) a list of ingredients, including identification of any major food allergens declared by name; and 

(4) the following statement: "Keep this product out of reach of children." 

(f) An edible cannabinoid product that is not intended to be consumed as a beverage must not contain more than five milligrams of any tetrahydrocannabinol in a single serving and must not contain more than a total of 50 milligrams of any tetrahydrocannabinol per package. 

(g) An edible cannabinoid product that is intended to be consumed as a beverage must not contain more than ten milligrams of any tetrahydrocannabinol in a single container. 

(h) An edible cannabinoid product may contain delta-8 tetrahydrocannabinol or delta-9 tetrahydrocannabinol that is extracted from hemp plants or hemp plant parts or is an artificially derived cannabinoid. Edible cannabinoid products are prohibited from containing any other artificially derived cannabinoid, including but not limited to THC-P, THC-O, and HHC, unless the office authorizes use of the artificially derived cannabinoid in edible cannabinoid products. Edible cannabinoid products are prohibited from containing synthetic cannabinoids. 

(i) Every person selling edible cannabinoid products to consumers, other than products that are intended to be consumed as a beverage, must ensure that all edible cannabinoid products are displayed behind a checkout counter where the public is not permitted or in a locked case. 

Subd. 5b.Registration; prohibitions. 
(a) Every person selling an edible cannabinoid product to a consumer must be registered with the office. Existing registrations through the Department of Health must be transferred to the office by July 1, 2024. All other persons required to register must register in a form and manner established by the office. The sale of edible cannabinoid products by a person who is not registered with the office is prohibited and subject to the penalties in section 342.09, subdivision 6; any applicable criminal penalty; and any other applicable civil or administrative penalty. 

(b) The registration form must contain an attestation of compliance and each registrant must affirm that it is operating and will continue to operate in compliance with the requirements of this section and all other applicable state and local laws and ordinances. 

(c) The office must not charge a fee for registration under this subdivision. 

Subd. 5c.Age verification. 
(a) Prior to initiating a sale or otherwise providing an edible cannabinoid product to an individual, an employee of a retailer must verify that the individual is at least 21 years of age. 

(b) Proof of age may be established only by one of the following: 

(1) a valid driver's license or identification card issued by Minnesota, another state, or a province of Canada and including the photograph and date of birth of the licensed person; 

(2) a valid Tribal identification card as defined in section 171.072, paragraph (b); 

(3) a valid passport issued by the United States; 

(4) a valid instructional permit issued under section 171.05 to a person of legal age to purchase edible cannabinoid products, which includes a photograph and the date of birth of the person issued the permit; or 

(5) in the case of a foreign national, by a valid passport. 

(c) A registered retailer may seize a form of identification listed under paragraph (b) if the registered retailer has reasonable grounds to believe that the form of identification has been altered or falsified or is being used to violate any law. A registered retailer that seizes a form of identification as authorized under this paragraph must deliver it to a law enforcement agency within 24 hours of seizing it. 

Subd. 6.Noncompliant products; enforcement. 
(a) A product regulated under this section, including an edible cannabinoid product, shall be considered a noncompliant product if the product is offered for sale in this state or if the product is manufactured, imported, distributed, or stored with the intent to be offered for sale in this state in violation of any provision of this section, including but not limited to if: 

(1) it consists, in whole or in part, of any filthy, putrid, or decomposed substance; 

(2) it has been produced, prepared, packed, or held under unsanitary conditions where it may have been rendered injurious to health, or where it may have been contaminated with filth; 

(3) its container is composed, in whole or in part, of any poisonous or deleterious substance that may render the contents injurious to health; 

(4) it contains any food additives, color additives, or excipients that have been found by the FDA to be unsafe for human or animal consumption; 

(5) it contains an amount or percentage of nonintoxicating cannabinoids that is different than the amount or percentage stated on the label; 

(6) it contains more than 0.3 percent of any tetrahydrocannabinol or, if the product is an edible cannabinoid product, an amount of tetrahydrocannabinol that exceeds the limits established in subdivision 5a, paragraph (f); or 

(7) it contains more than trace amounts of mold, residual solvents, pesticides, fertilizers, or heavy metals. 

(b) A product regulated under this section shall be considered a noncompliant product if the product's labeling is false or misleading in any manner or in violation of the requirements of this section. 

(c) The office may assume that any product regulated under this section that is present in the state, other than a product lawfully possessed for personal use, has been manufactured, imported, distributed, or stored with the intent to be offered for sale in this state if a product of the same type and brand was sold in the state on or after July 1, 2023, or if the product is in the possession of a person who has sold any product in violation of this section. 

(d) The office may enforce this section, including enforcement against a manufacturer or distributor of a product regulated under this section, under section 342.19. 

(e) The office may enter into an interagency agreement with the commissioner of agriculture to perform inspections and take other enforcement actions on behalf of the office. 

Subd. 7.Violations; criminal penalties. 
(a) A person who does any of the following regarding a product regulated under this section is guilty of a gross misdemeanor and may be sentenced to imprisonment for not more than 364 days or to payment of a fine of not more than $3,000, or both: 

(1) knowingly alters or otherwise falsifies testing results; 

(2) intentionally alters or falsifies any information required to be included on the label of an edible cannabinoid product; or 

(3) intentionally makes a false material statement to the office. 

(b) A person who does any of the following on the premises of a registered retailer or another business that sells retail goods to customers is guilty of a gross misdemeanor and may be sentenced to imprisonment for not more than 364 days or to payment of a fine of not more than $3,000, or both: 

(1) sells an edible cannabinoid product knowing that the product does not comply with the limits on the amount or types of cannabinoids that a product may contain; 

(2) sells an edible cannabinoid product knowing that the product does not comply with the applicable testing, packaging, or labeling requirements; or 

(3) sells an edible cannabinoid product to a person under the age of 21, except that it is an affirmative defense to a charge under this clause if the defendant proves by a preponderance of the evidence that the defendant reasonably and in good faith relied on proof of age as described in subdivision 5c. 

342.51 MEDICAL CANNABIS ENDORSEMENTS.Subdivision 1.Endorsement; authorized actions. 
(a) The office may issue a medical cannabis endorsement to a cannabis business authorizing the business to: 

(1) cultivate medical cannabis; 

(2) process medical cannabinoid products; or 

(3) sell or distribute medical cannabis flower and medical cannabinoid products to any person authorized to receive medical cannabis flower or medical cannabinoid products. 

(b) The office must issue a medical cannabis cultivation endorsement to a cannabis license holder if the license holder: 

(1) is authorized to cultivate cannabis; 

(2) submits a medical cannabis endorsement application to the office; and 

(3) otherwise meets all applicable requirements established by the office. 

(c) A medical cannabis cultivation endorsement entitles the license holder to grow cannabis plants within the approved amount of space from seed or immature plant to mature plant, harvest cannabis flower from a mature plant, package and label cannabis flower as medical cannabis flower, sell medical cannabis flower to cannabis businesses with a medical cannabis endorsement, and perform other actions approved by the office. 

(d) The office must issue a medical cannabis processor endorsement to a cannabis license holder if the license holder: 

(1) is authorized to manufacture cannabis products; 

(2) submits a medical cannabis endorsement application to the office; and 

(3) otherwise meets all applicable requirements established by the office. 

(e) A medical cannabis processor endorsement entitles the license holder to: 

(1) purchase medical cannabis flower, medical cannabinoid products, hemp plant parts, and hemp concentrate from cannabis businesses with a medical cannabis cultivator endorsement or a medical cannabis processor endorsement; 

(2) purchase hemp plant parts from industrial hemp growers; 

(3) make cannabis concentrate from medical cannabis flower; 

(4) make hemp concentrate, including hemp concentrate with a delta-9 tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight; 

(5) manufacture medical cannabinoid products; 

(6) package and label medical cannabinoid products for sale to cannabis businesses with a medical cannabis processer endorsement or a medical cannabis retailer endorsement; and 

(7) perform other actions approved by the office. 

(f) The office must issue a medical cannabis retailer endorsement to a cannabis license holder if the license holder: 

(1) submits a medical cannabis retail endorsement application to the office; 

(2) has at least one employee who earned a medical cannabis consultant certificate issued by the office and has completed the required training or has at least one employee who is a licensed pharmacist under chapter 151; and 

(3) otherwise meets all applicable requirements established by the office. 

(g) A medical cannabis retail endorsement entitles the license holder to purchase medical cannabis flower and medical cannabinoid products from cannabis businesses with medical cannabis cultivator endorsements and medical cannabis processor endorsements, and sell or distribute medical cannabis flower, medical cannabinoid products, and associated paraphernalia to any person authorized to receive medical cannabis flower or medical cannabinoid products. 

(h) A medical cannabis business with a medical cannabis retail endorsement must verify that all medical cannabis flower and medical cannabinoid products have passed safety, potency, and consistency testing at a cannabis testing facility approved by the office for the testing of medical cannabis flower and medical cannabinoid products before the cannabis business with a medical cannabis retail endorsement may distribute the medical cannabis flower or medical cannabinoid product to any person enrolled in the registry program.